TRANSAMERICA IDEX MUTUAL FUNDS
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities
Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the
Registrant o
Check the appropriate box:
þ Preliminary
Proxy Statement
o Confidential,
For Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
o Definitive Proxy
Statement
o Definitive
Additional Materials
o Soliciting
Material Pursuant to
Rule 14a-12
TRANSAMERICA IDEX MUTUAL FUNDS
AEGON/TRANSAMERICA SERIES TRUST
TRANSAMERICA INCOME SHARES, INC.
(Name of Registrant as Specified in
its Charter)
N/A
(Name of Person(s) Filing Proxy
Statement, if Other Than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
þ
|
No fee required.
|
|
o
|
Fee computed on table below per Exchange Act
Rules 14a-6(i)(1)
and 0-11.
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed
pursuant to
Rule 0-11
(set forth the amount on which the filing fee is calculated and
state how it was determined):
|
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
|
o
|
Fee paid previously with preliminary materials.
|
|
o
|
Check box if any part of the fee is offset as provided by
Exchange Act
Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
TABLE
OF CONTENTS
|
|
|
|
|
|
|
Page
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
2
|
|
|
|
|
3
|
|
|
|
|
3
|
|
|
|
|
5
|
|
|
|
|
19
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
25
|
|
|
|
|
27
|
|
|
|
|
27
|
|
|
|
|
27
|
|
|
|
|
28
|
|
|
|
|
28
|
|
|
|
|
28
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
|
|
A-1
|
|
|
|
|
B-1
|
|
|
|
|
C-1
|
|
|
|
|
D-1
|
|
|
|
|
E-1
|
|
|
|
|
F-1
|
|
Transamerica IDEX Mutual Funds
(TA IDEX)
AEGON/Transamerica
Series Trust (ATST)
Transamerica Income Shares,
Inc. (TIS)
(Each an Investment Company and collectively, the
Investment Companies)
570 Carillon Parkway
St. Petersburg, Florida
33716-1294
Notice of Special Meeting of
Shareholders
to be held on October 30,
2007
Please take notice that a special meeting of shareholders of
each of TA IDEX, ATST and TIS will be held at the offices of
Transamerica Fund Advisors, Inc. (TFAI), 570
Carillon Parkway, St. Petersburg, Florida 33716, on
October 30, 2007, at 11:00 a.m. (Eastern time), as
adjourned from time to time (each, a Special
Meeting). At the Special Meetings, shareholders of each
fund on the attached list (the Funds) will be asked
to consider the following proposals (the Proposals):
I. To elect a new Board (to be voted on by shareholders
of each Fund);
|
|
|
|
II.
|
To approve an amendment to the Agreement and Declaration of
Trust (to be voted on by shareholders of each Fund, except
TIS); and
|
III. To transact such other business as may properly come
before the Special Meetings.
After careful consideration of each Proposal, the Board of
Trustees of each of TA IDEX and ATST approved Proposals I
and II and recommends that shareholders of the TA IDEX and
ATST Funds vote FOR these Proposals.
After careful consideration of Proposal I, the Board of
Directors of TIS approved Proposal I, and recommends that
the shareholders of TIS vote FOR this Proposal.
Shareholders of record of each Fund at the close of business on
August 15, 2007 are entitled to notice of, and to vote
at, the Special Meeting of the Fund on each Proposal applicable
to the Fund. Your attention is called to the accompanying joint
proxy statement. Shareholders who do not expect to attend the
Special Meeting in person are requested to complete, date, and
sign the enclosed proxy card and return it promptly in the
envelope provided for that purpose. Your proxy card also
provides instructions for voting via telephone or the Internet,
if you wish to take advantage of these voting options. Proxies
may be revoked at any time by executing and submitting a revised
proxy, by giving written notice of revocation to the Secretary
at the principal executive offices of the Fund at the address
above, or by voting in person at the Special Meeting.
By Order of the Boards,
Dennis P. Gallagher
Senior Vice President, General Counsel and Secretary
,
2007
YOUR VOTE IS VERY IMPORTANT TO US REGARDLESS OF THE NUMBER OF
VOTES THAT YOU HOLD. SHAREHOLDERS WHO DO NOT EXPECT TO ATTEND
THE SPECIAL MEETING ARE REQUESTED TO COMPLETE, SIGN, DATE AND
RETURN THE ACCOMPANYING PROXY CARD IN THE ENCLOSED ENVELOPE,
WHICH NEEDS NO POSTAGE IF MAILED IN THE UNITED STATES. IT IS
IMPORTANT THAT YOUR PROXY CARD BE RETURNED PROMPTLY.
FOR YOUR CONVENIENCE, YOU MAY ALSO VOTE BY TELEPHONE OR VIA
THE INTERNET BY FOLLOWING THE ENCLOSED INSTRUCTIONS. IF YOU VOTE
BY TELEPHONE OR VIA THE INTERNET, PLEASE DO NOT
RETURN YOUR PROXY CARD UNLESS YOU ELECT TO CHANGE YOUR VOTE.
I
FUNDS
PARTICIPATING IN THE SPECIAL MEETINGS
ON OCTOBER 30, 2007
TRANSAMERICA IDEX MUTUAL FUNDS
TA IDEX AllianceBernstein International Value
TA IDEX American Century Large Company Value
TA IDEX Asset Allocation Conservative Portfolio
TA IDEX Asset Allocation Growth Portfolio
TA IDEX Asset Allocation Moderate Growth Portfolio
TA IDEX Asset Allocation Moderate Portfolio
TA IDEX Bjurman, Barry Micro Emerging Growth
TA IDEX BlackRock Global Allocation (formerly, TA IDEX
Mercury Global Allocation)
TA IDEX BlackRock Large Cap Value (formerly, TA IDEX Mercury
Large Cap Value)
TA IDEX BlackRock Natural Resources
TA IDEX Clarion Global Real Estate Securities
TA IDEX Evergreen Health Care (formerly, TA IDEX T. Rowe
Price Health Sciences)
TA IDEX Evergreen International Small Cap
TA IDEX Federated Market Opportunity
TA IDEX Jennison Growth
TA IDEX JPMorgan International Bond
TA IDEX JPMorgan Mid Cap Value
TA IDEX Legg Mason Partners All Cap (formerly, TA IDEX
Salomon All Cap)
TA IDEX Legg Mason Partners Investors Value (formerly, TA
IDEX Salomon Investors Value)
TA IDEX Loomis Sayles Bond
TA IDEX Marsico Growth
TA IDEX Marsico International Growth
TA IDEX Mellon Market Neutral Strategy
TA IDEX MFS International Equity
TA IDEX Multi-Manager Alternative Strategies Fund
TA IDEX Multi-Manager International Fund
TA IDEX Neuberger Berman International
TA IDEX Oppenheimer Developing Markets
TA IDEX Oppenheimer Small- & Mid-Cap Value
TA IDEX PIMCO Real Return TIPS
TA IDEX PIMCO Total Return
TA IDEX Protected Principal Stock
TA IDEX Templeton Transamerica Global (formerly, TA IDEX
Templeton Great Companies Global)
TA IDEX Third Avenue Value
TA IDEX Transamerica Balanced
TA IDEX Transamerica Convertible Securities
TA IDEX Transamerica Equity
TA IDEX Transamerica Flexible Income
TA IDEX Transamerica Growth Opportunities
TA IDEX Transamerica High-Yield Bond
TA IDEX Transamerica Money Market
TA IDEX Transamerica Science & Technology (formerly, TA
IDEX Great Companies
Technologysm)
TA IDEX Transamerica Short-Term Bond
TA IDEX Transamerica Small/Mid Cap Value
TA IDEX Transamerica Value Balanced
TA IDEX UBS Dynamic Alpha
TA IDEX UBS Large Cap Value
TA IDEX Van Kampen Emerging Markets Debt
TA IDEX Van Kampen Mid-Cap Growth
TA IDEX Van Kampen Small Company Growth
II
AEGON/TRANSAMERICA
SERIES TRUST
American Century Large Company Value
Asset Allocation Conservative Portfolio
Asset Allocation Growth Portfolio
Asset Allocation Moderate Growth Portfolio
Asset Allocation Moderate Portfolio
BlackRock Large Cap Value (formerly, Mercury Large Cap
Value)
Capital Guardian Global
Capital Guardian U.S. Equity
Capital Guardian Value
Clarion Global Real Estate Securities
Federated Market Opportunity (formerly, Federated
Growth & Income)
International Moderate Growth Fund
Jennison Growth
JPMorgan Core Bond (formerly, AEGON Bond)
JPMorgan Enhanced Index
JPMorgan Mid Cap Value
Legg Mason Partners All Cap (formerly, Salomon All Cap)
Marsico Growth
MFS High Yield
MFS International Equity
Munder Net50
PIMCO Total Return
Templeton Transamerica Global (formerly, Templeton Great
Companies Global)
Third Avenue Value
Transamerica Balanced
Transamerica Convertible Securities
Transamerica Equity
Transamerica Equity II
Transamerica Growth Opportunities
Transamerica Money Market
Transamerica Science & Technology (formerly, Great
Companies
Technologysm)
Transamerica Small/Mid Cap Value
Transamerica U.S. Government Securities
Transamerica Value Balanced
T. Rowe Price Equity Income
T. Rowe Price Growth Stock
T. Rowe Price Small Cap
Van Kampen Active International Allocation
Van Kampen Large Cap Core
Van Kampen Mid-Cap Growth
TRANSAMERICA
INCOME SHARES, INC.
III
Transamerica
IDEX Mutual Funds
AEGON/Transamerica
Series Trust
Transamerica
Income Shares, Inc.
570 Carillon Parkway
St. Petersburg, Florida
33716-1294
JOINT PROXY STATEMENT
Special Meeting of Shareholders
To be held on October 30, 2007
This joint proxy statement (Joint Proxy Statement)
and enclosed notice and proxy card are being furnished in
connection with the solicitation of proxies by the Board of
Trustees or the Board of Directors (each, a Board
and each member of a Board, a Board Member) of each
of Transamerica IDEX Mutual Funds (TA IDEX),
AEGON/Transamerica Series Trust (ATST) and
Transamerica Income Shares, Inc. (TIS and together
with TA IDEX and ATST, the Investment Companies or
the TFAI Fund Family). The proxies are being
solicited for use at a special meeting of shareholders of each
of TA IDEX, ATST and TIS to be held at the offices of
Transamerica Fund Advisors, Inc. (TFAI), 570
Carillon Parkway, St. Petersburg, Florida 33716, at
11:00 A.M. on October 30, 2007 (each, a
Special Meeting), and at any and all adjournments or
postponements thereof.
The Boards have called the Special Meetings and are soliciting
proxies from shareholders of each fund listed in the
accompanying notice (the Funds) with respect to the
following proposals (the Proposals):
I. To elect a new Board (to be voted on by shareholders
of each Fund);
II. To approve an amendment to the Agreement and
Declaration of Trust (to be voted on by shareholders of each
Fund, except TIS); and
III. To transact such other business as may properly
come before the Special Meetings.
The Board of each Investment Company has determined that the use
of this Joint Proxy Statement for each Special Meeting is in the
best interests of each Fund and its shareholders in light of the
similar matters being considered and voted on by the
shareholders of the other Funds.
You are entitled to vote at the Special Meeting of each Fund of
which you are a shareholder as of the close of business on
August 15, 2007 (the Record Date).
If you have any questions about the Proposals or about voting,
please call Computershare Fund Services, the Funds proxy
solicitor, at
(866) 436-5968.
This Joint Proxy Statement and the accompanying notice and the
proxy card are being first mailed to shareholders on or about
August 27, 2007.
1
INTRODUCTION
Funds
Subject to this Solicitation of Proxies
Each of TA IDEX, ATST and TIS is an investment company
registered under the Investment Company Act of 1940, as amended
(the 1940 Act). TA IDEX and ATST are Delaware
statutory trusts, and TIS is a Maryland corporation. For
purposes of this Joint Proxy Statement, each of TA IDEX and ATST
is referred to as a Trust, and the Trusts and TIS
are referred to collectively as the Investment
Companies. Attached as Appendix A is a list of
the Funds that are a series of each Trust. TIS is itself a Fund
and has no series. In certain cases, for ease of comprehension,
the term Fund is used in this Joint Proxy Statement
where it may be more precise to refer to the Investment
Company of which the Fund is a series.
Overview
of Proposals
The Funds in the TFAI Fund Family are managed by
Transamerica Fund Advisors, Inc. (TFAI) as
investment adviser to the Funds. An affiliate of TFAI,
Diversified Investment Advisors, Inc. (Diversified),
serves as investment adviser to another complex of registered
investment companies (the Diversified
Fund Family).
Both TFAI and Diversified are indirect, wholly-owned
subsidiaries of AEGON, N.V., a Netherlands corporation that is a
publicly traded international insurance group, and both are part
of the AEGON Group of Companies. TFAI and Diversified currently
render comparable manager of managers management
services to investment companies. The AEGON Group of Companies
has decided to consolidate all manager of managers
investment advisory services in TFAI in order to form a premier
fund management and administration organization combining the
expertise of the personnel of both TFAI and Diversified. This
consolidation is expected to result in a combined fund
management organization with significant experience, resources
and depth. The AEGON Group of Companies is also recommending
that the TFAI and Diversified Fund Families be consolidated. As
part of the consolidation and restructuring of funds in the TFAI
Fund Family and the Diversified Fund Family
(collectively, the Fund Complex), it is
anticipated that TFAI will, in the future, propose the
combination of certain existing Funds, though no specific
combinations have yet been proposed to the Boards of the Funds.
In order to implement these plans, at a meeting held on July 10
and 11, 2007, each Funds Board approved a series of
measures that it believes will, among other things:
(1) simplify oversight of the Funds through the election of
a new Board, composed both of current members of the Boards and
new members who currently oversee funds in the Diversified
Fund Family that are proposed to be managed by TFAI; and
(2) simplify and modernize the Trusts and the Funds to
permit them to respond more quickly and favorably to changed
circumstances with less expense and delay by adopting modernized
and more standardized agreements and declarations of trust. The
implementation of these measures, which are summarized below, is
subject to the approval of shareholders of the Funds.
Proposal I: Five of the current Board
Members of the Investment Companies, Leo J. Hill, Russell A.
Kimball, Jr., Norm R. Nielsen, John W. Waechter and John K.
Carter, as well as four new Board Member nominees, Neal M.
Jewell, Eugene M. Mannella, Joyce Galpern Norden and Patricia L.
Sawyer are proposed for election to each Investment
Companys Board (hereafter, the five current Board Members
and the four proposed new Board Members are referred to as the
Nominees). Each Nominee, except John K. Carter, is
not an interested person, as that term is defined in
the 1940 Act, of the Investment Companies. As further discussed
in this Joint Proxy Statement, Proposal I is designed to
create operational and administrative efficiencies by electing a
Board composed of Board Members who are familiar with the
Investment Companies, TFAI, and the funds currently managed by
Diversified.
Proposal II: The Board of each Trust
seeks approval of an amendment to the Trusts current
agreement and declaration of trust that, if approved, will
enable the Board to amend the Trusts agreement and
declaration of trust without the expense and delay associated
with soliciting approval of the shareholders. The Boards are
currently able to amend the agreements and declarations of trust
in many respects without shareholder approval and, as discussed
below, whether or not Proposal II is approved, the Boards
intend to implement a
2
number of changes that they deem to be in the shareholders
best interests. Proposal II would allow the Boards to
manage the Trusts and the Funds more effectively and more
efficiently by expanding their ability to revise the agreements
and declarations of trust to respond to future contingencies,
changes in industry standards, economic conditions and
regulatory changes.
The implementation of each Proposal is not contingent upon the
approval of the other Proposal.
The cost of this proposed restructuring, including the costs of
these proxy materials and the costs of soliciting shareholders,
will be borne by TFAI
and/or its
affiliates, and not the Funds or their shareholders.
The Board of each Investment Company recommends that you vote
FOR each of these two Proposals for which you are
entitled to vote.
Important
Voting Information
Each shareholder of record of a Fund at the close of business on
the Record Date is entitled to one vote for each share held of
the applicable Fund (with proportional fractional votes for
fractional shares). The total number of shares of each Fund
outstanding at the close of business on the Record Date is shown
in Appendix A.
The Fund with respect to which your vote is being solicited is
named on the proxy card included with this Joint Proxy
Statement. If you have the right to vote with respect to more
than one Fund as of the Record Date, you may receive more than
one proxy card. Please sign, date and return each proxy card, or
if you prefer to provide voting instructions by telephone or
over the Internet, please vote on the Proposal(s) affecting each
applicable Fund. If you vote by telephone or over the Internet,
you will be asked to enter a unique code that has been assigned
to you, which is printed on your proxy card(s). This code is
designed to confirm your identity, provide access to the voting
sites and confirm that your voting instructions are properly
recorded.
All properly executed proxies received prior to a Funds
Special Meeting will be voted at that Special Meeting. On the
matters coming before each Special Meeting as to which a
shareholder has specified a choice on that shareholders
proxy, the shareholders shares will be voted accordingly.
If a proxy is properly executed and returned and no choice is
specified with respect to one or more Proposals, the shares will
be voted FOR each such Proposal. The duly appointed
proxies may, in their discretion, vote upon such other matters
as may properly come before the Special Meetings.
Shareholders who execute proxies or provide voting instructions
by telephone or the Internet may revoke them with respect to
either or both Proposals at any time before a vote is taken on a
Proposal by filing with the applicable Fund a written notice of
revocation (addressed to the Secretary at the principal
executive offices of the Fund at the address above), by
delivering a duly executed proxy bearing a later date or by
attending the Special Meeting and voting in person, in all cases
prior to the exercise of the authority granted in the proxy.
Merely attending the Special Meeting, however, will not revoke
any previously executed proxy. If you hold your shares through a
bank or other intermediary or if you are the holder of a
variable annuity contract or variable life insurance policy (as
discussed under Quorum, Vote Required and Manner of Voting
Proxies below), please consult your bank or intermediary
or your participating insurance company regarding your ability
to revoke voting instructions after such instructions have been
provided.
Quorum,
Vote Required and Manner of Voting Proxies
Quorum
A quorum of shareholders is required to take action at each
Special Meeting. With respect to each of ATST and TA IDEX,
shareholders of at least one-third
(331/3%)
of the outstanding shares as of the Record Date of all of the
Funds that are series of the Trust taken together as a whole,
present in person or by proxy, shall constitute a quorum for the
transaction of business at the Special Meeting. With respect to
TIS, the shareholders of a majority of outstanding shares as of
the Record Date, present in person or by proxy, shall constitute
a quorum for the transaction of business at the Special Meeting.
3
Only proxies that are voted, abstentions and broker
non-votes will be counted toward establishing a quorum.
Broker non-votes are shares held by a broker or
nominee as to which proxies have been returned but
(a) instructions have not been received from the beneficial
owners or persons entitled to vote and (b) the broker or
nominee does not have discretionary voting power on a particular
matter.
In the absence of a quorum, or if a quorum is present but
sufficient votes to approve a Proposal are not received, a
Special Meeting may be adjourned by the affirmative vote of a
majority of the shares present in person or represented by proxy
at the Special Meeting. The persons named as proxies may, at
their discretion, vote those proxies in favor of an adjournment
of a Special Meeting. A vote may be taken on any Proposal prior
to any such adjournment if sufficient votes have been received.
Vote
Required
Proposal I. Each Nominee must be elected
by a plurality of the votes cast at the Special Meetings. For
each of ATST and TA IDEX, shareholders of all of the Funds that
are series of the Trust vote together as a single class.
Similarly, all shareholders of TIS vote together as a single
class. Assuming the presence of a quorum, abstentions and broker
non-votes have no effect on Proposal I.
Proposal II. Approval by each of ATST and
TA IDEX of the proposed amendment to the Trusts agreement
and declaration of trust requires the affirmative vote of a
majority of the shares entitled to vote and voting on the
Proposal, with the outstanding shares as of the Record Date of
all of the Funds that are series of the Trust voting together as
a single class. Accordingly, assuming the presence of a quorum,
abstentions and broker non-votes have no effect on
Proposal II. Shareholders of TIS are not being asked to
vote on Proposal II.
Manner
of Voting
Broker-dealer firms holding shares in a Fund in street
name for the benefit of their customers and clients will
request the instructions of such customers and clients on how to
vote their shares on each Proposal before the Special Meetings.
The New York Stock Exchange (the NYSE) may take the
position that a broker-dealer that is a member of the NYSE and
that has not received instructions from a customer or client
prior to the date specified in the broker-dealer firms
request for voting instructions may not vote such customer or
clients shares with respect to Proposal II. A signed
proxy card or other authorization by a beneficial owner of
shares in a Fund that does not specify how the beneficial
owners shares should be voted on a Proposal may be deemed
an instruction to vote such shares in favor of the applicable
Proposal.
If you hold shares in a Fund through a bank or other financial
institution or intermediary (called a service agent) that has
entered into a service agreement with the Fund or a distributor
of the Fund, the service agent may be the record shareholder of
your shares. At the Special Meetings, a service agent will vote
shares for which it receives instructions from its customers in
accordance with those instructions. A signed proxy card or other
authorization by a beneficial shareholder that does not specify
how the beneficial shareholders shares should be voted on
a Proposal may be deemed an instruction to vote such shares in
favor of the applicable Proposal. Depending on its policies,
applicable law or contractual or other restrictions, a service
agent may be permitted to vote shares with respect to which it
has not received specific voting instructions from its
customers. In those cases, the service agent may, but may not be
required to, vote such shares in the same proportion as those
shares for which the service agent has received voting
instructions or in the same proportion as those shares for which
the Fund receives voting instructions from other shareholders.
This practice is sometimes called proportional
voting or echo voting.
In the case of shares of Funds (such as the Funds that are
series of ATST) that are offered to variable annuity separate
accounts established by insurance companies (including Western
Reserve Life Assurance Co. of Ohio, Transamerica Life Insurance
Company, Transamerica Financial Life Insurance Company, Peoples
Benefit Life Insurance Company and Transamerica Occidental Life
Insurance Company (the Insurance Companies)) to fund
variable annuity contracts and variable life insurance policies,
ownership of the shares is legally vested in the separate
accounts. The Insurance Companies will vote shares held by these
separate accounts in a manner consistent with voting
instructions timely received from the shareholders of the
variable annuity contracts and variable life insurance policies
used to fund the accounts. A signed proxy card or other
4
authorization by a shareholder that does not specify how the
shareholders shares should be voted on a Proposal may be
deemed an instruction to vote such shares in favor of the
applicable Proposal. The Insurance Companies will use
proportional voting to vote shares held by separate accounts for
which no timely instructions are received from the shareholders
of variable annuity contracts and variable life insurance
policies. As a result, a small number of owners of variable
annuity contracts and variable life insurance policies could
determine how the Insurance Companies vote, if other owners fail
to vote. Other participating insurance companies may follow
similar voting procedures.
If you beneficially own shares that are held in street
name through a broker-dealer or that are held of record by
a service agent, or if you hold shares through a variable
annuity contract or a variable life insurance policy, and if you
do not give specific voting instructions for your shares, they
may not be voted at all or, as described above, they may be
voted in a manner that you may not intend. Therefore, you are
strongly encouraged to give your broker-dealer, service agent or
participating insurance company specific instructions as to how
you want your shares to be voted.
Under TFAIs proxy voting policies and procedures, in the
case of Funds that invest their assets in other Funds, TFAI will
vote shares of the underlying Funds in accordance with the
recommendations of the Boards of the Funds. Such shares will,
therefore, be voted FOR the election of each Nominee
described in Proposal I and FOR the approval of
the amendment to the agreement and declaration of trust
described in Proposal II.
PROPOSAL I
TO ELECT BOARD MEMBERS
The purpose of this Proposal I is for each Investment
Company to elect a Board that will assume office upon election
by the shareholders. At a Board meeting held on July 10 and 11,
2007, the current Board Members of each Investment Company
nominated the nine persons listed below (the
Nominees) to serve as Board Members.
As described above, the AEGON Group of Companies has decided to
consolidate all manager of managers investment
advisory services in TFAI in order to form a premier fund
management and administration organization combining the
expertise of the personnel of both TFAI and Diversified. As a
result of this consolidation, representatives of TFAI and
Diversified proposed to the Boards a combination of the
investment and administration operations of the TFAI and
Diversified Fund Families. TFAI and Diversified also
recommended the election of a single board (the New
Board) to oversee the consolidated Fund Complex. The
Boards have concluded that the funds in the TFAI
Fund Family will enjoy operational and administrative
efficiencies if the same individuals serve as Board Members for
the Investment Companies and other investment companies in the
Fund Complex, as discussed below.
Five of the Nominees, Leo J. Hill, Russell A. Kimball, Jr.,
Norm R. Nielsen, John W. Waechter and John K. Carter, currently
serve as members of each Board; the other four Nominees, Neal M.
Jewell, Eugene M. Mannella, Joyce Galpern Norden and Patricia L.
Sawyer, currently serve as board members of investment companies
in the Diversified Fund Family.
The Nominees were nominated by Board Members who are not
interested persons of the Fund Complex, as that
term is defined in Section 2(a)(19) of the 1940 Act.
It is intended that the enclosed proxy card will be voted for
all Nominees for the New Board unless a proxy contains specific
instructions to the contrary.
Reason
for Proposed Realignment and Consolidation
Each Board has determined that the election of the New Board to
oversee the Funds and other funds in the combined
Fund Complex may provide benefits to shareholders of the
Funds. In reaching this conclusion, each Board identified
numerous potential advantages to the Funds and their
shareholders, including:
|
|
|
|
|
increased availability of managements time and resources
for providing services to the Funds and focusing on long-term
strategic initiatives;
|
5
|
|
|
|
|
greater Board access to senior management as a result of a
decrease in demands on senior managements time to prepare
for and attend Board and committee meetings of multiple Boards;
|
|
|
|
consistent governance and operations approaches for the Funds
and the other funds in the Fund Complex;
|
|
|
|
more efficient Board oversight, including a uniform approach to
overseeing investment and compliance operations;
|
|
|
|
potential cost savings from a consolidation of Board Members and
Board meetings throughout the Fund Complex;
|
|
|
|
the enhanced influence of a single Board for all funds in the
Fund Complex;
|
|
|
|
facilitation of the anticipated future integration of other
funds in the Fund Complex, offering the possibility of
additional economies of scale for shareholders; and
|
|
|
|
the benefits of having Board Members who are familiar with funds
in the TFAI Fund Family and in the Diversified
Fund Family, as well as with management personnel serving
the Funds and other funds in the Fund Complex.
|
The Boards also noted that a consolidated board structure would
be consistent with that of many other fund groups having a
common investment adviser.
Nominees
You are being asked to elect the Board Members of your Fund. If
elected, the Nominees will comprise the entire Board of each of
the Investment Companies, and each of them will hold office
until his or her successor has been duly elected or appointed,
until reaching the mandatory retirement age, or until his or her
earlier death, resignation or removal.
Each Nominee has consented to serve on the New Board if elected
by shareholders. If, however, before the election, any Nominee
refuses or is unable to serve, proxies may be voted for a
replacement Nominee, if any, designated by members of your Board.
A Nominee is deemed independent if the Nominee is
not an interested person of the Fund Complex,
as that term is defined in Section 2(a)(19) of the 1940 Act
(an Independent Nominee). Each of the Nominees other
than Mr. John K. Carter is considered an Independent
Nominee. Mr. Carter is an interested
person under the 1940 Act by virtue of his position with
TFAI and its affiliates, as described in the table below. If
elected, Mr. Carter will serve as Chairman of the New Board.
The mailing address of each Nominee is
c/o Secretary
of the Funds, 570 Carillon Parkway, St. Petersburg, Florida
33716-1297.
The Nominees, their ages, their principal occupations for the
past five years (their titles
6
may have varied during that period), the number of funds in the
Fund Complex the Nominees are nominated to oversee if
elected, and other board memberships they hold are set forth in
the table below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
Portfolios
|
|
|
|
|
|
|
|
|
|
|
|
in Fund
|
|
|
|
|
|
|
|
|
|
Principal
|
|
Complex
|
|
|
|
|
|
Position(s)
|
|
Length
|
|
Occupation(s)
|
|
to be
|
|
|
Other Board
|
|
|
Held with
|
|
of Time
|
|
During Past
|
|
Overseen
|
|
|
Memberships
|
Name and Age
|
|
the Investment Companies
|
|
Served
|
|
Five Years
|
|
by Nominee
|
|
|
Held by Nominee
|
|
Independent Nominees
:
|
Leo J. Hill
Age: 51
|
|
Nominee/ Board Member
|
|
Since
2001
|
|
Principal, Advisor Network
Solutions, LLC (business consulting) (2006 to present); Trustee,
TA IDEX (2002 to present); Director, TIS (2002 to present);
Trustee, ATST (2001 to present); Owner and President, Prestige
Automotive Group (2001 to 2005); President, L. J. Hill &
Company (1999 to present); Market President, Nations Bank of Sun
Coast Florida (1998 to 1999); President and Chief Executive
Officer, Barnett Banks of Treasure Coast Florida (1994 to 1998);
Executive Vice President and Senior Credit Officer, Barnett
Banks of Jacksonville, Florida (1991 to 1994); Senior Vice
President and Senior Loan Administration Officer, Wachovia Bank
of Georgia (1976 to 1991).
|
|
|
160
|
|
|
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russell A. Kimball, Jr.
Age: 63
|
|
Nominee/ Board Member
|
|
Since
1986
|
|
Trustee, TA IDEX (2002 to present);
Director, TIS (2002 to present); Trustee, ATST (1986 to
present); General Manager, Sheraton Sand Key Resort (1975 to
present).
|
|
|
160
|
|
|
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Norm R. Nielsen
Age: 68
|
|
Nominee/ Board Member
|
|
Since
2006
|
|
Retired (2005 to present); Trustee,
TA IDEX (2006 to present); Director, TIS (2006 to present);
Trustee, ATST (2006 to present); Director, Iowa City Area
Development (1996 to 2004); Director, Iowa Health Systems (1994
to 2003); Director, U.S. Bank (1988 to 2006); President,
Kirkwood Community College (1979 to 2005).
|
|
|
160
|
|
|
Buena Vista University Board of
Trustees (2004 to present)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
John W. Waechter
Age: 55
|
|
Nominee/ Board Member
|
|
Since
2004
|
|
Trustee, TA IDEX (2005 to present);
Director, TIS (2004 to present); Trustee, ATST (2004 to
present); employee, RBC Dain Rauscher (securities dealer) (March
2004 to May 2004); Executive Vice President, Chief Financial
Officer and Chief Compliance Officer, William R. Hough &
Co. (securities dealer) (1979 to 2004); Treasurer, The Hough
Group of Funds (1993 to 2004).
|
|
|
160
|
|
|
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Neal M. Jewell
Age: 72
|
|
Nominee
|
|
N/A
|
|
Retired (2004 to present); Trustee,
Diversified Investors Portfolios (DIP), The
Diversified Investors Funds Group (DIFG), The
Diversified Investors Funds Group II (DIFG II),
and Diversified Investors Strategic Variable Funds
(DISVF) (1993 to present); Independent Trustee, EAI
Select Managers Equity Fund (a mutual fund) (1996 to 2004).
|
|
|
160
|
|
|
None
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
Portfolios
|
|
|
|
|
|
|
|
|
|
|
|
in Fund
|
|
|
|
|
|
|
|
|
|
Principal
|
|
Complex
|
|
|
|
|
|
Position(s)
|
|
Length
|
|
Occupation(s)
|
|
to be
|
|
|
Other Board
|
|
|
Held with
|
|
of Time
|
|
During Past
|
|
Overseen
|
|
|
Memberships
|
Name and Age
|
|
the Investment Companies
|
|
Served
|
|
Five Years
|
|
by Nominee
|
|
|
Held by Nominee
|
|
Eugene M. Mannella
Age: 53
|
|
Nominee
|
|
N/A
|
|
Self-employed consultant (2006 to
present); President, Arapain Partners LLC (limited purpose
broker/dealer) (1998 to present); Trustee, DIP, DIFG, DIFG II,
and DISVF (1994 to present); President, International Fund
Services (alternative asset administration) (1993 to 2005).
|
|
|
160
|
|
|
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Joyce Galpern Norden
Age: 68
|
|
Nominee
|
|
N/A
|
|
Retired (2004 to present); Trustee,
DIP (2002 to present); Trustee, DIFG, DIFG II, and DISVF (1993
to present); Vice President, Institutional Advancement,
Reconstructionist Rabbinical College (1996 to 2004).
|
|
|
160
|
|
|
None
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patricia L. Sawyer
Age: 57
|
|
Nominee
|
|
N/A
|
|
Trustee, DIP, DIFG, DIFG II, and
DISVF (1993 to present); President and Executive Search
Consultant, Smith & Sawyer LLC (consulting) (1989 to
present).
|
|
|
160
|
|
|
None
|
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of
|
|
|
|
|
|
|
|
|
|
|
|
Portfolios
|
|
|
|
|
|
|
|
|
|
|
|
in Fund
|
|
|
|
|
|
|
|
|
|
Principal
|
|
Complex
|
|
|
|
|
|
Position(s)
|
|
Length
|
|
Occupation(s)
|
|
to be
|
|
|
Other Board
|
|
|
Held with
|
|
of Time
|
|
During Past
|
|
Overseen
|
|
|
Memberships
|
Name and Age
|
|
the Investment Companies
|
|
Served
|
|
Five Years
|
|
by Nominee
|
|
|
Held by Nominee
|
|
Interested
Nominee:
|
John K. Carter
Age: 46
|
|
Nominee/ Board Member
|
|
Since
2006
|
|
President and Chief Executive
Officer, DIP, DIFG, DIFG II and DISVF (August 2007 to present);
Trustee (September 2006 to present), President and Chief
Executive Officer (July 2006 to present), Senior Vice President
(1999 to June 2006), Chief Compliance Officer, General Counsel
and Secretary (1999 to August 2006), TA IDEX; Trustee (September
2006 to present), President and Chief Executive Officer (July
2006 to present), Senior Vice President (1999 to June 2006),
Chief Compliance Officer, General Counsel and Secretary (1999 to
August 2006), ATST; Director (September 2006 to present),
President and Chief Executive Officer (July 2006 to present),
Senior Vice President (2002 to June 2006), General Counsel,
Secretary and Chief Compliance Officer (2002 to August 2006),
TIS; President and Chief Executive Officer (July 2006 to
present), Senior Vice President (1999 to June 2006), Director
(2000 to present), General Counsel and Secretary (2000 to August
2006), Chief Compliance Officer (2004 to August 2006), TFAI;
President and Chief Executive Officer (July 2006 to present),
Senior Vice President (1999 to June 2006), Director (2001 to
present), General Counsel and Secretary (2001 to August 2006),
Transamerica Fund Services, Inc. (TFS); Vice
President, AFSG Securities Corporation (2001 to present); Chief
Executive Officer (July 2006 to present), Vice President,
Secretary and Chief Compliance Officer (2003 to August 2006),
Transamerica Investors, Inc. (TII); Senior Vice
President, General Counsel and Secretary, Transamerica Index
Funds, Inc. (TIFI) (2002 to 2004); Vice President,
Transamerica Investment Services, Inc. (TISI) (2003
to 2005) and Transamerica Investment Management, LLC
(TIM) (2001 to 2005).
|
|
|
160
|
|
|
None
|
|
|
|
|
|
Indicates the earliest year in
which the Nominee became a board member for a fund in the
Fund Complex.
|
|
|
|
Independent Nominee
means a person who is not an interested person as
that term is defined in Section 2(a)(19) of the 1940 Act.
|
|
|
|
Mr. Carter is an interested person under the
1940 Act because of his position with TFAI and certain of its
affiliates. If elected, Mr. Carter will serve as Chairman
of the New Board.
|
On July 10 and 11, 2007, each Board voted to establish a
mandatory retirement age of 75 for Board Members, effective on
the date on which the Nominees who are not currently Board
Members of the Investment Companies (or any one of them) accept
their elections and commence service as members of the New Board
(the Effective Date). Pursuant to the mandatory
retirement policy, any Independent Board Member who attained the
age of 75 prior to the Effective Date will be deemed to have
retired as of the Effective Date and any Independent Board
Member who attains the age of 75 after the Effective Date will
be
9
deemed to have retired as of the last day of the calendar year
in which he or she attains the age of 75. The policy also allows
any Independent Board Member to elect to retire as of the
Effective Date.
Each Investment Company will indemnify its Board Members and
officers against liabilities and expenses incurred in connection
with litigation in which they may be involved because of their
offices with the Investment Company unless, as to liability to
the Investment Company or its shareholders, it is finally
adjudicated that they engaged in willful misfeasance, bad faith,
gross negligence or reckless disregard of the duties involved in
their offices, or unless with respect to any other matter it is
finally adjudicated that they did not act in good faith in the
reasonable belief that their actions were in the best interests
of the Investment Company. In the case of settlement, such
indemnification will not be provided unless it has been
determined by a court or other body approving the settlement or
other disposition, or by a reasonable determination, based upon
a review of readily available facts, by vote of a majority of
disinterested Board Members or in a written opinion of legal
counsel chosen by a majority of the Board Members and determined
by them in their reasonable judgment to be independent, that
such officers or Board Members have not engaged in willful
misfeasance, bad faith, gross negligence or reckless disregard
of their duties.
Officers
of the Investment Companies
The mailing address of each officer is
c/o Secretary
of the Funds, 570 Carillon Parkway, St. Petersburg, Florida
33716. The following table shows information about the officers,
including their ages, their positions held with the Investment
Companies and their principal occupations during the past five
years (their titles may have varied during that period). Each
officer will hold office until his or her successor has been
duly elected or appointed or until his or her earlier death,
resignation or removal.
|
|
|
|
|
|
|
|
|
Position(s) Held
|
|
|
|
|
|
|
with
|
|
Length
|
|
|
|
|
the Investment
|
|
of Time
|
|
Principal Occupation(s)
|
Name and Age
|
|
Companies
|
|
Served*
|
|
During the Past Five Years
|
|
John K. Carter
Age: 46
|
|
Chief Executive Officer and
President
|
|
Since 2006
|
|
See the table above.
|
Dennis P. Gallagher
Age: 36
|
|
Senior Vice President, General
Counsel and Secretary
|
|
Since 2006
|
|
Senior Vice President, General
Counsel and Secretary, TA IDEX, ATST and TIS (September 2006 to
present); Vice President, General Counsel and Secretary, DIP,
DIFG, DIFG II and DISVF (August 2007 to present); Vice President
and Secretary, TII (September 2006 to present); Director, Senior
Vice President, General Counsel and Secretary, TFAI and TFS
(September 2006 to present); Director, Deutsche Asset Management
(1998 to 2006).
|
10
|
|
|
|
|
|
|
|
|
Position(s) Held
|
|
|
|
|
|
|
with
|
|
Length
|
|
|
|
|
the Investment
|
|
of Time
|
|
Principal Occupation(s)
|
Name and Age
|
|
Companies
|
|
Served*
|
|
During the Past Five Years
|
|
Elizabeth L. Belanger
Age: 35
|
|
Deputy General Counsel, Assistant
Secretary and Conflicts of Interest Officer
|
|
Since 2007
|
|
Deputy General Counsel, Assistant
Secretary and Conflicts of Interest Officer, TA IDEX, ATST and
TIS (July 2007 to present); Deputy General Counsel and Conflicts
of Interest Officer (August 2007 to present), Assistant
Secretary (August 2005 to present), DIP, DIFG, DIFG II and
DISVF; Vice President and Senior Counsel, Diversified (with
Diversified since 2005); Director, TFLIC (April 2006 to
present); Director of Compliance, Domini Social Investments LLC
(November 2003 to May 2005); Associate, Bingham McCutchen LLP
(September 1997 to October 2003).
|
Joe Carusone
Age: 41
|
|
Vice President, Treasurer and
Principal Financial Officer
|
|
Since 2007
|
|
Vice President, Treasurer and
Principal Financial Officer, TA IDEX, ATST and TIS (July 2007 to
present); Vice President (August 2007 to present), Treasurer and
Principal Financial Officer (2001 to present), DIP, DIFG, DIFG
II and DISVF; Vice President, Diversified (with Diversified
since 1999); President, Diversified Investors Securities Corp.
(DISC) (February 2007 to present); Director, TFLIC
(2004 to present).
|
Christopher A. Staples
Age: 37
|
|
Vice President and Chief
Investment Officer
|
|
Since 2007
|
|
Vice President (July 2007 to
present), Chief Investment Officer (June 2007 to present),
Senior Vice President (June 2007 to July 2007), Senior Vice
President - Investment Management (July 2006 to June 2007), Vice
President - Investment Management (2004 to July 2006), TA IDEX,
ATST and TIS; Vice President and Chief Investment Officer, DIP,
DIFG, DIFG II and DISVF (August 2007 to present); Vice
President, Investment Administration, TII (2004 to present);
Director, TFS (2005 to present); Assistant Vice President,
Raymond James & Associates (1999 to 2004).
|
11
|
|
|
|
|
|
|
|
|
Position(s) Held
|
|
|
|
|
|
|
with
|
|
Length
|
|
|
|
|
the Investment
|
|
of Time
|
|
Principal Occupation(s)
|
Name and Age
|
|
Companies
|
|
Served*
|
|
During the Past Five Years
|
|
T. Gregory Reymann, II
Age: 49
|
|
Chief Compliance Officer
|
|
Since 2006
|
|
Chief Compliance Officer TA IDEX,
ATST, TIS and TFAI (September 2006 to present); Senior Vice
President, TFAI (September 2006 to present); Senior Vice
President, TA IDEX, ATST and TIS (September 2006 to July 2007);
Chief Compliance Officer (September 2006 to present) and Vice
President (2005 to present), TII; Vice President and Senior
Counsel, TFS (2005 to 2006); Vice President and Counsel, TA
IDEX, ATST, TFAI and TIS (2004 to 2006), TFS (2004 to 2005) and
TIF (2004); Attorney, Gould, Cooksey, et al. (2002 to 2004).
|
Michael Masson
Age: 36
|
|
Assistant Treasurer
|
|
Since 2005
|
|
Assistant Treasurer, TA IDEX, ATST
and TIS (July 2007 to present); Assistant Treasurer, DIP, DIFG,
DIFG II and DISVF (August 2007 to present); Assistant Vice
President, ATST and TIS (2005 to present); Assistant Vice
President, TII (2005 to present); Assistant Vice President, TFS
and TFAI (2005 to present); Assistant Vice President, JPMorgan
Chase & Co. (1999 to 2005).
|
Suzanne Valerio-Montemurro
Age: 42
|
|
Assistant Treasurer
|
|
Since 2007
|
|
Assistant Treasurer, TA IDEX, ATST
and TIS (July 2007 to present); Assistant Treasurer, DIP, DIFG,
DIFG II and DISVF (August 2007 to present); Vice President,
Diversified (with Diversified since 1998).
|
|
|
|
*
|
|
If an officer has held offices for
different Funds for different periods of time, the earliest
applicable date is shown.
|
As of June 30, 2007, all Board Members and officers as a
group owned less than 1% of the outstanding shares of each Fund.
12
Nominee
Ownership of Equity Securities
The following table shows the amount of equity securities
beneficially owned by the Nominees as of June 30, 2007 in
the Funds that they oversee and in all the funds in the Fund
Complex.
|
|
|
|
|
|
|
|
|
Aggregate Dollar
|
|
|
|
|
Range of Equity
|
|
|
|
|
Securities in all
|
|
|
|
|
Funds to be
|
|
|
|
|
Overseen
|
|
|
|
|
by Nominee in
|
|
|
|
|
Family of
|
|
|
|
|
Investment
|
Nominee
|
|
Dollar Range of Equity Securities in Each Fund
|
|
Companies*
|
|
Independent
Nominees:
|
Leo J. Hill**
|
|
TA IDEX
|
|
Over $100,000
|
|
|
TA IDEX Legg Mason
Partners All Cap - $10,001 - $50,000
|
|
|
|
|
TA IDEX Legg Mason
Partners Investors Value - $50,001 - $100,000
|
|
|
|
|
TA IDEX Marsico
Growth - $10,001 - $50,000
|
|
|
|
|
TA IDEX MFS
International Equity - Over $100,000
|
|
|
|
|
TA IDEX PIMCO Total
Return - $10,001 - $50,000
|
|
|
|
|
TA IDEX Templeton
Transamerica Global $10,001 - $50,000
|
|
|
|
|
TA IDEX Transamerica
Balanced - $10,001 - $50,000
|
|
|
|
|
TA IDEX Transamerica
Equity - $10,001 - $50,000
|
|
|
|
|
TA IDEX Transamerica
Growth Opportunities - $1 - $10,000
|
|
|
|
|
TA IDEX Transamerica
Value Balanced - $10,001 - $50,000
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
Russell A. Kimball, Jr.**
|
|
TA IDEX
|
|
Over $100,000
|
|
|
TA IDEX Asset
Allocation - Growth Portfolio - $10,001 - $50,000
|
|
|
|
|
TA IDEX Asset
Allocation - Moderate Growth Portfolio - Over
$100,000
|
|
|
|
|
TA IDEX Asset
Allocation - Moderate Portfolio - Over $100,000
|
|
|
|
|
TA IDEX Jennison Growth
- $1 - $10,000
|
|
|
|
|
TA IDEX Legg Mason
Partners All Cap - $50,001 - $100,000
|
|
|
|
|
TA IDEX Templeton
Transamerica Global - Over $100,000
|
|
|
|
|
TA IDEX Transamerica
Equity - Over $100,000
|
|
|
|
|
TA IDEX Transamerica
Flexible Income - $1 - $10,000
|
|
|
|
|
TA IDEX Transamerica
Growth Opportunities - $10,001 - $50,000
|
|
|
|
|
TA IDEX Transamerica
High-Yield Bond - $1 - $10,000
|
|
|
|
|
TA IDEX Transamerica
Money Market - Over $100,000
|
|
|
|
|
TA IDEX Transamerica
Science & Technology - $10,001 - $50,000
|
|
|
|
|
TA IDEX Transamerica
Value Balanced - $50,001 - $100,000
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
Norm R. Nielsen
|
|
TA IDEX
|
|
Over $100,000
|
|
|
TA IDEX Asset
Allocation - Growth Portfolio - $10,001 - $50,000
|
|
|
|
|
TA IDEX Asset
Allocation - Moderate Growth
Portfolio - $50,001 -
$100,000
|
|
|
|
|
TA IDEX Transamerica
Equity - $1 - $10,000
|
|
|
|
|
TA IDEX Transamerica
Small/Mid
Cap Value - $10,001 - $50,000
|
|
|
|
|
TA IDEX Multi-Manager
International Fund - $10,001 - $50,000
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
13
|
|
|
|
|
|
|
|
|
Aggregate Dollar
|
|
|
|
|
Range of Equity
|
|
|
|
|
Securities in all
|
|
|
|
|
Funds to be
|
|
|
|
|
Overseen
|
|
|
|
|
by Nominee in
|
|
|
|
|
Family of
|
|
|
|
|
Investment
|
Nominee
|
|
Dollar Range of Equity Securities in Each Fund
|
|
Companies*
|
|
John W. Waechter
|
|
TA IDEX
|
|
Over $100,000
|
|
|
TA IDEX Asset
Allocation - Growth Portfolio - Over $100,000
|
|
|
|
|
TA IDEX Asset
Allocation - Moderate Growth Portfolio - Over
$100,000
|
|
|
|
|
TA IDEX Multi-Manager
International Fund - Over $100,000
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS -
$10,001 - $50,000
|
|
|
Neal M. Jewell
|
|
TA IDEX
|
|
None
|
|
|
None
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
Eugene M. Mannella
|
|
TA IDEX
|
|
None
|
|
|
None
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
Joyce Galpern Norden
|
|
TA IDEX
|
|
None
|
|
|
None
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
Patricia L. Sawyer
|
|
TA IDEX
|
|
None
|
|
|
None
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
Interested Nominee:
|
|
|
|
|
John K. Carter
|
|
TA IDEX
|
|
Over $100,000
|
|
|
None
|
|
|
|
|
ATST
|
|
|
|
|
None
|
|
|
|
|
TIS
|
|
|
|
|
None
|
|
|
|
|
|
*
|
|
The family of investment companies
consists of all funds in the Fund Complex.
|
|
**
|
|
A portion of the dollar range of
equity securities in TA IDEX for this Board Member consists of
allocations made under TA IDEXs and ATSTs deferred
compensation plan. The deferred compensation amounts are based
on the value of Class A shares of TA IDEX elected by such
Board Member (without the imposition of the sales charge).
|
None of the Independent Nominees or their immediate family
members had any interest in the investment adviser, subadvisers
or distributor of the Investment Companies, or any person
controlling, controlled by or under common control with such
persons. For this purpose, immediate family member
includes the Nominees spouse, children residing in the
Nominees household and dependents of the Nominee.
14
Compensation
Information relating to compensation paid to the Board Members
is set forth in Appendix B hereto.
Committees
and Meetings of Each Board
The business and affairs of each Investment Company are managed
by or under the direction of its Board.
During the fiscal year ended October 31, 2006, the Board of
TA IDEX (the TA IDEX Board) met six times. During
the fiscal year ended December 31, 2006, the Board of ATST
(the ATST Board) met six times. During the fiscal
year ended March 31, 2007, the Board of TIS (the TIS
Board) met seven times. Each Board Member then in office
attended at least 75% of the aggregate of the total number of
meetings of the Board and of the total number of meetings held
by all committees of the Board on which the member served.
TA IDEX and ATST do not hold annual meetings of shareholders,
and therefore do not have a policy regarding attendance of Board
members at annual meetings of shareholders. TIS holds annual
meetings of shareholders, but does not have a policy with regard
to attendance of Board members at such meetings. No TIS Board
members attended last years annual meeting of shareholders.
Audit
Committee
Each Board has established a separately designated Audit
Committee in accordance with the 1940 Act. Each Boards
standing Audit Committee is composed of John W. Waechter
(Chairman), Janice B. Case, Leo J. Hill, Daniel Calabria and
Peter R. Brown, each of whom is an Independent Board Member and
qualifies as an independent Board member for
purposes of New York Stock Exchange listing standards. Each
Audit Committee oversees the accounting and reporting policies
and practices of the Investment Company, oversees the quality
and integrity of the financial statements of the Investment
Company, approves, prior to appointment, the engagement of the
Investment Companys independent auditors, and reviews and
evaluates the independent auditors qualifications,
independence and performance. The Audit Committee of the TIS
Board also oversees TISs compliance with legal and
regulatory requirements and prepares the audit committee report
required by the Securities and Exchange Commission (the
SEC) to be included in the annual proxy statement
relating to each annual meeting of TIS shareholders. Each Audit
Committee acts pursuant to a written charter. A copy of the
written charter pursuant to which the Audit Committee of the TIS
Board operates was included in an appendix to TISs proxy
statement on Schedule 14A filed with the SEC on
May 31, 2007. During the fiscal year ended October 31,
2006, the Audit Committee of the TA IDEX Board met six times.
During the fiscal year ended December 31, 2006, the Audit
Committee of the ATST Board met two times. During the fiscal
year ended March 31, 2007, the Audit Committee of the TIS
Board met five times.
The Audit Committee of the TIS Board has reviewed and discussed
the audited financial statements for the fiscal year ended
March 31, 2007 with its management, and discussed certain
matters with TISs independent public accountant addressed
by Statement on Auditing Standards No. 61. The Audit
Committee has received written disclosures and a letter required
by Independence Standards Board No. 1 from the independent
public accountant and has discussed with the independent public
accountant its independence. Based on the foregoing, the Audit
Committee recommended to the TIS Board that its audited
financial statements be included in TISs Annual Report for
the fiscal year ended March 31, 2007 for filing with the
SEC.
Governance
and Nominating Committee
Each Board also has a standing Governance and Nominating
Committee composed of Leo J. Hill (Chairman), Janice B. Case,
Russell A. Kimball, Jr., John W. Waechter and Peter R.
Brown, each of whom is an Independent Board Member and qualifies
as an independent Board member for purposes of New
York Stock Exchange listing standards. Each Governance and
Nominating Committee has been established by each Board to
(i) identify individuals qualified to become members of the
Board in the event that a position is
15
vacated or created, (ii) consider all candidates proposed
to become members of the Board, (iii) select and nominate,
or recommend for nomination to the Board, candidates for
election as Board Members, and (iv) set necessary standards
or qualifications for service on the Board. Each Governance and
Nominating Committee acts pursuant to a written charter a copy
of which is attached hereto as Appendix C.
Prior to the formation of the Governance and Nominating
Committee of each Board on October 3 and 4, 2006, each Board had
a separate Governance Committee and a Nominating Committee.
During the fiscal year ended October 31, 2006, the
Governance and Nominating Committee of the TA IDEX Board met
once, and, prior to the formation of the Governance and
Nominating Committee, the Governance Committee of the TA IDEX
Board met two times and the Nominating Committee of the TA IDEX
Board met once. During the fiscal year ended December 31,
2006, the Governance and Nominating Committee of the ATST Board
did not meet and, prior to the formation of the Governance and
Nominating Committee, the Governance Committee of the ATST Board
met three times and the Nominating Committee of the ATST Board
met once. During the fiscal year ended March 31, 2007, the
Governance and Nominating Committee of the TIS Board met once
and, prior to the formation of the Governance and Nominating
Committee, the Governance Committee of the TIS Board met two
times and the Nominating Committee of the TIS Board met once.
The charter states that the Governance and Nominating Committee
is solely responsible for the selection and nomination of
potential candidates to serve on its applicable Board, the
Governance and Nominating Committee may consider and evaluate
nominations properly submitted by shareholders of a Fund.
Nominations proposed by shareholders will be properly submitted
for consideration by a Governance and Nominating Committee only
if shareholders submit their nominations in accordance with the
qualifications and procedures set forth in the charter of the
Governance and Nominating Committee. With regard to the
Nominees, the Governance and Nominating Committee referred the
consideration of their nomination to the Independent Board
Members.
In order for each Governance and Nominating Committee to
consider shareholder submissions, the following requirements,
among others, must be satisfied regarding the nominee:
|
|
|
|
|
the nominee must satisfy all qualifications provided in the
Investment Companys organizational documents, including
qualification as a possible Independent Board Member if the
nominee is to serve in that capacity;
|
|
|
|
the nominee may not be the nominating shareholder, a member of
the nominating shareholder group or a member of the immediate
family of the nominating shareholder or any member of the
nominating shareholder group;
|
|
|
|
neither the nominee nor any member of the nominees
immediate family may be currently employed or employed within
the year prior to the nomination by any nominating shareholder
entity or entity in a nominating shareholder group;
|
|
|
|
neither the nominee nor any immediate family member of the
nominee is permitted to have accepted directly or indirectly,
during the year of the election for which the nominees
name was submitted, during the immediately preceding calendar
year, or during the year when the nominees name was
submitted, any consulting, advisory, or other compensatory fee
from the nominating shareholder or any member of a nominating
shareholder group;
|
|
|
|
the nominee may not be an executive officer, director/trustee or
person fulfilling similar functions for the nominating
shareholder or any member of the nominating shareholder group,
or for an affiliate of the nominating shareholder or any such
member of the nominating shareholder group;
|
|
|
|
the nominee may not control the nominating shareholder or any
member of the nominating shareholder group (or, in the case of a
shareholder or member that is a fund, an interested person of
such shareholder or member as defined by Section 2(a)(19)
of the 1940 Act); and
|
|
|
|
a shareholder or shareholder group may not submit for
consideration a nominee who has previously been considered by
the Governance and Nominating Committee.
|
16
In addition, in order for the Governance and Nominating
Committee to consider shareholder submissions, the following
requirements must be satisfied regarding the shareholder or
shareholder group submitting the proposed nominee:
|
|
|
|
|
Any shareholder or shareholder group submitting a proposed
nominee must beneficially own, either individually or in the
aggregate, more than 5% of an Investment Companys (or a
series thereof) securities that are eligible to vote both at the
time of submission of the nominee and at the time of the Board
Member election. Each of the securities used for purposes of
calculating this ownership must have been held continuously for
at least two years as of the date of the nomination). In
addition, such securities must continue to be held through the
date of the meeting and the nominating shareholder or
shareholder group must also bear the economic risk of the
investment.
|
|
|
|
The nominating shareholder or shareholder group must also submit
a certification which provides the number of shares which the
person or group has (a) sole power to vote or direct the
vote, (b) shared power to vote or direct the vote,
(c) sole power to dispose or direct the disposition of such
shares, and (d) shared power to dispose or direct the
disposition of such shares. In addition the certification shall
provide that the shares have been held continuously for at least
two years).
|
In connection with the identification, evaluation and nomination
of candidates to the Board, each Governance and Nominating
Committee evaluates the qualifications of candidates for Board
membership and their independence from the Investment
Companys investment advisers and other principal service
providers. The Governance and Nominating Committee considers the
effect of any relationships beyond those delineated in the 1940
Act that might impair independence. In assessing the
qualification of a potential candidate for membership on the
Board, the Governance and Nominating Committee may consider the
candidates potential contribution to the operation of the
Board and its committees and such other factors as it may deem
relevant. Specific desired (but not required) qualities of
Independent Board Member candidates include:
|
|
|
|
|
public or private sector stature sufficient to instill
confidence;
|
|
|
|
high personal and professional integrity;
|
|
|
|
good business sense;
|
|
|
|
ability to commit the necessary time to prepare for and attend
meetings;
|
|
|
|
not financially dependent on Board Member retainer and meeting
fees;
|
|
|
|
general understanding of financial issues, investing, financial
markets and technology;
|
|
|
|
general understanding of balance sheets and operating statements;
|
|
|
|
first-hand knowledge of investing;
|
|
|
|
experience in working in a highly regulated and complex legal
framework;
|
|
|
|
demonstrated ability to maintain independence of
management and other service agents while maintaining a
constructive working relationship;
|
|
|
|
ability to be critical, but not confrontational;
|
|
|
|
demonstrated ability to contribute to Board and committee
process;
|
|
|
|
ability to consider diverse issues and make timely,
well-informed decisions;
|
|
|
|
familiarity with the securities industry; and
|
|
|
|
qualification as an Audit Committee Financial Expert.
|
The Governance and Nominating Committee has oversight
responsibilities and monitors certain issues, including the
advisers and subadvisers codes of ethics,
shareholder communications and shareholder complaint resolution
and disaster recovery policies, in consultation with the Chief
Compliance Officer and Independent Board Member counsel, that
affect the duties of Independent Board Members.
17
Compensation
Committee
Each Board has a Compensation Committee composed of Janice B.
Case (Chairwoman), Leo J. Hill, Russell A. Kimball, Jr.,
Peter R. Brown and Charles C. Harris, each of whom is an
Independent Board Member. Each Compensation Committee reviews
compensation arrangements for each Board Member and makes
recommendations regarding such compensation. Each Compensation
Committee meets periodically, as necessary. During the fiscal
year ended October 31, 2006, the Compensation Committee of
the TA IDEX Board met once. During the fiscal year ended
December 31, 2006, the Compensation Committee of the ATST
Board met once. During the fiscal year ended March 31,
2007, the Compensation Committee of the TIS Board met two times.
Valuation
Oversight Committee
Each Board has a Valuation Oversight Committee composed of
Russell A. Kimball, Jr. (Chairman), Robert L. Anderson,*
Peter R. Brown, Charles C. Harris and William W.
Short, Jr., each of whom is an Independent Board Member.
Each Valuation Oversight Committee oversees the process by which
the Investment Company calculates its net asset value to verify
consistency with the Investment Companys valuation
policies and procedures, industry guidance, interpretative
positions issued by the SEC and its staff, and industry best
practices. Each Valuation Oversight Committee meets
periodically, as necessary. During the fiscal year ended
October 31, 2006, the Valuation Oversight Committee of the
TA IDEX Board met three times. During the fiscal year ended
December 31, 2006, the Valuation Oversight Committee of the
ATST Board met three times. During the fiscal year ended
March 31, 2007, the Valuation Oversight Committee of the
TIS Board met three times.
Marketing
and Proxy Voting Committee
Each Board has a Marketing and Proxy Voting Committee composed
of Robert L. Anderson (Chairman),* Peter R. Brown, William W.
Short, Jr., Norm R. Nielsen and Jack E. Zimmerman,* each of
whom is an Independent Board Member. Each Marketing and Proxy
Voting Committees objective is to (i) provide
oversight and leadership relating to the marketing of the
Funds shares and to oversee the Funds distribution
arrangements, including the distribution related services
provided to the Funds and their shareholders, (ii) provide
oversight to the proxy voting committee of management, and
(iii) vote proxies on behalf of the Funds in certain
conflict situations such as in matters where the Funds
consent to vote proxies is required where a Funds
investment adviser or sub-adviser seeks such consent because of
a conflict of interest that arises in connection with a
particular vote, or for other reasons. Prior to the formation of
the Marketing and Proxy Voting Committee of each Board on
October 3 and 4, 2006, each Board had a separate Marketing
Committee and a Proxy Voting Committee. During the fiscal year
ended October 31, 2006, the Marketing and Proxy Voting
Committee of the TA IDEX Board met once and, prior to the
formation of the Marketing and Proxy Voting Committee, the
Marketing Committee of the TA IDEX Board did not meet and the
Proxy Voting Committee of the TA IDEX Board did not meet. During
the fiscal year ended December 31, 2006, the Marketing and
Proxy Voting Committee of the ATST Board did not meet and, prior
to the formation of the Marketing and Proxy Voting Committee,
the Marketing Committee of the ATST Board met once and the Proxy
Voting Committee of the ATST Board did not meet. During the
fiscal year ended March 31, 2007, the Marketing and Proxy
Voting Committee of the TIS Board met once and, prior to the
formation of the Marketing and Proxy Voting Committee, the
Marketing Committee of the TIS Board did not meet and the Proxy
Voting Committee of the TIS Board did not meet.
Contract
Review Committee
Each Board has a Contract Review Committee composed of Charles
C. Harris (Chairman), Peter R. Brown, Daniel Calabria, Norm R.
Nielsen and Jack E. Zimmerman,* each of whom is an Independent
Board Member. Each Contract Review Committee oversees the
Investment Companys relationship with key service
providers by overseeing the contract review process, helps
ensure that the best interests of the Investment
* Mr. Anderson and
Mr. Zimmerman serve as Board Members of TA IDEX only.
18
Company and its shareholders are served by the terms of each
contract and makes recommendations to the Board. Each Board, not
the Contract Review Committee, approves, rejects or continues a
contract. Each Contract Review Committee meets periodically, as
necessary. During the fiscal year ended October 31, 2006,
the Contract Review Committee of the TA IDEX Board met once.
During the fiscal year ended December 31, 2006, the
Contract Review Committee of the ATST Board met once. During the
fiscal year ended March 31, 2007, the Contract Review
Committee of the TIS Board met once.
Other
Information About TFAI
There continues to be significant federal and state regulatory
activity relating to financial services companies, particularly
mutual fund companies and their investment advisers. As part of
an ongoing investigation regarding potential market timing,
recordkeeping and trading compliance issues and matters
affecting TFAI, as investment adviser to ATST and TA IDEX, and
certain affiliates and former employees of TFAI, the SEC staff
has indicated that it is likely to take some action against TFAI
and certain of its affiliates at the conclusion of the
investigation. The potential timing and the scope of any such
action is difficult to predict. The investigation does not
affect any of the Investment Companies or the Funds. Although
the impact of any action brought against TFAI
and/or its
affiliates is difficult to assess at the present time, TFAI
believes that the likelihood that it will have a material
adverse impact on TFAI is remote. TFAI and its affiliates are
actively working with the SEC in regard to this matter; however,
the exact resolution cannot be determined at this time. TFAI
will take such actions that it deems necessary or appropriate to
continue providing management services to mutual funds and to
bring all matters to an appropriate conclusion. TFAI
and/or its
affiliates, and not the Investment Companies or the Funds, will
bear the costs regarding these regulatory matters.
Required
Vote
This Proposal I must be approved by a plurality of the
votes cast in person or by proxy at a Special Meeting at which a
quorum exists.
YOUR BOARD RECOMMENDS THAT YOU VOTE FOR THE
ELECTION OF EACH OF THE NOMINEES TO THE BOARD.
PROPOSAL II
APPROVAL OF AN AMENDMENT TO THE AGREEMENT AND DECLARATION OF
TRUST
Mutual funds are subject to comprehensive federal laws and
regulations, and in particular, the 1940 Act. Each mutual fund
is also subject to state law. TA IDEX and ATST are subject to
Delaware law because each of these Trusts is organized as an
entity known as a Delaware statutory trust. Delaware law
provides a statutory framework for the powers, duties, rights
and obligations of the trustees and the shareholders of the
statutory trust, while the more specific powers, duties, rights
and obligations of the trustees and the shareholders are
determined by the trustees and set forth in a governing
instrument, usually called an agreement and declaration of
trust. Each of the Trusts currently operates under an agreement
and declaration of trust (each, an Existing
Declaration).
At each Funds Special Meeting, shareholders entitled to
vote with respect to a Fund will be asked to approve an
amendment to the Existing Declaration applicable to that Fund.
The proposed amendment for each Existing Declaration (the
Amendment) would permit future amendments to the
agreement and declaration of trust to be made by action of the
Board without approval of the shareholders. The Existing
Declarations currently may be amended by the Boards without
shareholder approval except for (i) an amendment affecting
the voting powers specifically granted to them in the Existing
Declaration, (ii) any amendment to the amendment provisions
of the Existing Declaration, (iii) any amendment required
by law or the Trusts registration statement; and
(iv) any amendment submitted to shareholders by the Boards.
19
In addition, each Existing Declaration provides that no
amendment to the Existing Declaration may be made that would
limit the rights of insurance with respect to acts or omissions
of persons covered by the insurance provisions of the Existing
Declaration prior to such amendment, or that would limit the
rights to indemnification as provided in the Existing
Declaration. The Amendment contains similar but not identical
provisions.
The proposed Amendment and the corresponding provision in the
Existing Declarations for TA IDEX and ATST are set forth below.
|
|
|
Proposed Amendment
|
|
Corresponding Existing Provision
|
|
Amendments to Declaration and
Certificate of
Trust.
(a) The Trustees may by vote of a majority of the Trustees
then in office amend or otherwise supplement the Declaration by
making an amendment, a Declaration supplemental hereto or an
amended and restated Declaration, provided, however, that an
amendment to any provision of Article V hereof shall
require the vote of two-thirds (2/3) of the Trustees then in
office.
(b) Nothing contained in this Declaration shall permit the
amendment of this Declaration to impair the exemption from
personal liability of any Person who is or has been a
Shareholder, Trustee, officer, or employee of the Trust, or
limit the rights to indemnification or insurance provided in
Article IX with respect to actions or omissions of persons
entitled to indemnification under such Article prior to such
amendment.
(c) The Trusts Certificate of Trust may be amended
at any time for any purpose as the Trustees may determine and
such amendment shall be signed by one or more of the Trustees or
by an officer of the Trust as duly authorized by vote of a
majority of the Trustees then in office.
|
|
Amendment
Procedure. Except
as specifically provided in this section, the Trustees may,
without shareholder vote, restate, amend or otherwise supplement
this Declaration of Trust. Shareholders shall have the right to
vote (i) on any amendment that would affect their right to vote
granted in Section 5.9 hereof, (ii) on any amendment to this
section, (iii) on any amendment that may be required to be
approved by Shareholders by applicable law or by the
Trusts Registration Statement filed with the Commission,
and (iv) on any amendment submitted to them by the Trustees. Any
amendment required or permitted to be submitted to the
Shareholders that, as the Trustees determine, shall affect the
Shareholders of one or more Series or Class shall be authorized
by a vote of the Shareholders of each Series or Class affected
and no vote of Shareholders of a Series or Class not affected
shall be required. Notwithstanding anything else herein, no
amendment hereof shall limit the rights of insurance provided by
Section 4.5 with respect to acts or omissions of Persons covered
thereby prior to such amendment nor shall any such amendment
limit the rights to indemnification referenced in
Article IV hereof. The Trustees may, without Shareholder
vote, restate, amend or otherwise supplement the Certificate of
Trust as they deem necessary or desirable.
|
By allowing future amendments of an agreement and declaration of
trust without shareholder approval, the Amendment gives the
Boards the necessary authority to react quickly to future
contingencies. A Board would still be required to submit a
future amendment to a vote of a Funds shareholders if such
a vote were required by applicable law, or a Board could
determine at any time to submit a future amendment to the
agreement and declaration of trust for a vote of the
shareholders, even though not required by law or by the
agreement and declaration of trust itself.
At a meeting of the Funds Boards held in July 2007, the
Boards approved the Amendment as well as further changes to the
Existing Declarations which are designed to provide more
flexibility to the Boards in governing the Funds. Many of these
further changes approved by the Boards may be made under the
terms of the Existing Declarations without the approval or
consent of the shareholders, and each Board intends to make
these changes even if the Amendment is not approved by
shareholders. Other changes, which affect the voting rights of
shareholders provided in the Existing Declarations, will be made
only if shareholders approve the Amendment. The form of amended
and restated agreement and declaration of trust for TA IDEX and
ATST, incorporating all of the changes approved by the Boards
(the New Declaration), is attached hereto as
Appendix D. A summary of some of the more important
differences between the Existing Declarations and the New
Declarations is set forth below. The summary is qualified in its
entirety by reference to Appendix D. Shareholders
should carefully review the New Declaration and carefully
consider the differences described
20
below, as a vote in favor of the Amendment will have the effect
of authorizing the Trusts Board to adopt the New
Declaration in its entirety.
Summary
of Significant Differences between Existing Declarations and New
Declarations
The 1940 Act requires a vote by shareholders of mutual funds on
various matters that Congress has determined might have a
material effect on shareholders and their investments. For
example, shareholder consent is required under the 1940 Act and
the regulations thereunder to approve new investment advisory
agreements in most cases, an increase in an advisory fee or a
12b-1 fee,
changes to fundamental investment policies, the election of
directors or trustees in certain circumstances, and the merger
or reorganization of a fund in certain circumstances where the
merger or consolidation involves an affiliated party. The New
Declarations provide for shareholder voting as required by the
1940 Act or other applicable laws but otherwise permit,
consistent with Delaware law, actions by the Boards without
seeking the consent of shareholders. This provision permits the
Boards to act quickly in response to competitive or regulatory
conditions without the cost and delay of a meeting of the
shareholders when the Boards believe that the action is in the
best interests of shareholders. Similarly, as discussed below,
the Boards have broad authority to provide for the merger or
consolidation of the trust into another trust or entity, to
reorganize the trust or any series or class into another trust
or entity or a series or class of another entity, to sell all or
substantially all of the assets of the trust or any series or
class to another entity, or a series or class of another entity,
or to terminate the trust or any series or class. Under the
Existing Declarations, shareholders are also entitled to vote on
certain amendments to the declarations of trust, as described
above. Although under both the Existing Declarations and the New
Declarations, the Boards may terminate the Trust or a Fund
without shareholder approval, under the Existing Declarations,
but not the New Declarations, shareholders may vote to terminate
the Trust or a Fund.
The New Declarations provide for dollar-weighted voting, where
each shareholder of a Fund is entitled to one vote for each
dollar of net asset value of the Fund represented by the
shareholders shares of the Fund, on each matter on which
that shareholder is entitled to vote. This means that
shareholders with larger economic investments will have more
votes than shareholders with smaller economic investments. The
Existing Declarations provide that each share of each Fund is
entitled to one vote on each matter on which shares of that Fund
are entitled to vote. Each of TA IDEX and ATST is composed of
multiple Funds or series. Because each Fund, as a series of a
Trust, can have a different share price than other Funds that
are also series of the Trust, shareholders of a Fund with
lower-priced shares may have more voting power than shareholders
of a Fund with higher-priced shares. For example, if a
Funds shares are selling for $10 per share, a $1,000
investment will purchase 100 shares. If another Fund in the
same Trust has shares selling for $50 a share, that same $1,000
investment will purchase only 20 shares of that Fund.
Therefore, under the Existing Declarations, when shareholders of
the Trust vote together as a single class, a shareholder of the
first Fund has five times the vote of a shareholder in the
second Fund, even though the economic interest of each
shareholder is the same. For this reason, the Boards believe
that the change to dollar-weighted voting, which would assure
that a shareholders voting power matches the
shareholders economic interest in the Trust, is
appropriate.
The New Declarations provide that the Trustees may set in the
bylaws provisions relating to the calling and holding of
shareholder meetings (including the holding of meetings by
electronic or other similar means) and related matters. The
Existing Declarations specify who may call a meeting of
shareholders, and provide that a meeting may be called at any
time upon the written request of a shareholder or the holders of
not less than 10% of all of the shares entitled to be voted at
such meeting.
The New Declarations would permit the Boards to reorganize or
combine a Trust, any Fund that is a series of the Trust or any
class of a Fund, into any corporation, association, trust or
series (including another series or class of the Trust), or
other entity, whether currently existing or newly created,
without shareholder approval where approval of the shareholders
is not otherwise required under the 1940 Act. The 1940 Act
requires reorganizations or fund combinations involving
affiliated funds to be approved by the shareholders of the fund
being acquired where certain conditions are not satisfied. Like
the New Declarations, the Existing Declarations do not require
shareholder approval for reorganizations or combinations of the
Trust as a whole with other operating entities, or to merge or
reorganize a series into a newly-created entity, except when
shareholder approval would be required under the 1940 Act; the
Existing Declarations do not specifically
21
address reorganizations or combinations with other operating
entities involving only series or classes of the Trust.
Permitting the Trustees to authorize reorganizations and
combinations without seeking shareholder approval gives a Board
the flexibility, when considering reorganizations, to make
decisions it feels are in the shareholders best interests,
without causing the Funds to incur the time and expense of
soliciting approval of the shareholders. As part of the
consolidation and restructuring of the Fund Complex, it is
expected that in the relatively near future TFAI will propose
the combination of certain existing Funds. In that case, if the
Amendment is approved by shareholders and if a Board determines
that a particular fund combination is in the best interests of a
fund and its shareholders, the Board may further determine to
combine the funds without seeking approval of the shareholders,
if approval is not otherwise required under the 1940 Act. The
New Declarations require that shareholders receive written
notification of any such transaction. A fund combination or
reorganization could, in certain circumstances, adversely affect
a Funds or classs expense ratio or other aspects of
a shareholders investment.
The New Declarations and Existing Declarations authorize the
Trustees to establish classes of shares and to abolish any
classes so established. The New Declarations also specifically
authorize the Trustees to determine and change the rights and
preferences, qualifications for ownership, conversion and
exchange features, minimum purchase and account size, expenses
and charges, and other features of the classes so established,
and to combine one or more classes of a series with another
class in that series.
The Existing Declarations, unlike the New Declarations, contain
detailed provisions relating to the custody of fund assets, and
provide for shareholder voting in connection therewith under
certain circumstances. The New Declarations also change, from a
1940 Act majority vote to a two-thirds vote, the shareholder
vote required to remove a Trustee from office, as discussed
below.
If the Amendment is not approved by shareholders of a Trust,
those provisions of the New Declarations discussed above that
would change a shareholders voting rights from those
rights provided in the Existing Declarations will not go into
effect for that Trust, and the form of New Declaration for that
Trust will be accordingly revised so that it will be
substantially the same as the Existing Declarations with respect
to those voting provisions.
In addition to the changes described above, the New Declarations
contain a number of other significant changes that may be
effected without approval of the shareholders. The New
Declarations provide a detailed process for the bringing of
derivative actions by shareholders in order to permit legitimate
inquiries and claims while avoiding the time, expense,
distraction, and other harm that can be caused to a Fund or its
shareholders as a result of spurious shareholder demands and
derivative actions. The New Declarations provide that, subject
to Delaware law, prior to bringing a derivative action, a demand
by three unrelated shareholders must first be made on the
Funds Board. The provisions of the New Declarations detail
various information, certifications, undertakings and
acknowledgements that must be included in the demand. Following
receipt of the demand, the Boards have a period of 90 days,
which may be extended by an additional 60 days, to consider
the demand. If a majority of the Board Members who are
considered independent for the purposes of considering the
demand or a committee of such Boards determine that maintaining
the suit would not be in the best interests of the Fund, the
Boards are required to reject the demand and the complaining
shareholders may not proceed with the derivative action unless
the shareholders are able to sustain the burden of proof to a
court that the decision of the Boards not to pursue the
requested action was not a good faith exercise of their business
judgment on behalf of the Fund. These provisions further provide
that shareholders owning shares representing at least 5% of the
voting power of the affected Fund must join in bringing the
derivative action. If a demand is rejected, the complaining
shareholders will be responsible for the costs and expenses
(including attorneys fees) incurred by the Fund in
connection with the consideration of the demand, if a court
determines that the demand was made without reasonable cause or
for an improper purpose. If a derivative action is brought in
violation of the agreement and declaration of trust, the
shareholders bringing the action may be responsible for the
Funds costs, including attorneys fees.
The New Declarations further provide that a Fund shall be
responsible for payment of attorneys fees and legal
expenses incurred by a complaining shareholder only if required
by law, and then only fees that are
22
reasonable and that do not exceed an amount calculated using
reasonable hourly rates. The New Declarations also require that,
subject to Delaware law, actions by shareholders against a Fund
be brought only in a specified federal court in New York, or a
specified state court in New York, and provide that the right to
jury trial be waived to the fullest extent permitted by law.
The Existing Declarations provide that shareholders may not
bring or maintain any court action, proceeding or claim on
behalf of a Trust without first making demand on the Board
requesting the Board to bring the action and require that
shareholders who hold at least 10% of the outstanding shares of
the Trust, or of the outstanding shares of the series or class
to which the action relates, must join in a demand. Such demand
may be excused only when a majority of the Board, or a majority
of any committee of the Board established to consider the merits
of such action, has a personal financial interest in the
transaction at issue. Under both the New Declarations and the
Existing Declarations, a Trustee is not deemed interested in a
transaction or otherwise disqualified from ruling on the merits
of a shareholder demand by virtue of the fact that such Trustee
receives remuneration for his or her service on the Board of the
Trust or on the boards of one or more trusts that are under
common management with or otherwise affiliated with the Trust.
The Existing Declarations also set forth procedures for making
such demand and the procedures to be followed by the Boards in
considering such request, but these procedures are not as
detailed as those provided in the New Declarations.
These provisions of the New and Existing Declarations are
intended to save the time and expense of bringing a suit that a
Board in its judgment does not believe would be in the best
interests of the Trust and to align more closely the rights and
powers of shareholders and the Board of the Trust with respect
to derivative actions to those of shareholders and directors,
respectively, of a Delaware business corporation. The effect of
these provisions may be to discourage suits brought in the name
of a Trust or Fund by shareholders.
The Existing Declarations permit the Board to set a minimum
amount for shareholder accounts from time to time, and to redeem
the shares in accounts that fall below that level. The New
Declarations would continue to permit a Fund to involuntarily
redeem shares in accounts that fall below the minimum account
size set by the Board. The New Declarations would also permit,
as an alternative, fees to be charged to shareholders holding
accounts below the minimum account size, and would permit a Fund
to involuntarily redeem shares in order to pay such account
fees, and provide further flexibility to a Board to take action
with respect to minimum investment amounts as the Board may deem
necessary or appropriate. Each Fund currently pays certain costs
that are incurred in whole or in part on a per account basis. A
large number of relatively small shareholder accounts can,
therefore, materially increase a Funds expense ratio. The
Boards believe it is important for the Funds to have the
flexibility to be able to charge an additional fee for accounts
falling below a specified minimum investment level. This would
allow the Funds to cause those shareholders who maintain small
accounts to bear a fair portion of the costs of maintaining such
accounts. While the Boards have not determined to charge small
account fees, small account fees may be imposed in the future.
To the extent that a company affiliated with a Funds
investment adviser serves as the Funds transfer agent or
sub-transfer agent, the Funds investment adviser would
benefit from the payment of small account fees.
The New Declarations are similar to the Existing Declarations
with respect to those provisions governing the election,
retirement and removal of Board Members, except that under the
New Declarations, a Board Member may be removed by action of
two-thirds of the other Board Members or by vote of two-thirds
of the shareholders, with or without cause. Under the Existing
Declarations, Board Members may be removed by action of
two-thirds of the other Board Members only for cause, or by a
1940 Act majority vote of the shareholders, with or without
cause. As a result, under the New Declarations, it may be more
difficult for shareholders to remove a Board Member. Also, under
the New Declarations, the Board Members would have the power to
remove a Board Member (including a Board Member who had been
elected by shareholders) even though such Board Member had not
engaged in any conduct that would give rise to cause
for removal. A Board Member would be removed only if two-thirds
of the remaining Board Members deem such removal as necessary to
ensure the effective operation of the Board and otherwise serve
the best interest of shareholders.
23
For the avoidance of doubt, the New Declarations also clarify
that the standard of care or liability imposed upon chairpersons
of the Board, a member or chairperson of a committee of the
Board, an expert on any topic or in any area (including an audit
committee financial expert), the lead independent Board Member
or a Board Member who has special skills or any other special
appointment, designation or identification shall be the same as
that imposed on a Board Member in the absence of such
designations, appointments, expertise or identifications and
that such a designation will not affect that Board Members
rights or entitlement to indemnification. The Existing
Declarations contain such a provision only as to a Board Member
designated as a financial expert.
The New Declarations provide for the indemnification of Board
Members and officers to the fullest extent provided by law, and
the Existing Declarations similarly provide for the
indemnification of Board Members and officers. For the avoidance
of doubt, the New Declarations specifically provide that the
Trust may enter into contracts to provide indemnification to a
Board Member, officer, or any other person (including a trustee
or officer of another fund that is combined with a series of the
Trust), and such contracts would not be subject to the
indemnification provisions in the agreement and declaration of
trust, and further, that a persons right to
indemnification under the agreement and declaration of trust
does not affect any rights such person might have under contract
or law.
Both the Existing Declarations and the New Declarations provide
that no assessments may be made against shareholders of the
Funds. For the avoidance of doubt, the New Declarations make
clear that any sales loads or charges, redemption or account
fees or any other fees and charges not prohibited as charges to
shareholders under the 1940 Act or other applicable laws are not
deemed to be assessments for the purposes of this provision.
The New Declarations, unlike the Existing Declarations, permit
Board action by written consent of a majority of the Board,
rather than by all Board Members. This change will give the
Board additional flexibility to take actions without the
requirement of holding a meeting, or obtaining the consent of
the entire Board and, therefore, will allow the Board to take
actions more quickly, if necessary, and with less expense.
Each Trusts Board has approved the Amendment and
recommends that you vote to approve the Amendment also. The
Boards believe that it is in the best interests of shareholders
to permit the modernization of the Funds Existing
Declarations and to make them uniform, to the extent possible,
across all the Investment Companies in the expanded
Fund Complex. It is anticipated that the overall effect of
the changes to the declarations of trust will be to make the
administration of the Funds more efficient and provide more
flexibility for the operation of the Funds, within the limits of
applicable law. This increased flexibility may allow the Boards
to react more quickly to changes in competitive and regulatory
conditions. Adoption of the Amendment and any subsequent changes
to the declarations of trust will not remove any of the
protections provided to shareholders of mutual funds under
federal law or alter in any way the Boards existing
fiduciary obligations under both federal and Delaware law to act
with due care and in the best interests of the shareholders.
Before utilizing any new flexibility that the New Declarations
may afford, the Boards must first consider shareholders
interests and then act in accordance with those interests.
You should note that your Funds current investments and
investment policies will not change by virtue of the adoption of
the Amendment or the New Declarations.
Required
Vote
To become effective for a Trust, Proposal II must be
approved by a majority of the shares entitled to vote and voting
on the matter, with the shareholders of each Fund that is a
series of that Trust voting together as a single class.
YOUR BOARD RECOMMENDS THAT YOU VOTE FOR THE
APPROVAL OF THE AMENDMENT TO THE AGREEMENT AND DECLARATION OF
TRUST.
24
OTHER
BUSINESS
The Board Members do not know of any matters to be presented at
the Special Meetings other than those set forth in this Joint
Proxy Statement. If other business should properly come before
the Special Meetings, proxies will be voted in accordance with
the judgment of the persons named in the accompanying proxy.
ADDITIONAL
INFORMATION
Administrator,
Transfer Agent and Principal Underwriter
Transamerica Fund Services, Inc. (TFS), the
administrator of the Funds, is located at 570 Carillon Parkway,
St. Petersburg, Florida 33716. TFS is also the transfer agent of
TA IDEX and ATST. Mellon Investors Services, LLC, Newport Office
Center VII, 480 Washington Boulevard, Jersey City, New Jersey
07310 is TISs transfer agent. The current principal
underwriter/distributor of the Funds (other than TIS) is
Transamerica Capital, Inc. (TCI), located at 4600
South Syracuse Street, Suite 1100, Denver, Colorado 80237.
TFAI, TFS and TCI are all affiliated due to their common
ultimate ownership by AEGON, N.V.
Annual
and Semi-Annual Reports
Shareholders of TA IDEX can find important information about TA
IDEXs funds in their annual reports dated October 31,
2006 and their semi-annual reports dated April 30, 2007
which have been previously mailed to shareholders. Shareholders
of ATST can find important information about ATSTs
portfolios in their annual reports dated December 31, 2006
and their semi-annual reports dated June 30, 2007, which
have been or are being mailed to shareholders. Shareholders of
TIS can find important information about TIS in its annual
report dated March 31, 2007, which has been previously
mailed to shareholders. You may obtain copies of these reports
without charge by writing to the Funds at the address shown on
the first page of this Joint Proxy Statement or by calling the
Funds at (888) 233-4339.
Proxy
Solicitation
The principal solicitation of proxies will be by the mailing of
this Joint Proxy Statement beginning on or about August 27,
2007, but proxies may also be solicited by telephone
and/or in
person by representatives of the Funds, regular employees of
TFAI or its affiliate(s), or Computershare Fund Services
(Computershare), a private proxy services firm. The
estimated cost of retaining Computershare is approximately
$3.9 million. If we have not received your vote as the date
of the Special Meeting approaches, you may receive a call from
these parties to ask for your vote. Arrangements will be made
with brokerage houses and custodians, nominees and fiduciaries
to forward proxies and proxy materials to their clients.
The cost of the Special Meetings, including the preparation and
mailing of the notice, Joint Proxy Statement and the
solicitation of proxies, including reimbursement to
broker-dealer and others who forwarded proxy materials to their
clients, will be borne by TFAI
and/or its
affiliates.
Independent
Registered Public Accounting Firm
The Board Members, including a majority of the independent Board
Members, of each Fund have selected PricewaterhouseCoopers LLP
(PwC) as the independent registered public
accounting firm for the Funds. PwC, in accordance with
Independence Standards Board Standard No. 1 (ISB
No. 1), has confirmed to each applicable Audit Committee
that it is an independent registered public accounting firm with
respect to the Funds.
Each Funds Audit Committee approved the engagement of PwC
as each Funds independent registered public accounting
firm for the Funds most recent fiscal year, as well as for
the current fiscal year. PwC provides audit and accounting
services including audit to the annual financial statements,
assistance and consultation with respect to filings with the
SEC, and preparation for annual income tax returns.
25
The reports of PwC on each Funds financial statements for
each of the last two fiscal years audited by PwC contained no
adverse opinion or disclaimer of opinion and were not qualified
or modified as to uncertainty, audit scope or accounting
principles. There have been no disagreements with PwC during
such fiscal years and any subsequent interim period on any
matter of accounting principles or practices, financial
statement disclosure or auditing scope or procedure which, if
not resolved to the satisfaction of PwC, would have caused them
to make reference thereto in their reports on the financial
statements for such years.
No representatives of PwC will be present at the Special
Meetings.
Appendix E sets forth for each Fund, for each of the
Funds two most recent fiscal years, the fees billed by the
Funds independent registered public accounting firm for
all audit and non-audit services provided directly to the Fund.
The fee information in Appendix E is presented under
the following captions:
(a) Audit Fees fees related to the audit
and review of the financial statements included in annual
reports and registration statements, and other services that are
normally provided in connection with statutory and regulatory
filings or engagements.
(b) Audit-Related Fees fees related to
assurance and related services that are reasonably related to
the performance of the audit or review of financial statements,
but not reported under Audit Fees including
accounting consultations,
agreed-upon
procedure reports, attestation reports, comfort letters and
internal control reviews not required by regulators.
(c) Tax Fees fees associated with tax
compliance, tax advice and tax planning, including services
relating to the filing or amendment of federal, state or local
income tax returns, regulated investment company qualification
reviews and tax distribution and analysis reviews.
(d) All Other Fees fees for products and
services provided to the Fund other than those reported under
Audit Fees, Audit-Related Fees and
Tax Fees.
The charter of each Audit Committee requires that the Audit
Committee shall approve (a) all audit and permissible
non-audit services to be provided to each Fund and (b) all
permissible non-audit services to be provided by the Funds
independent auditors to TFAI and any service providers
controlling, controlled by or under common control with TFAI
that provide ongoing services to the Fund (Covered Service
Providers) if the engagement relates directly to the
operations and financial reporting of the Fund. The Audit
Committee may implement policies and procedures by which such
services are approved other than by the full Audit Committee.
No Audit Committee may approve non-audit services that the Audit
Committee believes may impair the independence of the
independent registered public accounting firms. Permissible
non-audit services include any professional services (including
tax services) that are not prohibited services as described
below provided to the Fund by the independent registered public
accounting firms, other than those provided to a Fund in
connection with an audit or a review of the financial statements
of the Fund. Permissible non-audit services may not include
(a) bookkeeping or other services related to the accounting
records or financial statements of the Fund; (b) financial
information systems design and implementation;
(c) appraisal or valuation services, fairness opinions or
contribution-in-kind
reports; (d) actuarial services; (e) internal audit
outsourcing services; (f) management functions or human
resources; (g) broker or dealer, investment adviser or
investment banking services; (h) legal services and expert
services unrelated to the audit; and (i) any other service
the Public Company Accounting Oversight Board determines, by
regulation, is impermissible.
Pre-approval by the Audit Committee of any permissible non-audit
services is not required so long as: (a) the aggregate
amount of all such permissible non-audit services provided to a
Fund, TFAI and any Covered Service Provider constitutes not more
than 5% of the total amount of revenues paid to the independent
registered public accounting firms during the fiscal year in
which the permissible non-audit services are provided to
(i) the Fund, (ii) TFAI and (iii) any Covered
Service Provider during the fiscal year in which services are
provided that would not have to be approved by the Audit
Committee; (b) the permissible non-audit services were not
recognized by the Fund at the time of the engagement to be
non-audit services; and
26
(c) such services are promptly brought to the attention of
the Audit Committee and approved by the Audit Committee (or its
delegate(s)) prior to completion of the audit.
Each Audit Committee has considered whether the provision of
non-audit services that were rendered by PwC to TFAI and Covered
Service Providers that were not pre-approved (not requiring
pre-approval) is compatible with maintaining such auditors
independence. All services provided by PwC to each Fund, TFAI or
Covered Service Providers that were required to be pre-approved
were pre-approved as required.
For each Funds two most recent fiscal years, there were no
services rendered by PwC to the Fund for which the pre-approval
requirement was waived.
There were no non-audit fees billed by PwC for services rendered
to TA IDEX in each of the last two fiscal years ended
October 31, 2005 and October 31, 2006, respectively.
In addition, there were no non-audit fees billed by PwC for
services rendered to TFAI or any Covered Service Provider(s)
that provide ongoing services to TA IDEX in each of the last two
fiscal years ended October 31, 2005 and October 31,
2006, respectively.
There were no non-audit fees billed by PwC for services rendered
to ATST in each of the last two fiscal years ended
December 31, 2005 and December 31, 2006, respectively.
In addition, there were no non-audit fees billed by PwC for
services rendered to TFAI or any Covered Service Provider(s)
that provide ongoing services to ATST in each of the last two
fiscal years ended December 31, 2005 and December 31,
2006, respectively.
There were no non-audit fees billed by PwC for services rendered
to TIS in each of the last two fiscal years ended March 31,
2006 and March 31, 2007, respectively. In addition, there
were no aggregate non-audit fees billed by PwC for services
rendered to TFAI or any Covered Service Provider(s) that
provides ongoing services to TIS in each of the last two fiscal
years ended March 31, 2006 and March 31, 2007,
respectively.
5% Share
Ownership
As of August 15, 2007, the persons listed in
Appendix F owned of record the amount of shares of
the Funds indicated in Appendix F.
Compliance
with Section 16(a) of the Securities Exchange Act of
1934
Applicable laws require Board members and officers of TIS, TFAI,
the affiliated persons of TFAI and the beneficial owners of more
than 10% of the interests of TIS (collectively, Reporting
Persons) to file initial reports of ownership and reports
of changes in ownership with the SEC and the New York Stock
Exchange and to provide copies of these reports to TIS. Based
solely on its review of the copies of such forms received by it
and written representations of certain Reporting Persons, TIS
believes that no person owned beneficially more than 10% of its
interests during the fiscal year ended March 31, 2007 and
that the Reporting Persons complied with all applicable filing
requirements during such period.
Shareholders
Communications to the Boards
Shareholders of a Fund may mail written communications to the
Funds Board, addressed to the care of the Secretary of the
Fund, at the Funds address. Each shareholder communication
must (i) be in writing and be signed by the shareholder,
and (ii) identify the full name of the Fund. The Secretary
is responsible for collecting, reviewing and organizing all
properly submitted shareholder communications. Except as
provided below, with respect to each properly submitted
shareholder communication, the Secretary will either
(i) provide a copy of the communication to the Board at the
next regularly scheduled Board meeting, or (ii) if the
Secretary determines that the communication requires more
immediate attention, forward the communication to the Board
promptly after receipt. The Secretary may, in good faith,
determine that a shareholder communication should not be
provided to the Board because the communication, among other
things, (i) does not reasonably relate to the Fund or its
operations, management, activities, policies, service providers,
Board, officers, shareholders or other matters relating to an
investment in the Fund, or (ii) is ministerial in nature
(such as a request for Fund literature, share data or financial
information).
27
Shareholders
Sharing the Same Address
As permitted by law, each Fund will deliver only one copy of
this Joint Proxy Statement to shareholders or owners of variable
annuity contracts and variable life policies, as applicable,
(for purposes of this paragraph, collectively,
shareholders) residing at the same address, unless
such shareholders have notified the Fund of their desire to
receive multiple copies of the shareholder reports and proxy
statements the Fund sends. If you would like to receive an
additional copy, please contact your Fund by writing to the
address shown on the front page of this Joint Proxy Statement or
by calling the Funds at
(888) 233-4339.
The Fund will then promptly deliver, upon request, a separate
copy of this Joint Proxy Statement to any shareholder residing
at an address to which only one copy was mailed. Shareholders
wishing to receive separate copies of each Funds
shareholder reports and proxy statements in the future, and
shareholders sharing an address that wish to receive a single
copy if they are receiving multiple copies, should also send a
request as indicated.
Shareholder
Proposals
As a general matter, neither ATST nor TA IDEX holds annual
shareholder meetings. Shareholders wishing to submit proposals
for inclusion in a proxy statement for a subsequent meeting (if
any) should send their written proposals to Dennis P. Gallagher,
Secretary, 570 Carillon Parkway, St. Petersburg, Florida 33716.
Proposals relating to Funds that are series of ATST or TA IDEX
must be received a reasonable time prior to the date of a
meeting of shareholders of the applicable Fund to be considered
for inclusion in the proxy materials for the meeting. Timely
submission of a proposal does not, however, necessarily mean
that the proposal will be included. Persons named as proxies for
any subsequent shareholder meeting will vote in their discretion
with respect to proposals submitted on an untimely basis.
Shareholders of TIS wishing to submit proposals for inclusion in
a proxy statement for its next annual shareholder meeting should
send their written proposals to Dennis P. Gallagher, Secretary,
570 Carillon Parkway, St. Petersburg, Florida 33716 no later
than January 29, 2008 in order to be included in the
Funds proxy statement and form of proxy relating to that
subsequent meeting. Notice of a proposal will be considered
untimely if it is submitted after April 9, 2008. However,
timely submission of a proposal does not necessarily mean that
the proposal will be included in the funds proxy
statement. If a shareholder fails to give timely notice, then
the persons named as proxies in the proxies solicited by the
Board for the Funds annual meeting of shareholders in
2008 may exercise discretionary voting power, to the extent
permitted by New York Stock Exchange rules, with respect to any
such proposal.
Fiscal
Year
The fiscal year end of each Fund that is a series of ATST is
December 31. The fiscal year end of each Fund that is a
series of TA IDEX is October 31. The fiscal year end of TIS
is March 31.
General
Management does not intend to present and does not have reason
to believe that any other items of business will be presented at
any Special Meeting. However, if other matters are properly
presented to a Special Meeting for a vote, the proxies will be
voted by the persons acting under the proxies upon such matters
in accordance with their judgment of the best interests of the
applicable Fund.
A list of shareholders entitled to be present and to vote at the
Special Meetings will be available at the offices of the Funds,
570 Carillon Parkway, St. Petersburg, Florida 33716 for
inspection by any shareholder during regular business hours
beginning ten days prior to the date of the Special Meetings.
Failure of a quorum to be present at a Special Meeting will
necessitate adjournment. The persons named in the enclosed proxy
may also move for an adjournment of a Special Meeting to permit
further solicitation of proxies with respect to any of the
proposals if they determine that adjournment and further
solicitation are reasonable and in the best interests of
shareholders. Under each Funds By-Laws, an adjournment of
a meeting requires the affirmative vote of a majority of the
shares present in person or represented by proxy at the meeting.
28
Information
about the Funds
Each of the Funds is subject to the informational requirements
of the Securities Exchange Act of 1934, as amended, and certain
other federal securities statutes, and files reports and other
information with the SEC. Proxy materials, reports and other
information filed by the Funds can be inspected and copied at
the Public Reference Facilities maintained by the SEC at
100 F Street, NE, Washington, DC 20549. The SEC
maintains an Internet web site (at
http://www.sec.gov),
which contains other information about the Funds.
Please submit your voting instructions promptly by signing
and dating each enclosed proxy card and returning it in the
accompanying postage-paid return envelope OR by following the
enclosed instructions to similarly providing voting instructions
by telephone or by the Internet.
To ensure the presence of a quorum at the Special Meetings,
we request prompt execution and return of the enclosed proxy. A
self-addressed, postage-paid envelope is enclosed for your
convenience.
|
|
|
|
|
By Order of the Board of each
of Transamerica IDEX Mutual Funds, AEGON/Transamerica Series
Trust and Transamerica Income Shares, Inc.
|
|
|
|
,
2007
|
|
|
570 Carillon Parkway
|
|
Dennis P. Gallagher
|
St. Petersburg, FL 33716
|
|
Senior Vice President, Secretary
and General Counsel
|
29
LIST OF
APPENDICES
|
|
|
Appendix A:
|
|
Funds Issued and Outstanding
Shares
|
Appendix B:
|
|
Compensation of the Board Members
|
Appendix C:
|
|
Governance and Nominating
Committee Charter
|
Appendix D:
|
|
Form of New Agreement and
Declaration of Trust
|
Appendix E:
|
|
Audit Fees, Audit-Related Fees,
Tax Fees and All Other Fees
|
Appendix F:
|
|
Beneficial Owners of 5% or More of
the Outstanding Shares of the Funds
|
30
Appendix A
Funds
Issued and Outstanding Shares
|
|
|
|
|
Outstanding Shares
|
Fund
|
|
as of the Record Date
|
|
Transamerica IDEX Mutual
Funds
|
|
|
TA IDEX AllianceBernstein
International Value
|
|
|
TA IDEX American Century Large
Company Value
|
|
|
TA IDEX Asset
Allocation Conservative Portfolio
|
|
|
TA IDEX Asset
Allocation Growth Portfolio
|
|
|
TA IDEX Asset
Allocation Moderate Growth Portfolio
|
|
|
TA IDEX Asset
Allocation Moderate Portfolio
|
|
|
TA IDEX Bjurman, Barry Micro
Emerging Growth
|
|
|
TA IDEX BlackRock Global Allocation
|
|
|
TA IDEX BlackRock Large Cap Value
|
|
|
TA IDEX BlackRock Natural Resources
|
|
|
TA IDEX Clarion Global Real Estate
Securities
|
|
|
TA IDEX Evergreen Health Care
|
|
|
TA IDEX Evergreen International
Small Cap
|
|
|
TA IDEX Federated Market
Opportunity
|
|
|
TA IDEX Jennison Growth
|
|
|
TA IDEX JPMorgan International Bond
|
|
|
TA IDEX JPMorgan Mid Cap Value
|
|
|
TA IDEX Legg Mason Partners All Cap
|
|
|
TA IDEX Legg Mason Partners
Investors Value
|
|
|
TA IDEX Loomis Sayles Bond
|
|
|
TA IDEX Marsico Growth
|
|
|
TA IDEX Marsico International
Growth
|
|
|
TA IDEX Mellon Market Neutral
Strategy
|
|
|
TA IDEX MFS International Equity
|
|
|
TA IDEX Multi-Manager Alternative
Strategies Fund
|
|
|
TA IDEX Multi-Manager
International Fund
|
|
|
TA IDEX Neuberger Berman
International
|
|
|
TA IDEX Oppenheimer Developing
Markets
|
|
|
TA IDEX Oppenheimer
Small- & Mid-Cap Value
|
|
|
TA IDEX PIMCO Real Return TIPS
|
|
|
TA IDEX PIMCO Total Return
|
|
|
TA IDEX Protected Principal Stock
|
|
|
TA IDEX Templeton Transamerica
Global
|
|
|
TA IDEX Third Avenue Value
|
|
|
TA IDEX Transamerica Balanced
|
|
|
TA IDEX Transamerica Convertible
Securities
|
|
|
TA IDEX Transamerica Equity
|
|
|
TA IDEX Transamerica Flexible
Income
|
|
|
TA IDEX Transamerica Growth
Opportunities
|
|
|
TA IDEX Transamerica High-Yield
Bond
|
|
|
A-1
|
|
|
|
|
Outstanding Shares
|
Fund
|
|
as of the Record Date
|
|
TA IDEX Transamerica Money Market
|
|
|
TA IDEX Transamerica
Science & Technology
|
|
|
TA IDEX Transamerica Short-Term
Bond
|
|
|
TA IDEX Transamerica Small/Mid Cap
Value
|
|
|
TA IDEX Transamerica Value Balanced
|
|
|
TA IDEX UBS Dynamic Alpha
|
|
|
TA IDEX UBS Large Cap Value
|
|
|
TA IDEX Van Kampen Emerging
Markets Debt
|
|
|
TA IDEX Van Kampen Mid-Cap Growth
|
|
|
TA IDEX Van Kampen Small Company
Growth
|
|
|
AEGON/Transamerica
Series Trust
|
|
|
American Century Large Company
Value
|
|
|
Asset Allocation
Conservative Portfolio
|
|
|
Asset Allocation
Growth Portfolio
|
|
|
Asset Allocation
Moderate Growth Portfolio
|
|
|
Asset Allocation
Moderate Portfolio
|
|
|
BlackRock Large Cap Value
|
|
|
Capital Guardian Global
|
|
|
Capital Guardian U.S. Equity
|
|
|
Capital Guardian Value
|
|
|
Clarion Global Real Estate
Securities
|
|
|
Federated Market Opportunity
|
|
|
International Moderate Growth Fund
|
|
|
Jennison Growth
|
|
|
JPMorgan Core Bond
|
|
|
JPMorgan Enhanced Index
|
|
|
JPMorgan Mid Cap Value
|
|
|
Legg Mason Partners All Cap
|
|
|
Marsico Growth
|
|
|
MFS High Yield
|
|
|
MFS International Equity
|
|
|
Munder Net50
|
|
|
PIMCO Total Return
|
|
|
Templeton Transamerica Global
|
|
|
Third Avenue Value
|
|
|
Transamerica Balanced
|
|
|
Transamerica Convertible Securities
|
|
|
Transamerica Equity
|
|
|
Transamerica Equity II
|
|
|
Transamerica Growth Opportunities
|
|
|
Transamerica Money Market
|
|
|
Transamerica Science &
Technology
|
|
|
Transamerica Small/Mid Cap Value
|
|
|
Transamerica U.S. Government
Securities
|
|
|
A-2
|
|
|
|
|
Outstanding Shares
|
Fund
|
|
as of the Record Date
|
|
Transamerica Value Balanced
|
|
|
T. Rowe Price Equity Income
|
|
|
T. Rowe Price Growth Stock
|
|
|
T. Rowe Price Small Cap
|
|
|
Van Kampen Active International
Allocation
|
|
|
Van Kampen Large Cap Core
|
|
|
Van Kampen Mid-Cap Growth
|
|
|
Transamerica Income Shares,
Inc.
|
|
|
A-3
Appendix B
Compensation
of the Board Members
Members of each Board who are not interested
persons, as defined in the 1940 Act, receive an annual
retainer fee as well as an additional annual fee for service on
one or more committees and are reimbursed for all travel and
out-of-pocket expenses relating to attendance at such meetings.
Mr. John K. Carter, an interested person, as
defined in the 1940 Act, does not receive compensation from the
Funds, but may be reimbursed for out-of-pocket expenses relating
to attendance at such meetings.
TA IDEX
Board
Each Independent Board Member of the TA IDEX Board receives a
total annual retainer fee of $64,000 from the Funds that are
series of TA IDEX (collectively, the TA IDEX Funds).
Each TA IDEX Fund pays a pro rata share of the fee allocable to
the Fund based on the relative assets of the Fund. The Chairman
of the Board also receives an additional retainer of $20,000 per
year. Effective January 1, 2007, a TA IDEX Board Member
serving on one committee of the TA IDEX Board will receive an
additional annual fee of $3,000 and a TA IDEX Board Member that
serves on two or more committees will receive an additional
annual fee of $6,000. Any Audit Committee Financial
Expert of the Audit Committee also receives an additional
retainer of $5,000. Any fees and expenses paid to Board Members
who are affiliates of TFAI or Transamerica Capital, Inc., the
Funds underwriter and distributor (TCI), are
paid by TFAI
and/or TCI
and not by the TA IDEX Funds. During the fiscal year ended
October 31, 2006, the TA IDEX Funds reimbursed Board Member
expenses in an aggregate amount of $16,313. TA IDEX Board
Members who also serve on the ATST Board or the
TIS Board receive compensation for service on those Boards
as well, as discussed in this Appendix B.
Under a non-qualified deferred compensation plan effective
January 1, 1996 (the Deferred Compensation
Plan) all or a portion of compensation that would
otherwise be payable to an Independent Board Member on a current
basis for services rendered as a member of the TA IDEX Board may
be deferred. Deferred compensation amounts will accumulate based
on the value of Class A shares of a Fund (without
imposition of a sales charge), as elected by the Board Member.
It is not anticipated that the Deferred Compensation Plan will
have any material impact on the TA IDEX Funds.
The following table sets forth the compensation amounts paid to
the Independent Board Members of the TA IDEX Board for the
fiscal year ended October 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert
|
|
|
Peter
|
|
|
|
|
|
Janice
|
|
|
Charles
|
|
|
Leo
|
|
|
Russell
|
|
|
Norm
|
|
|
William
|
|
|
John
|
|
|
Jack
|
|
|
|
L.
|
|
|
R.
|
|
|
Daniel
|
|
|
B.
|
|
|
C.
|
|
|
J.
|
|
|
A.
|
|
|
R.
|
|
|
W.
|
|
|
W.
|
|
|
E.
|
|
Fund
|
|
Anderson
|
|
|
Brown
|
|
|
Calabria
|
|
|
Case
|
|
|
Harris
|
|
|
Hill
|
|
|
Kimball, Jr.
|
|
|
Nielsen
|
|
|
Short, Jr.
|
|
|
Waechter
|
|
|
Zimmerman
|
|
|
TA IDEX AllianceBernstein
International Value
|
|
$
|
785
|
|
|
$
|
1,178
|
|
|
$
|
923
|
|
|
$
|
923
|
|
|
$
|
923
|
|
|
$
|
923
|
|
|
$
|
847
|
|
|
$
|
220
|
|
|
$
|
923
|
|
|
$
|
975
|
|
|
$
|
785
|
|
TA IDEX American Century Large
Company Value
|
|
|
966
|
|
|
|
1,450
|
|
|
|
1,136
|
|
|
|
1,136
|
|
|
|
1,136
|
|
|
|
1,136
|
|
|
|
1,043
|
|
|
|
271
|
|
|
|
1,136
|
|
|
|
1,200
|
|
|
|
966
|
|
TA IDEX Asset
Allocation Conservative Portfolio
|
|
|
1,574
|
|
|
|
2,361
|
|
|
|
1,850
|
|
|
|
1,850
|
|
|
|
1,850
|
|
|
|
1,850
|
|
|
|
1,698
|
|
|
|
442
|
|
|
|
1,850
|
|
|
|
1,954
|
|
|
|
1,574
|
|
TA IDEX Asset
Allocation Growth Portfolio
|
|
|
4,011
|
|
|
|
6,017
|
|
|
|
4,715
|
|
|
|
4,715
|
|
|
|
4,715
|
|
|
|
4,715
|
|
|
|
4,328
|
|
|
|
1,126
|
|
|
|
4,715
|
|
|
|
4,979
|
|
|
|
4,011
|
|
TA IDEX Asset
Allocation Moderate Growth Portfolio
|
|
|
7,484
|
|
|
|
11,225
|
|
|
|
8,797
|
|
|
|
8,797
|
|
|
|
8,797
|
|
|
|
8,797
|
|
|
|
8,074
|
|
|
|
2,101
|
|
|
|
8,797
|
|
|
|
9,289
|
|
|
|
7,484
|
|
TA IDEX Asset
Allocation Moderate Portfolio
|
|
|
4,664
|
|
|
|
6,996
|
|
|
|
5,482
|
|
|
|
5,482
|
|
|
|
5,482
|
|
|
|
5,482
|
|
|
|
5,032
|
|
|
|
1,309
|
|
|
|
5,482
|
|
|
|
5,789
|
|
|
|
4,664
|
|
TA IDEX Bjurman, Barry Micro
Emerging Growth
|
|
|
130
|
|
|
|
195
|
|
|
|
153
|
|
|
|
153
|
|
|
|
153
|
|
|
|
153
|
|
|
|
140
|
|
|
|
36
|
|
|
|
153
|
|
|
|
161
|
|
|
|
130
|
|
TA IDEX BlackRock Global Allocation
|
|
|
1,165
|
|
|
|
1,747
|
|
|
|
1,369
|
|
|
|
1,369
|
|
|
|
1,369
|
|
|
|
1,369
|
|
|
|
1,257
|
|
|
|
327
|
|
|
|
1,369
|
|
|
|
1,446
|
|
|
|
1,165
|
|
B-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert
|
|
|
Peter
|
|
|
|
|
|
Janice
|
|
|
Charles
|
|
|
Leo
|
|
|
Russell
|
|
|
Norm
|
|
|
William
|
|
|
John
|
|
|
Jack
|
|
|
|
L.
|
|
|
R.
|
|
|
Daniel
|
|
|
B.
|
|
|
C.
|
|
|
J.
|
|
|
A.
|
|
|
R.
|
|
|
W.
|
|
|
W.
|
|
|
E.
|
|
Fund
|
|
Anderson
|
|
|
Brown
|
|
|
Calabria
|
|
|
Case
|
|
|
Harris
|
|
|
Hill
|
|
|
Kimball, Jr.
|
|
|
Nielsen
|
|
|
Short, Jr.
|
|
|
Waechter
|
|
|
Zimmerman
|
|
|
TA IDEX BlackRock Large Cap Value
|
|
|
1,473
|
|
|
|
2,210
|
|
|
|
1,732
|
|
|
|
1,732
|
|
|
|
1,732
|
|
|
|
1,732
|
|
|
|
1,590
|
|
|
|
414
|
|
|
|
1,732
|
|
|
|
1,829
|
|
|
|
1,473
|
|
TA IDEX BlackRock Natural Resources*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Clarion Global Real Estate
Securities
|
|
|
535
|
|
|
|
802
|
|
|
|
628
|
|
|
|
628
|
|
|
|
628
|
|
|
|
628
|
|
|
|
577
|
|
|
|
150
|
|
|
|
628
|
|
|
|
664
|
|
|
|
535
|
|
TA IDEX Evergreen Health Care
|
|
|
1,309
|
|
|
|
1,963
|
|
|
|
1,538
|
|
|
|
1,538
|
|
|
|
1,538
|
|
|
|
1,538
|
|
|
|
1,412
|
|
|
|
367
|
|
|
|
1,538
|
|
|
|
1,624
|
|
|
|
1,309
|
|
TA IDEX Evergreen International
Small Cap
|
|
|
1,029
|
|
|
|
1,543
|
|
|
|
1,209
|
|
|
|
1,209
|
|
|
|
1,209
|
|
|
|
1,209
|
|
|
|
1,110
|
|
|
|
289
|
|
|
|
1,209
|
|
|
|
1,277
|
|
|
|
1,029
|
|
TA IDEX Federated Market Opportunity
|
|
|
290
|
|
|
|
436
|
|
|
|
341
|
|
|
|
341
|
|
|
|
341
|
|
|
|
341
|
|
|
|
313
|
|
|
|
82
|
|
|
|
341
|
|
|
|
360
|
|
|
|
290
|
|
TA IDEX Jennison Growth
|
|
|
452
|
|
|
|
678
|
|
|
|
531
|
|
|
|
531
|
|
|
|
531
|
|
|
|
531
|
|
|
|
487
|
|
|
|
127
|
|
|
|
531
|
|
|
|
561
|
|
|
|
452
|
|
TA IDEX JPMorgan International Bond
|
|
|
1,519
|
|
|
|
2,279
|
|
|
|
1,786
|
|
|
|
1,786
|
|
|
|
1,786
|
|
|
|
1,786
|
|
|
|
1,639
|
|
|
|
426
|
|
|
|
1,786
|
|
|
|
1,886
|
|
|
|
1,519
|
|
TA IDEX JPMorgan Mid Cap Value
|
|
|
785
|
|
|
|
1,177
|
|
|
|
923
|
|
|
|
923
|
|
|
|
923
|
|
|
|
923
|
|
|
|
847
|
|
|
|
220
|
|
|
|
923
|
|
|
|
974
|
|
|
|
785
|
|
TA IDEX Legg Mason Partners All Cap
|
|
|
360
|
|
|
|
540
|
|
|
|
423
|
|
|
|
423
|
|
|
|
423
|
|
|
|
423
|
|
|
|
388
|
|
|
|
101
|
|
|
|
423
|
|
|
|
447
|
|
|
|
360
|
|
TA IDEX Legg Mason Partners
Investors Value
|
|
|
529
|
|
|
|
794
|
|
|
|
622
|
|
|
|
622
|
|
|
|
622
|
|
|
|
622
|
|
|
|
571
|
|
|
|
149
|
|
|
|
622
|
|
|
|
657
|
|
|
|
529
|
|
TA IDEX Loomis Sayles Bond
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Marsico Growth
|
|
|
476
|
|
|
|
715
|
|
|
|
560
|
|
|
|
560
|
|
|
|
560
|
|
|
|
560
|
|
|
|
514
|
|
|
|
134
|
|
|
|
560
|
|
|
|
591
|
|
|
|
476
|
|
TA IDEX Marsico International Growth
|
|
|
1,122
|
|
|
|
1,682
|
|
|
|
1,318
|
|
|
|
1,318
|
|
|
|
1,318
|
|
|
|
1,318
|
|
|
|
1,210
|
|
|
|
315
|
|
|
|
1,318
|
|
|
|
1,392
|
|
|
|
1,122
|
|
TA IDEX Mellon Market Neutral
Strategy*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX MFS International Equity
|
|
|
219
|
|
|
|
329
|
|
|
|
257
|
|
|
|
257
|
|
|
|
257
|
|
|
|
257
|
|
|
|
236
|
|
|
|
61
|
|
|
|
257
|
|
|
|
272
|
|
|
|
219
|
|
TA IDEX Multi-Manager Alternative
Strategies Fund*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Multi-Manager International
Fund
|
|
|
286
|
|
|
|
430
|
|
|
|
337
|
|
|
|
337
|
|
|
|
337
|
|
|
|
337
|
|
|
|
309
|
|
|
|
80
|
|
|
|
337
|
|
|
|
355
|
|
|
|
286
|
|
TA IDEX Neuberger Berman
International
|
|
|
1,419
|
|
|
|
2,129
|
|
|
|
1,668
|
|
|
|
1,668
|
|
|
|
1,668
|
|
|
|
1,668
|
|
|
|
1,531
|
|
|
|
398
|
|
|
|
1,668
|
|
|
|
1,762
|
|
|
|
1,419
|
|
TA IDEX Oppenheimer Developing
Markets
|
|
|
1,079
|
|
|
|
1,618
|
|
|
|
1,268
|
|
|
|
1,268
|
|
|
|
1,268
|
|
|
|
1,268
|
|
|
|
1,164
|
|
|
|
303
|
|
|
|
1,268
|
|
|
|
1,339
|
|
|
|
1,079
|
|
TA IDEX Oppenheimer Small- &
Mid-Cap Value
|
|
|
268
|
|
|
|
402
|
|
|
|
315
|
|
|
|
315
|
|
|
|
315
|
|
|
|
315
|
|
|
|
289
|
|
|
|
75
|
|
|
|
315
|
|
|
|
332
|
|
|
|
268
|
|
TA IDEX PIMCO Real Return TIPS
|
|
|
2,110
|
|
|
|
3,165
|
|
|
|
2,480
|
|
|
|
2,480
|
|
|
|
2,480
|
|
|
|
2,480
|
|
|
|
2,276
|
|
|
|
592
|
|
|
|
2,480
|
|
|
|
2,619
|
|
|
|
2,110
|
|
TA IDEX PIMCO Total Return
|
|
|
816
|
|
|
|
1,225
|
|
|
|
960
|
|
|
|
960
|
|
|
|
960
|
|
|
|
960
|
|
|
|
881
|
|
|
|
229
|
|
|
|
960
|
|
|
|
1,013
|
|
|
|
816
|
|
TA IDEX Protected Principal Stock
|
|
|
144
|
|
|
|
217
|
|
|
|
170
|
|
|
|
170
|
|
|
|
170
|
|
|
|
170
|
|
|
|
156
|
|
|
|
41
|
|
|
|
170
|
|
|
|
179
|
|
|
|
144
|
|
TA IDEX Templeton Transamerica
Global
|
|
|
434
|
|
|
|
652
|
|
|
|
511
|
|
|
|
511
|
|
|
|
511
|
|
|
|
511
|
|
|
|
469
|
|
|
|
122
|
|
|
|
511
|
|
|
|
539
|
|
|
|
434
|
|
TA IDEX Third Avenue Value*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
B-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Robert
|
|
|
Peter
|
|
|
|
|
|
Janice
|
|
|
Charles
|
|
|
Leo
|
|
|
Russell
|
|
|
Norm
|
|
|
William
|
|
|
John
|
|
|
Jack
|
|
|
|
L.
|
|
|
R.
|
|
|
Daniel
|
|
|
B.
|
|
|
C.
|
|
|
J.
|
|
|
A.
|
|
|
R.
|
|
|
W.
|
|
|
W.
|
|
|
E.
|
|
Fund
|
|
Anderson
|
|
|
Brown
|
|
|
Calabria
|
|
|
Case
|
|
|
Harris
|
|
|
Hill
|
|
|
Kimball, Jr.
|
|
|
Nielsen
|
|
|
Short, Jr.
|
|
|
Waechter
|
|
|
Zimmerman
|
|
|
TA IDEX Transamerica Balanced
|
|
|
408
|
|
|
|
612
|
|
|
|
480
|
|
|
|
480
|
|
|
|
480
|
|
|
|
480
|
|
|
|
440
|
|
|
|
115
|
|
|
|
480
|
|
|
|
506
|
|
|
|
408
|
|
TA IDEX Transamerica Convertible
Securities
|
|
|
702
|
|
|
|
1,052
|
|
|
|
825
|
|
|
|
825
|
|
|
|
825
|
|
|
|
825
|
|
|
|
757
|
|
|
|
197
|
|
|
|
825
|
|
|
|
871
|
|
|
|
702
|
|
TA IDEX Transamerica Equity
|
|
|
2,549
|
|
|
|
3,824
|
|
|
|
2,997
|
|
|
|
2,997
|
|
|
|
2,997
|
|
|
|
2,997
|
|
|
|
2,751
|
|
|
|
716
|
|
|
|
2,997
|
|
|
|
3,164
|
|
|
|
2,549
|
|
TA IDEX Transamerica Flexible Income
|
|
|
1,105
|
|
|
|
1,657
|
|
|
|
1,298
|
|
|
|
1,298
|
|
|
|
1,298
|
|
|
|
1,298
|
|
|
|
1,192
|
|
|
|
310
|
|
|
|
1,298
|
|
|
|
1,371
|
|
|
|
1,105
|
|
TA IDEX Transamerica Growth
Oppor-
tunities
|
|
|
1,685
|
|
|
|
2,528
|
|
|
|
1,981
|
|
|
|
1,981
|
|
|
|
1,981
|
|
|
|
1,981
|
|
|
|
1,818
|
|
|
|
473
|
|
|
|
1,981
|
|
|
|
2,092
|
|
|
|
1,685
|
|
TA IDEX Transamerica High-Yield Bond
|
|
|
1,611
|
|
|
|
2,417
|
|
|
|
1,894
|
|
|
|
1,894
|
|
|
|
1,894
|
|
|
|
1,894
|
|
|
|
1,738
|
|
|
|
452
|
|
|
|
1,894
|
|
|
|
2,000
|
|
|
|
1,611
|
|
TA IDEX Transamerica Money Market
|
|
|
5,202
|
|
|
|
7,802
|
|
|
|
6,114
|
|
|
|
6,114
|
|
|
|
6,114
|
|
|
|
6,114
|
|
|
|
5,612
|
|
|
|
1,460
|
|
|
|
6,114
|
|
|
|
6,456
|
|
|
|
5,202
|
|
TA IDEX Transamerica
Science & Technology
|
|
|
687
|
|
|
|
1,030
|
|
|
|
807
|
|
|
|
807
|
|
|
|
807
|
|
|
|
807
|
|
|
|
741
|
|
|
|
193
|
|
|
|
807
|
|
|
|
853
|
|
|
|
687
|
|
TA IDEX Transamerica Short-Term Bond
|
|
|
1,139
|
|
|
|
1,709
|
|
|
|
1,339
|
|
|
|
1,339
|
|
|
|
1,339
|
|
|
|
1,339
|
|
|
|
1,229
|
|
|
|
320
|
|
|
|
1,339
|
|
|
|
1,414
|
|
|
|
1,139
|
|
TA IDEX Transamerica Small/Mid Cap
Value
|
|
|
1,174
|
|
|
|
1,762
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,380
|
|
|
|
1,267
|
|
|
|
330
|
|
|
|
1,380
|
|
|
|
1,458
|
|
|
|
1,174
|
|
TA IDEX Transamerica Value Balanced
|
|
|
198
|
|
|
|
297
|
|
|
|
232
|
|
|
|
232
|
|
|
|
232
|
|
|
|
232
|
|
|
|
213
|
|
|
|
55
|
|
|
|
232
|
|
|
|
245
|
|
|
|
198
|
|
TA IDEX T. Rowe Price Small
Cap
|
|
|
126
|
|
|
|
190
|
|
|
|
149
|
|
|
|
149
|
|
|
|
149
|
|
|
|
149
|
|
|
|
136
|
|
|
|
36
|
|
|
|
149
|
|
|
|
157
|
|
|
|
126
|
|
TA IDEX T. Rowe Price Tax-Efficient
Growth
|
|
|
56
|
|
|
|
83
|
|
|
|
65
|
|
|
|
65
|
|
|
|
65
|
|
|
|
65
|
|
|
|
60
|
|
|
|
16
|
|
|
|
65
|
|
|
|
69
|
|
|
|
56
|
|
TA IDEX UBS Dynamic Alpha*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX UBS Large Cap Value
|
|
|
620
|
|
|
|
930
|
|
|
|
729
|
|
|
|
729
|
|
|
|
729
|
|
|
|
729
|
|
|
|
669
|
|
|
|
174
|
|
|
|
729
|
|
|
|
770
|
|
|
|
620
|
|
TA IDEX Van Kampen Emerging Markets
Debt
|
|
|
1,268
|
|
|
|
1,902
|
|
|
|
1,491
|
|
|
|
1,491
|
|
|
|
1,491
|
|
|
|
1,491
|
|
|
|
1,368
|
|
|
|
356
|
|
|
|
1,491
|
|
|
|
1,574
|
|
|
|
1,268
|
|
TA IDEX Van Kampen Mid-Cap Growth
|
|
|
209
|
|
|
|
313
|
|
|
|
245
|
|
|
|
245
|
|
|
|
245
|
|
|
|
245
|
|
|
|
225
|
|
|
|
59
|
|
|
|
245
|
|
|
|
259
|
|
|
|
209
|
|
TA IDEX Van Kampen Small Company
Growth
|
|
|
828
|
|
|
|
1,242
|
|
|
|
973
|
|
|
|
973
|
|
|
|
973
|
|
|
|
973
|
|
|
|
893
|
|
|
|
232
|
|
|
|
973
|
|
|
|
1,027
|
|
|
|
828
|
|
Pension or Retirement Benefits
Accrued
|
|
|
0
|
|
|
|
210,000
|
|
|
|
96,000
|
|
|
|
64,000
|
|
|
|
96,000
|
|
|
|
64,000
|
|
|
|
96,000
|
|
|
|
0
|
|
|
|
160,000
|
|
|
|
0
|
|
|
|
160,000
|
|
Total Compensation from Fund
Complex
|
|
|
57,000
|
|
|
|
201,125
|
|
|
|
161,625
|
|
|
|
161,625
|
|
|
|
161,625
|
|
|
|
161,625
|
|
|
|
156,125
|
|
|
|
38,800
|
|
|
|
161,625
|
|
|
|
169,125
|
|
|
|
57,000
|
|
Number of Funds in
Fund Complex Overseen by Board Member
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
|
*
|
|
Fund had not commenced operations
during the fiscal year ended October 31, 2006.
|
|
|
|
As of February 28, 2007, Fund
was no longer operational.
|
|
|
|
Of this aggregate compensation, the
total amounts deferred (including earnings) and accrued for the
benefit of the participating Board Members for the fiscal year
ended October 31, 2006 were as follows: Peter R. Brown,
$27; Daniel Calabria, $65,350; William W. Short, Jr., $37;
Charles C. Harris, $2,900; Russell A. Kimball, Jr., $16,665; Leo
J. Hill, $22,270; and Robert L. Anderson, $12,000.
|
B-3
Until its amendment as described below, an emeritus plan (the
TA IDEX Emeritus Plan) is available to the
Independent Board Members of the TA IDEX Board. Under the TA
IDEX Emeritus Plan prior to its amendment, each Independent
Board Member is deemed to have elected to serve as an emeritus
Board Member of TA IDEX upon his or her termination of service,
other than removal for cause, for a maximum period of five years
determined by his or her years of service as a Board Member on
the TA IDEX Board, calculated as follows:
|
|
|
|
|
Years of Service
|
|
Years Eligible for Service as
|
as Board Member
|
|
Emeritus Board Member (Eligible Years)
|
|
5
|
|
|
2
|
|
10
|
|
|
3
|
|
15
|
|
|
5
|
|
In a year in which an Independent Board Member earns an
eligibility benefit (years 5, 10 and 15), TA IDEX accrues, and
the Independent Board Member is credited, an amount equal to 50%
of his or her then-current annual retainer for the appropriate
number of Eligible Years (2, 3 or 5). Such amounts are accrued
by TA IDEX on a pro rata basis allocable to each TA IDEX Fund
based on the relative assets of the Fund. The Chairman of the TA
IDEX Board and the Audit Committee Financial Expert
also earns 50% of the additional retainers designated for such
positions. If retainers increase, past accruals (and credits)
are adjusted upward so that 50% of the Board Members
retainer is accrued and credited at all times. Upon death,
disability or termination of service, other than removal for
cause, amounts deferred become payable to an emeritus Board
Member (or his or her beneficiary). Upon the commencement of
service as an emeritus Board Member, compensation will be paid
on a quarterly basis during the time period that the emeritus
Board Member is allowed to serve as such. In addition, under the
TA IDEX Emeritus Plan prior to its amendment as described below,
an emeritus Board Member may be invited by the Board, but is not
required, to attend meetings, and will be available for
consultation by the Board Members, officers and counsel. An
emeritus Board Member will receive reimbursement of actual and
reasonable expenses incurred for attendance at TA IDEX Board
meetings. No person served as an emeritus Board Member during
the most recent fiscal year.
Amounts deferred and accrued under the Deferred Compensation and
TA IDEX Emeritus Plans are unfunded and unsecured claims against
the general assets of TA IDEX.
The TA IDEX Board has voted to amend the TA IDEX Emeritus Plan
effective as of the date on which the Nominees elected in
accordance with this Joint Proxy Statement accept their
elections and commence service as members of the New Board.
Under the amended TA IDEX Emeritus Plan, the following emeritus
Board Members and current Board Members will be the sole
participants in the plan, and their accrued benefits under the
plan shall be fixed at the amounts indicated:
|
|
|
|
|
Emeritus/Current
|
|
|
|
Board Member
|
|
Accrued Benefits
|
|
|
Peter R. Brown
|
|
$
|
210,000
|
|
Daniel Calabria
|
|
|
96,000
|
|
Janice B. Case
|
|
|
64,000
|
|
Charles C. Harris
|
|
|
96,000
|
|
Leo J. Hill
|
|
|
64,000
|
|
Russell A. Kimball, Jr.
|
|
|
96,000
|
|
William W. Short, Jr.
|
|
|
160,000
|
|
Jack E. Zimmerman
|
|
|
160,000
|
|
ATST
Board
Each Independent Board Member of the ATST Board receives a total
annual retainer fee of $84,000 from ATST, of which ATST pays a
pro rata share allocable to each Fund that is a portfolio of
ATST (collectively, the ATST Funds) based on the
relative assets of the ATST Fund. The Chairman of the Board also
receives an additional retainer of $20,000 per year. Effective
January 1, 2007, an ATST Board Member serving on one
B-4
committee will receive an additional annual fee of $3,000 and an
ATST Board Member that serves on two or more committees will
receive an additional annual fee of $6,000. Any audit
committee financial expert of the Audit Committee also
receives an additional retainer of $5,000. Any fees and expenses
paid to Board Members who are affiliates of TFAI or TCI are paid
by TFAI
and/or TCI
and not by the ATST Funds. During the fiscal year ended
December 31, 2006, the ATST Funds reimbursed Board Member
expenses in an aggregate amount of $11,382. ATST Board Members
who also serve on the TA IDEX Board or the TIS Board
receive compensation for service on those Boards as well, as
discussed in this Appendix B.
Independent members of the ATST Board may defer compensation
under the Deferred Compensation Plan, as described above. It is
not anticipated that the Deferred Compensation Plan will have
any material impact on the ATST Funds.
The following table sets forth the compensation amounts paid to
the Independent Board Members of the ATST Board for the fiscal
year ended December 31, 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter
|
|
|
|
|
|
Janice
|
|
|
Charles
|
|
|
Leo
|
|
|
Russell
|
|
|
Norm
|
|
|
William
|
|
|
John
|
|
|
|
R.
|
|
|
Daniel
|
|
|
B.
|
|
|
C.
|
|
|
J.
|
|
|
A.
|
|
|
R.
|
|
|
W.
|
|
|
W.
|
|
Fund
|
|
Brown
|
|
|
Calabria
|
|
|
Case
|
|
|
Harris
|
|
|
Hill
|
|
|
Kimball, Jr.
|
|
|
Nielsen
|
|
|
Short, Jr.
|
|
|
Waechter
|
|
|
American Century Large Company Value
|
|
$
|
592
|
|
|
$
|
484
|
|
|
$
|
484
|
|
|
$
|
484
|
|
|
$
|
484
|
|
|
$
|
484
|
|
|
$
|
226
|
|
|
$
|
484
|
|
|
$
|
511
|
|
Asset Allocation
Conservative Portfolio
|
|
|
3,593
|
|
|
|
2,940
|
|
|
|
2,940
|
|
|
|
2,940
|
|
|
|
2,940
|
|
|
|
2,940
|
|
|
|
1,372
|
|
|
|
2,940
|
|
|
|
3,103
|
|
Asset Allocation Growth
Portfolio
|
|
|
6,316
|
|
|
|
5,168
|
|
|
|
5,168
|
|
|
|
5,168
|
|
|
|
5,168
|
|
|
|
5,168
|
|
|
|
2,412
|
|
|
|
5,168
|
|
|
|
5,455
|
|
Asset Allocation
Moderate Growth Portfolio
|
|
|
15,697
|
|
|
|
12,843
|
|
|
|
12,843
|
|
|
|
12,843
|
|
|
|
12,843
|
|
|
|
12,843
|
|
|
|
5,993
|
|
|
|
12,843
|
|
|
|
13,556
|
|
Asset Allocation
Moderate Portfolio
|
|
|
11,063
|
|
|
|
9,052
|
|
|
|
9,052
|
|
|
|
9,052
|
|
|
|
9,052
|
|
|
|
9,052
|
|
|
|
4,224
|
|
|
|
9,052
|
|
|
|
9,554
|
|
BlackRock Large Cap Value
|
|
|
4,626
|
|
|
|
3,785
|
|
|
|
3,785
|
|
|
|
3,785
|
|
|
|
3,785
|
|
|
|
3,785
|
|
|
|
1,766
|
|
|
|
3,785
|
|
|
|
3,996
|
|
Capital Guardian Global
|
|
|
1,050
|
|
|
|
859
|
|
|
|
859
|
|
|
|
859
|
|
|
|
859
|
|
|
|
859
|
|
|
|
401
|
|
|
|
859
|
|
|
|
907
|
|
Capital Guardian U.S. Equity
|
|
|
1,225
|
|
|
|
1,002
|
|
|
|
1,002
|
|
|
|
1,002
|
|
|
|
1,002
|
|
|
|
1,002
|
|
|
|
468
|
|
|
|
1,002
|
|
|
|
1,058
|
|
Capital Guardian Value
|
|
|
3,547
|
|
|
|
2,902
|
|
|
|
2,902
|
|
|
|
2,902
|
|
|
|
2,902
|
|
|
|
2,902
|
|
|
|
1,354
|
|
|
|
2,902
|
|
|
|
3,063
|
|
Clarion Global Real Estate
Securities
|
|
|
3,538
|
|
|
|
2,895
|
|
|
|
2,895
|
|
|
|
2,895
|
|
|
|
2,895
|
|
|
|
2,895
|
|
|
|
1,351
|
|
|
|
2,895
|
|
|
|
3,056
|
|
Federated Market Opportunity
|
|
|
2,699
|
|
|
|
2,208
|
|
|
|
2,208
|
|
|
|
2,208
|
|
|
|
2,208
|
|
|
|
2,208
|
|
|
|
1,031
|
|
|
|
2,208
|
|
|
|
2,331
|
|
International Moderate Growth Fund
|
|
|
102
|
|
|
|
83
|
|
|
|
83
|
|
|
|
83
|
|
|
|
83
|
|
|
|
83
|
|
|
|
39
|
|
|
|
83
|
|
|
|
88
|
|
Jennison Growth
|
|
|
674
|
|
|
|
551
|
|
|
|
551
|
|
|
|
551
|
|
|
|
551
|
|
|
|
551
|
|
|
|
257
|
|
|
|
551
|
|
|
|
582
|
|
JPMorgan Core Bond
|
|
|
839
|
|
|
|
687
|
|
|
|
687
|
|
|
|
687
|
|
|
|
687
|
|
|
|
687
|
|
|
|
320
|
|
|
|
687
|
|
|
|
725
|
|
JPMorgan Enhanced Index
|
|
|
909
|
|
|
|
743
|
|
|
|
743
|
|
|
|
743
|
|
|
|
743
|
|
|
|
743
|
|
|
|
347
|
|
|
|
743
|
|
|
|
785
|
|
JPMorgan Mid Cap Value
|
|
|
1,597
|
|
|
|
1,307
|
|
|
|
1,307
|
|
|
|
1,307
|
|
|
|
1,307
|
|
|
|
1,307
|
|
|
|
610
|
|
|
|
1,307
|
|
|
|
1,379
|
|
Legg Mason Partners All Cap
|
|
|
1,756
|
|
|
|
1,437
|
|
|
|
1,437
|
|
|
|
1,437
|
|
|
|
1,437
|
|
|
|
1,437
|
|
|
|
671
|
|
|
|
1,437
|
|
|
|
1,517
|
|
Marsico Growth
|
|
|
953
|
|
|
|
779
|
|
|
|
779
|
|
|
|
779
|
|
|
|
779
|
|
|
|
779
|
|
|
|
364
|
|
|
|
779
|
|
|
|
823
|
|
MFS High Yield
|
|
|
1,993
|
|
|
|
1,630
|
|
|
|
1,630
|
|
|
|
1,630
|
|
|
|
1,630
|
|
|
|
1,630
|
|
|
|
761
|
|
|
|
1,630
|
|
|
|
1,721
|
|
MFS International Equity
|
|
|
1,500
|
|
|
|
1,227
|
|
|
|
1,227
|
|
|
|
1,227
|
|
|
|
1,227
|
|
|
|
1,227
|
|
|
|
573
|
|
|
|
1,227
|
|
|
|
1,295
|
|
Munder Net50
|
|
|
512
|
|
|
|
419
|
|
|
|
419
|
|
|
|
419
|
|
|
|
419
|
|
|
|
419
|
|
|
|
196
|
|
|
|
419
|
|
|
|
443
|
|
PIMCO Total Return
|
|
|
3,717
|
|
|
|
3,041
|
|
|
|
3,041
|
|
|
|
3,041
|
|
|
|
3,041
|
|
|
|
3,041
|
|
|
|
1,419
|
|
|
|
3,041
|
|
|
|
3,210
|
|
Templeton Transamerica Global
|
|
|
2,760
|
|
|
|
2,258
|
|
|
|
2,258
|
|
|
|
2,258
|
|
|
|
2,258
|
|
|
|
2,258
|
|
|
|
1,054
|
|
|
|
2,258
|
|
|
|
2,384
|
|
Third Avenue Value
|
|
|
5,175
|
|
|
|
4,234
|
|
|
|
4,234
|
|
|
|
4,234
|
|
|
|
4,234
|
|
|
|
4,234
|
|
|
|
1,976
|
|
|
|
4,234
|
|
|
|
4,469
|
|
Transamerica Balanced
|
|
|
359
|
|
|
|
294
|
|
|
|
294
|
|
|
|
294
|
|
|
|
294
|
|
|
|
294
|
|
|
|
137
|
|
|
|
294
|
|
|
|
310
|
|
Transamerica Convertible Securities
|
|
|
1,958
|
|
|
|
1,602
|
|
|
|
1,602
|
|
|
|
1,602
|
|
|
|
1,602
|
|
|
|
1,602
|
|
|
|
748
|
|
|
|
1,602
|
|
|
|
1,691
|
|
Transamerica Equity
|
|
|
9,480
|
|
|
|
7,756
|
|
|
|
7,756
|
|
|
|
7,756
|
|
|
|
7,756
|
|
|
|
7,756
|
|
|
|
3,619
|
|
|
|
7,756
|
|
|
|
8,187
|
|
Transamerica Equity II
|
|
|
91
|
|
|
|
75
|
|
|
|
75
|
|
|
|
75
|
|
|
|
75
|
|
|
|
75
|
|
|
|
35
|
|
|
|
75
|
|
|
|
79
|
|
B-5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter
|
|
|
|
|
|
Janice
|
|
|
Charles
|
|
|
Leo
|
|
|
Russell
|
|
|
Norm
|
|
|
William
|
|
|
John
|
|
|
|
R.
|
|
|
Daniel
|
|
|
B.
|
|
|
C.
|
|
|
J.
|
|
|
A.
|
|
|
R.
|
|
|
W.
|
|
|
W.
|
|
Fund
|
|
Brown
|
|
|
Calabria
|
|
|
Case
|
|
|
Harris
|
|
|
Hill
|
|
|
Kimball, Jr.
|
|
|
Nielsen
|
|
|
Short, Jr.
|
|
|
Waechter
|
|
|
Transamerica Growth Opportunities
|
|
|
2,325
|
|
|
|
1,902
|
|
|
|
1,902
|
|
|
|
1,902
|
|
|
|
1,902
|
|
|
|
1,902
|
|
|
|
888
|
|
|
|
1,902
|
|
|
|
2,008
|
|
Transamerica Money Market
|
|
|
2,203
|
|
|
|
1,803
|
|
|
|
1,803
|
|
|
|
1,803
|
|
|
|
1,803
|
|
|
|
1,803
|
|
|
|
841
|
|
|
|
1,803
|
|
|
|
1,903
|
|
Transamerica Science &
Technology
|
|
|
670
|
|
|
|
548
|
|
|
|
548
|
|
|
|
548
|
|
|
|
548
|
|
|
|
548
|
|
|
|
256
|
|
|
|
548
|
|
|
|
579
|
|
Transamerica Small/Mid Cap Value
|
|
|
1,993
|
|
|
|
1,631
|
|
|
|
1,631
|
|
|
|
1,631
|
|
|
|
1,631
|
|
|
|
1,631
|
|
|
|
761
|
|
|
|
1,631
|
|
|
|
1,721
|
|
Transamerica U.S. Government
Securities
|
|
|
872
|
|
|
|
714
|
|
|
|
714
|
|
|
|
714
|
|
|
|
714
|
|
|
|
714
|
|
|
|
333
|
|
|
|
714
|
|
|
|
753
|
|
Transamerica Value Balanced
|
|
|
2,119
|
|
|
|
1,734
|
|
|
|
1,734
|
|
|
|
1,734
|
|
|
|
1,734
|
|
|
|
1,734
|
|
|
|
809
|
|
|
|
1,734
|
|
|
|
1,830
|
|
T. Rowe Price Equity Income
|
|
|
3,827
|
|
|
|
3,131
|
|
|
|
3,131
|
|
|
|
3,131
|
|
|
|
3,131
|
|
|
|
3,131
|
|
|
|
1,461
|
|
|
|
3,131
|
|
|
|
3,305
|
|
T. Rowe Price Growth Stock
|
|
|
1,408
|
|
|
|
1,152
|
|
|
|
1,152
|
|
|
|
1,152
|
|
|
|
1,152
|
|
|
|
1,152
|
|
|
|
538
|
|
|
|
1,152
|
|
|
|
1,216
|
|
T. Rowe Price Small Cap
|
|
|
1,415
|
|
|
|
1,158
|
|
|
|
1,158
|
|
|
|
1,158
|
|
|
|
1,158
|
|
|
|
1,158
|
|
|
|
540
|
|
|
|
1,158
|
|
|
|
1,222
|
|
Van Kampen Active International
Allocation
|
|
|
1,014
|
|
|
|
829
|
|
|
|
829
|
|
|
|
829
|
|
|
|
829
|
|
|
|
829
|
|
|
|
387
|
|
|
|
829
|
|
|
|
875
|
|
Van Kampen Large Cap Core
|
|
|
896
|
|
|
|
733
|
|
|
|
733
|
|
|
|
733
|
|
|
|
733
|
|
|
|
733
|
|
|
|
342
|
|
|
|
733
|
|
|
|
774
|
|
Van Kampen Mid-Cap Growth
|
|
|
2,936
|
|
|
|
2,402
|
|
|
|
2,402
|
|
|
|
2,402
|
|
|
|
2,402
|
|
|
|
2,402
|
|
|
|
1,121
|
|
|
|
2,402
|
|
|
|
2,536
|
|
Pension or Retirement Benefits
Accrued
|
|
|
260,000
|
|
|
|
84,000
|
|
|
|
84,000
|
|
|
|
210,000
|
|
|
|
84,000
|
|
|
|
210,000
|
|
|
|
0
|
|
|
|
84,000
|
|
|
|
0
|
|
Total Compensation from
Fund Complex*
|
|
|
208,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
77,600
|
|
|
|
168,000
|
|
|
|
178,000
|
|
Number of Funds in
Fund Complex Overseen by Board Member
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
|
*
|
|
Of this aggregate compensation, the
total amounts deferred (including earnings) and accrued for the
benefit of the participating Board Members for the fiscal year
ended December 31, 2006 were as follows: Peter R. Brown,
$597; Daniel Calabria, $111,325; Russell A. Kimball, Jr.,
$25,865; and Leo J. Hill, $42,179.
|
Until its amendment as described below, an emeritus plan (the
ATST Emeritus Plan) substantially similar to the TA
IDEX Emeritus Plan described above is available to the
Independent Board Members of the ATST Board. No person served as
an emeritus Board Member during the most recent fiscal year.
Amounts deferred and accrued under the Deferred Compensation and
ATST Emeritus Plans are unfunded and unsecured claims against
the general assets of ATST.
The ATST Board has voted to amend the ATST Emeritus Plan
effective as of the date on which the Nominees elected in
accordance with this Joint Proxy Statement accept their
elections and commence service as members of the New Board.
Under the amended ATST Emeritus Plan, the following emeritus
Board Members and current Board Members will be the sole
participants in the plan, and their accrued benefits under the
plan shall be fixed at the amounts indicated:
|
|
|
|
|
Emeritus/Current
|
|
|
|
Board Member
|
|
Accrued Benefits
|
|
|
Peter R. Brown
|
|
$
|
260,000
|
|
Daniel Calabria
|
|
|
84,000
|
|
Janice B. Case
|
|
|
84,000
|
|
Charles C. Harris
|
|
|
210,000
|
|
Leo J. Hill
|
|
|
84,000
|
|
Russell A. Kimball, Jr.
|
|
|
210,000
|
|
William W. Short, Jr.
|
|
|
84,000
|
|
B-6
TIS
Board
Each Independent Board Member of the TIS Board receives a total
annual retainer fee of $7,200 from TIS, plus $800 for Board
committee fees. Effective January 1, 2007, a TIS Board
Member serving on one committee of the TIS Board will receive an
additional annual fee of $400 and a TIS Board Member that serves
on two or more committees will receive an additional annual fee
of $800. During the fiscal year ended March 31, 2007, TIS
reimbursed Board Member expenses in an aggregate amount of $514.
TIS Board Members who also serve on the TA IDEX Board or the
ATST Board receive compensation for service on those Boards as
well, as discussed in this Appendix B.
The following table sets forth the compensation amounts paid to
the Independent Board Members of the TIS Board for the fiscal
year ended March 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peter
|
|
|
|
|
|
Janice
|
|
|
Charles
|
|
|
|
|
|
Russell
|
|
|
|
|
|
William
|
|
|
John
|
|
|
|
R.
|
|
|
Daniel
|
|
|
B.
|
|
|
C.
|
|
|
Leo J.
|
|
|
A.
|
|
|
Norm R.
|
|
|
W.
|
|
|
W.
|
|
Fund
|
|
Brown
|
|
|
Calabria
|
|
|
Case
|
|
|
Harris
|
|
|
Hill
|
|
|
Kimball, Jr.
|
|
|
Nielsen
|
|
|
Short, Jr.
|
|
|
Waechter
|
|
|
Transamerica Income Shares,
Inc.
|
|
$
|
8,000
|
|
|
$
|
8,000
|
|
|
$
|
8,000
|
|
|
$
|
8,000
|
|
|
$
|
8,000
|
|
|
$
|
8,000
|
|
|
$
|
5,400
|
|
|
$
|
8,000
|
|
|
$
|
8,000
|
|
Pension or Retirement Benefits
Accrued
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
|
|
N/A
|
|
Total Compensation from
Fund Complex
|
|
|
208,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
168,000
|
|
|
|
119,600
|
|
|
|
168,000
|
|
|
|
178,000
|
|
Number of Funds in
Fund Complex Overseen by Board Member
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
|
|
87
|
|
TIS does not currently provide any pension or retirement
benefits to its Board Members and officers.
B-7
Appendix C
TRANSAMERICA
IDEX MUTUAL FUNDS
AEGON/TRANSAMERICA SERIES TRUST
TRANSAMERICA INCOME SHARES, INC.
(each, a Fund and collectively, the
Funds)
GOVERNANCE
AND NOMINATING COMMITTEE CHARTER
The Governance and Nominating Committee (the
Committee) of the Funds Boards of
Directors/Trustees (the Boards) shall be composed
solely of directors (or trustees where the fund is organized as
a business trust) who are not interested persons of
the Funds as defined in Section 2(a)(19) of the Investment
Company Act of 1940 (the Independent Directors).
Other members of the Boards, while not serving as members of the
Committee, may assist the Committee in the discharge of its
responsibilities, e.g., identify and recommend potential
candidates. In addition, at the request of the Committee, the
Funds investment advisers and other service providers will
provide administrative support and other assistance to the
Committee.
The Chairman of the Board shall appoint one or more Independent
Board member(s) to serve as the Chairman of the Committee, to
serve at the pleasure of the Chairman of the Board, or until he
or she resigns such position, is no longer a member of the
Committee, or is removed by a majority of the Board members. The
Chairman of the Board shall promptly appoint an Independent
Board member to fill a vacancy in the position of Committee
Chairman. The Chairman of the Board will select additional
Independent Board members to serve on the Committee. The members
will serve at the pleasure of the Chairman of the Board, who
may, at his discretion, change the composition of the members of
the Committee. The Chairman of the Board, in his capacity as
such, will serve as a member of the Committee and will be
notified in advance of any and all Committee meetings.
|
|
B.
|
Objectives
of the Committee
|
The primary purposes and responsibilities of the Committee are
to (i) identify individuals qualified to become members of
the Boards in the event that a position is vacated or created,
(ii) consider all candidates proposed to become members of
the Boards, subject to the procedures and policies set forth in
this Charter, the Funds Bylaws or resolutions of the
Boards, (iii) select and nominate, or recommend for
nomination by the Boards, candidates for election as Directors
and (iv) set any necessary standards or qualifications for
service on the Boards. The Committees objective shall
further be to provide oversight and leadership regarding the
operations of the Boards (and its committees) generally, and to
provide oversight and monitoring of certain specific issues that
particularly affect the duties of the Independent
Directors.1
|
|
C.
|
Board
Nominations and Functions
|
1. In the event of any vacancies on the Boards, the
Committee shall oversee the process for the identification,
evaluation and nomination of potential candidates to serve on
the Boards. The Committee may solicit suggestions for
nominations from any source it deems appropriate.
2. The Committee shall evaluate each candidates
qualifications for Board membership, and, with respect to
nominees for Independent Director membership, their independence
from the Funds investment advisers and other principal
service providers. The Committee shall consider the effect of
any relationships beyond those delineated in the 1940 Act that
might impair the independence of a prospective Independent
Director.
3. In assessing the qualifications of a potential candidate
for membership on the Boards, the Committee may consider the
candidates potential contribution to the operation of the
Boards and its committees, and
1 The
members of the Committee shall not be subject to greater
fiduciary obligations and shall not be subject to a higher
standard of care than the other members of the Boards because of
their work for the Committee.
C-1
such other factors as it may deem relevant. Specific desired
(but not required) qualities of Independent Director candidates
are set forth in Schedule A to this Charter. All equally
qualified nominees will be treated equally in consideration by
the Nominating Committee. No person shall be qualified to be a
Board member unless the Committee, in consultation with legal
counsel, has determined that such person, if elected as a
Director, would not cause the Funds to be in violation of or not
in compliance with (a) applicable law, regulation or
regulatory interpretation, (b) its organizational
documents, or (c) any policy adopted by the Boards
regarding either the retirement age of any Board member or the
percentage of a Board that would be composed of Independent
Directors.
4. While the Committee is solely responsible for the
selection and nomination of potential candidates to serve on the
Boards, the Committee may consider and evaluate nominations
properly submitted by shareholders of the Funds. Nominations
proposed by shareholders will be properly submitted for
consideration by the Committee only if the qualifications and
procedures set forth in Schedule B of this Charter, as it
may be amended from time to time by the Committee or the Boards,
are met and followed. It shall be in the Committees sole
discretion whether to seek corrections of a deficient submission
or to exclude a nominee from consideration.
5. The Committee shall evaluate, as necessary, the
operations and effectiveness of the Boards as a whole and shall
evaluate the composition of the Boards to determine whether it
may be appropriate to add individuals with different backgrounds
or skills from those already on the Boards.
The Committee shall make nominations for membership on all
committees of the Boards and shall review committee assignments
as necessary.
|
|
E.
|
Oversight
Responsibilities
|
The Committee, in consultation with the Chief Compliance Officer
(CCO) and Independent Directors counsel, will
have oversight responsibilities and monitor certain issues that
affect the duties of independent members of the Boards
including, but not limited to the following:
|
|
|
|
|
Adviser and Sub-Adviser Codes of Ethics
|
|
|
|
Shareholder communications and shareholder complaint resolution
(reported as necessary)
|
|
|
|
Disaster Recovery Policies and issues relating to Disaster
Recovery (reported on an annual basis or as necessary)
|
The Committee shall monitor the performance of legal counsel to
the Independent Directors and the Funds, respectively, as well
as other service providers (with the exception of the
independent auditors, which are monitored by the Audit
Committee) that are chosen by the Independent Directors.
1. The Committee shall, with the assistance of its counsel,
define and clarify the legal and fiduciary duties of members,
including expectations regarding preparation, attendance and
participation at meetings.
2. It is contemplated that the Committee will regularly
consult with and rely upon the CCO and Independent
Directors counsel for guidance and direction in fulfilling
its duties to the Boards and Fund shareholders. It is also
contemplated that the oversight responsibilities of the
Committee may evolve over time. It is not the intention or
desire of the Committee, or its members, to
micro-manage the activities of the adviser or any
sub-advisers, nor is it the intention or desire of the
Committee, or its members, to act as an executive committee. All
matters between the members of the Committee, the CCO and
independent counsel are considered at all times to be privileged
and confidential.
3. The Committee shall periodically review and make
recommendations relative to education and related information
for incumbent Board members, including appropriate orientation
of new directors.
C-2
|
|
G.
|
Other
Powers and Responsibilities
|
The Committee shall meet as necessary to carry out its
responsibilities hereunder, and otherwise from time to time as
the Chairman of the Board or the Chairman of the Committee deems
appropriate.
The Committee shall, subject to a limit of $2,500 per occurrence
for legal fees, have the resources and authority appropriate to
discharge its responsibilities, including the ability to engage
and compensate third party consultants from each Funds
assets.
The Committee shall periodically assess this Charter and
recommend to the Boards any revisions or modifications that the
Committee deems necessary or appropriate to the effective
discharge of its responsibilities.
C-3
SCHEDULE A
RESPONSIBILITIES
AND DESIRED QUALITIES
OF
INDEPENDENT DIRECTORS
|
|
A.
|
Primary
Responsibilities
|
The Independent Directors primary responsibility is
management oversight of the Funds on behalf of shareholders.
Diverse responsibilities include review and negotiation of
contractual arrangements with management and other service
providers; and oversight and review of service provider
performance, investment performance, compliance, shareholder
services and communication with shareholders.
B. Personal
Attributes
|
|
|
|
|
Public or private sector stature sufficient to instill
confidence.
|
|
|
|
High personal and professional integrity.
|
|
|
|
Good business sense.
|
|
|
|
Able to commit the necessary time to prepare for and attend
meetings.
|
|
|
|
Not financially dependent on Director retainer and meeting fees.
|
|
|
C.
|
Skills,
Experience and Qualifications for decision making
|
|
|
|
|
|
General understanding of financial issues, investing, financial
markets and technology.
|
|
|
|
General understanding of balance sheets and operating statements.
|
|
|
|
First-hand knowledge of investing.
|
|
|
|
Experience in working in highly regulated and complex legal
framework.
|
|
|
|
Demonstrated ability to maintain independence of
management and other service agents while maintaining a
constructive working relationship.
|
|
|
|
Ability to be critical, but not confrontational.
|
|
|
|
Demonstrated ability to contribute to Board and committee
process.
|
|
|
|
Ability to consider diverse issues and make timely,
well-informed decisions.
|
|
|
|
Familiarity with the securities industry.
|
|
|
|
Qualification as an Audit Committee Financial Expert.
|
Note: The Personal Attributes listed in Section B above
should be possessed by all Directors. The Skills, Experience and
Qualifications listed in Section C include items that
should be possessed by all Directors as well as items that
should be possessed by at least some Directors.
C-4
SCHEDULE B
Procedures
for the Nominating Committees Consideration of
Candidates
Submitted by Shareholders
A candidate for nomination as Director submitted by a
shareholder will not be deemed to be properly submitted to the
Committee for the Committees consideration unless the
following requirements have been met and procedures followed:
1. Each eligible shareholder or shareholder group may
submit no more than one nominee each calendar year.
2. The nominee must satisfy all qualifications provided
herein and in the Funds organizational documents,
including qualification as a possible Independent Director if
the nominee is to serve in that capacity.
|
|
|
|
|
The nominee may not be the nominating shareholder, a member of
the nominating shareholder group or a member of the immediate
family of the nominating shareholder or any member of the
nominating shareholder
group.1
|
|
|
|
Neither the nominee nor any member of the nominees
immediate family may be currently employed or employed within
the year prior to the nomination by any nominating shareholder
entity or entity in a nominating shareholder group.
|
|
|
|
Neither the nominee nor any immediate family member of the
nominee is permitted to have accepted directly or indirectly,
during the year of the election for which the nominees
name was submitted, during the immediately preceding calendar
year, or during the year when the nominees name was
submitted, any consulting, advisory, or other compensatory fee
from the nominating shareholder or any member of a nominating
shareholder group.
|
|
|
|
The nominee may not be an executive officer, director or person
fulfilling similar functions of the nominating shareholder or
any member of the nominating shareholder group, or of an
affiliate of the nominating shareholder or any such member of
the nominating shareholder group.
|
|
|
|
The nominee may not control the nominating shareholder or any
member of the nominating shareholder group (or, in the case of a
holder or member that is a fund, an interested person of such
holder or member as defined by Section 2(a)(19) of the 1940
Act).
|
|
|
|
A shareholder or shareholder group may not submit for
consideration a nominee which has previously been considered by
the Committee.
|
3. In order for the Committee to consider shareholder
submissions, the following requirements must be satisfied
regarding the shareholder or shareholder group submitting the
proposed nominee:
|
|
|
|
|
Any shareholder or shareholder group submitting a proposed
nominee must beneficially own, either individually or in the
aggregate, more than 5% of a Funds (or a series thereof)
securities that are eligible to vote both at the time of
submission of the nominee and at the time of the Board member
election. Each of the securities used for purposes of
calculating this ownership must have been held continuously for
at least two years as of the date of the nomination. In
addition, such securities must continue to be held through the
date of the meeting. The nominating shareholder or shareholder
group must also bear the economic risk of the investment.
|
|
|
|
The nominating shareholder or shareholder group must also submit
a certification which provides the number of shares which the
person or group has (a) sole power to vote or direct the
vote; (b) shared power to vote or direct the vote;
(c) sole power to dispose or direct the disposition of such
shares; and (d) shared power to dispose or direct the
disposition of such shares. In addition the certification shall
provide that the shares have been held continuously for at least
two years.
|
1 Terms
such as immediate family member and
control shall be interpreted in accordance with the
federal securities laws.
C-5
4. Shareholders or shareholder groups submitting proposed
nominees must substantiate compliance with the above
requirements at the time of submitting their proposed nominee as
part of their written submission to the attention of the
Funds Secretary, who will provide all submissions to the
Committee. This submission to the Funds must include:
|
|
|
|
|
the shareholders contact information;
|
|
|
|
the nominees contact information and the number of
applicable Fund shares owned by the proposed nominee;
|
|
|
|
all information regarding the nominee that would be required to
be disclosed in solicitations of proxies for elections of
directors required by Regulation 14A under the Securities
Exchange Act of 1934; and
|
|
|
|
a notarized letter executed by the nominee, stating his or her
intention to serve as a nominee and be named in a Funds
proxy statement, if so designated by the Committee and the
Funds Board.
|
5. The Committee will consider all submissions meeting the
applicable requirements stated herein that are received by
December 31 of the most recently completed calendar year.
C-6
Appendix D
Form of
New Agreement and Declaration of Trust
AGREEMENT
AND DECLARATION OF TRUST
OF
[NAME OF TRUST]
THIS AMENDED AND RESTATED AGREEMENT AND DECLARATION OF TRUST is
made as of this
[ ]
day of [ ],
[ ] by the Trustees hereunder.
WHEREAS, the [NAME OF TRUST] was established pursuant to an
Agreement and Declaration of Trust dated [DATE OF ORIGINAL
DECLARATION] (as amended to the date hereof, the Original
Declaration) and the filing of a Certificate of Trust with
the Delaware Secretary of State for the purposes of carrying on
the business of a management investment company;
WHEREAS, the Trustees, pursuant to Section
[ ], Article
[ ] of the Original
Declaration, are authorized to amend the Original Declaration
with the vote or consent of the Shareholders as required by such
Section;
WHEREAS, this Amended and Restated Agreement and Declaration of
Trust has been amended in accordance with the provisions of the
Original Declaration in effect as of the date hereof;
NOW, THEREFORE, the Trustees and any successor Trustees elected
or appointed in accordance with Article V hereof hereby
declare that they will hold all cash, securities and other
assets and properties, which the Trust may from time to time
acquire in any manner, IN TRUST, and that they will manage and
dispose of the same and manage the affairs and business of the
Trust upon the following terms and conditions for the benefit of
the holders from time to time of shares of beneficial interest
in this Trust as hereinafter set forth.
ARTICLE I
NAME AND
DEFINITIONS
Section 1.1.
Name. This Trust shall be known as
[ ] and the Trustees shall
conduct the business of the Trust under that name or any other
name as they may from time to time determine.
Section 1.2. Definitions. Whenever
used herein, unless otherwise required by the context or
specifically provided, the following terms have the following
respective meanings:
(a) Bylaws means the Bylaws of the Trust
referred to in Section 6.8 hereof, as from time to time
amended, which Bylaws are expressly incorporated by reference
herein as part of the Trusts governing
instrument within the meaning of the Delaware Act (as
defined below).
(b) Certificate of Trust means the
certificate of trust of the Trust, as filed with the Secretary
of State of the State of Delaware (as defined below) in
accordance with the Delaware Act, and as such certificate of
trust may be amended or amended and restated from time to time.
(c) Class means one or more Shares (as
defined below) of a Series (as defined below) of the Trust as
may be established and designated as a Class from time to time
by the Trustees pursuant to Section 4.9(c) hereof.
(d) Code means the Internal Revenue Code
of 1986 (or any successor statute), as amended from time to
time, and the rules and regulations thereunder, as adopted or
amended from time to time.
(e) Commission shall have the same
meaning given to such term in the 1940 Act.
(f) Complaining Shareholder shall refer
to a Shareholder making a demand or bringing a claim pursuant to
Section 9.8 hereof.
D-1
(g) Declaration means this Agreement and
Declaration of Trust as amended, supplemented or amended and
restated from time to time, which shall be the Trusts
governing instrument within the meaning of the
Delaware Act. Reference in this Agreement and Declaration of
Trust to Declaration, hereof,
herein, and hereunder shall be deemed to
refer to this Declaration rather than exclusively to the article
or section in which such words appear.
(h) Delaware Act shall refer to the
Delaware Statutory Trust Act, as amended from time to time.
(i) He, Him and
His shall include the feminine and neuter, as
well as the masculine, genders.
(j) Interested Person shall have the
same meaning given to such term in the 1940 Act.
(k) 1940 Act refers to the Investment
Company Act of 1940 (and any successor statute) and the rules
thereunder, all as amended from time to time, as may apply to
the Trust or any Series or Class thereof, including pursuant to
any exemptive, interpretive or other relief or guidance issued
by the Commission or the staff of the Commission under such Act.
(l) Outstanding Shares means those
Shares shown from time to time on the books of the Trust or its
transfer agent as then issued and outstanding, but shall not
include Shares which have been redeemed, repurchased, cancelled
or terminated by the Trust.
(m) Person means and includes natural
persons, corporations, partnerships, limited partnerships,
business trusts, limited liability partnerships, statutory
trusts, limited liability companies, trusts, associations, joint
ventures, estates, nominees and any other entity in its own or
any representative capacity, whether or not legal entities, and
governments and agencies and political subdivisions thereof, in
each case whether domestic or foreign.
(n) Prospectus means the prospectus and
statement of additional information with respect to the Trust or
one or more Series or Classes thereof as the context shall
require, as contained in the most recent effective registration
statement filed with the Commission with respect to the Trust or
one or more such Series or Classes thereof, as the same may be
supplemented or modified from time to time in accordance with
the requirements of the federal securities laws.
(o) Series individually or collectively
means each Series of Shares as may be established and designated
from time to time by the Trustees pursuant to
Section 4.9(c) hereof.
(p) Shareholder means a record owner of
Outstanding Shares.
(q) Shares means the units of interest
into which the beneficial interest in the Trust shall be divided
from time to time, including the Shares of any and all Series
and Classes which may be established and designated by the
Trustees, and includes fractions of Shares as well as whole
Shares.
(r) Trust refers to the Delaware
statutory trust established under the Delaware Act by this
Declaration and the filing of the Certificate of Trust with the
Secretary of State of the State of Delaware.
(s) Trust Property means any and
all property, real or personal, tangible or intangible, which is
owned or held by or for the account of the Trust or any Series.
(t) Trustees means, at any time, the
person or persons who have signed this Declaration and all other
persons who may from time to time be duly qualified and serving
as Trustees in accordance with the provisions of Article V
hereof, in each case if they shall at that time continue in
office in accordance with the terms hereof, and reference herein
to a Trustee or the Trustees shall refer to such person or
persons in his capacity or their capacities as Trustees
hereunder.
ARTICLE II
NATURE AND
PURPOSE OF TRUST
The purpose of the Trust is to engage in, operate and carry on
the business of an open-end management investment company
through one or more Series, and to do any and all acts or things
as are necessary,
D-2
convenient, appropriate, incidental or customary in connection
therewith, both within and without the State of Delaware, and
without limiting the foregoing or the other provisions hereof,
the Trust may exercise all powers conferred by the laws of the
State of Delaware upon a Delaware statutory trust formed
pursuant to the Delaware Act.
ARTICLE III
REGISTERED
AGENT AND REGISTERED OFFICE
The registered agent and office of the Trust in the State of
Delaware are [ ]. Unless otherwise
required by applicable law, the Trust shall at all times
maintain at least one resident agent who shall be either a
citizen of the State of Delaware who resides in such State or a
Delaware corporation. The Trustees may change the registered
agent or registered office of the Trust from time to time by
making the appropriate filing or filings with the Secretary of
State of the State of Delaware.
ARTICLE IV
BENEFICIAL
INTERESTS; SHAREHOLDERS
Section 4.1. Shares
of Beneficial Interest. The beneficial interest
in the Trust shall be divided into such Shares of beneficial
interest, of such Series or Classes, and of such designations
and par values (if any) and with such rights, preferences,
privileges, limitations, restrictions and such other relative
terms as shall be determined by the Trustees, from time to time.
The number of Shares is unlimited. The Trustees shall have full
power and authority to take such action with respect to the
Shares as the Trustees may deem desirable.
Section 4.2. Issuance
of Shares. (a) Shares may be issued from
time to time to such Persons (including, without limitation, any
Trustee, officer, or agent of the Trust or any Person in which a
Trustee, officer or agent of the Trust has an interest) either
for cash or for such other consideration (which may be in any
one or more instances a certain specified consideration or
certain specified considerations) and on such terms as the
Trustees, from time to time, may deem advisable, and the Trust
may, in connection with an issuance of Shares, acquire other
assets (including the acquisition of assets subject to, and in
connection with, the assumption of liabilities), and all Shares
so issued hereunder, including without limitation Shares issued
in connection with a dividend in Shares or a split or reverse
split of Shares, shall be fully paid and nonassessable. The
Trust shall have the right to refuse to issue Shares to any
Person at any time and for any reason or for no reason
whatsoever.
(b) The Trust may issue Shares in fractional denominations
to the same extent as its whole Shares, and Shares in fractional
denominations shall be Shares having proportionately to the
respective fractions represented thereby all the rights of whole
Shares, including, without limitation, the right to vote, the
right to receive dividends and distributions and the right to
participate upon termination of the Trust.
(c) Any Shares issued by the Trust which have been
purchased, redeemed or otherwise reacquired by the Trust shall
be retired automatically and shall have the status of unissued
Shares.
Section 4.3. Rights
of Shareholders. The ownership of the
Trust Property of every description and the right to
conduct any business herein described is vested exclusively in
the Trust. The Shareholders shall have no right or title in or
to the Trust Property or to call for any partition or
division of any property, profits, rights or interests of the
Trust or any Series thereof and the Shareholders shall have no
interest therein other than the beneficial interest conferred by
their Shares. The death, incapacity, dissolution, termination,
or bankruptcy of a Shareholder during the continuance of the
Trust shall neither operate to terminate the Trust or any Series
thereof nor entitle the representative of any such Shareholder
to an accounting or to take any action in court or elsewhere
against the Trust, any Series thereof or the Trustees, but shall
entitle such representative only to the rights of said
Shareholder under this Declaration. Neither the Trust nor the
Trustees, nor any officer, employee or agent of the Trust shall
have any power to bind personally any Shareholder, or to call
upon any Shareholder for the payment of any sum of money or
assessment whatsoever other than such as the Shareholder may at
any time personally agree to pay, provided however that any
sales loads or charges,
D-3
redemption fees, account fees or any other fees or charges not
prohibited as charges to Shareholders under applicable law shall
not be deemed to be an assessment for the purposes of this
Declaration. The Shares shall be personal property giving only
the rights specifically set forth in this Declaration. The
holders of Shares shall not, as such holders, have any right to
acquire, purchase or subscribe for any Shares or securities of
the Trust that it may hereafter issue or sell, other than such
right, if any, as the Trustees may determine. The holders of
Shares shall not be entitled to exercise the rights of objecting
shareholders and shall have no appraisal rights with respect to
their Shares and, except as otherwise determined by the Trustees
from time to time, shall have no exchange or conversion rights
with respect to their Shares. Every Shareholder, by virtue of
purchasing Shares and becoming a Shareholder, shall be held to
have expressly assented and agreed to the terms of this
Declaration and any other governing instrument and shall be
bound thereby.
Section 4.4. Ownership
and Transfer of Shares; Small
Accounts. (a) The ownership and transfer of
Shares shall be recorded on the books of the Trust or, if there
is a transfer or similar agent with respect to such Shares, on
the books and records of such transfer or similar agent with
respect to such Shares, which records shall be maintained
separately for the Shares of each Series or Class of the Trust.
No certificates representing the ownership of Shares shall be
issued except as the Trustees may otherwise determine from time
to time. The Trustees may make such rules or impose such
restrictions as they consider necessary or appropriate for the
issuance of Share certificates, transfer of Shares and similar
matters. The record books of the Trust, as kept by the Trust or
any transfer or similar agent of the Trust, shall be conclusive
as to who are the holders of Shares and as to the number of
Shares held from time to time by each Shareholder. No
Shareholder shall be entitled to receive any payment of a
dividend or distribution, or to have notice given to him as
provided herein or in the Bylaws, until he has provided such
information as shall be required to the Trust or, as applicable,
the Trusts transfer or similar agent with respect to his
Shares.
(b) In the event any certificates representing Outstanding
Shares are at any time outstanding, the Trustees may at any time
or from time to time determine that Shares shall no longer be
represented by certificates, and in connection therewith, upon
written notice to any Shareholder holding certificates
representing Outstanding Shares, such certificates shall be
cancelled, provided that such cancellation shall not affect the
ownership by such Shareholder of such Shares, and following such
cancellation, ownership and transfer of such Shares shall be
recorded by book entry on the books of the Trust or its transfer
or similar agent.
(c) The Trustees may establish, from time to time, one or
more minimum investment amounts for Shareholder accounts, which
may differ within and among any Series or Classes, and may
impose account fees on (which may be satisfied by involuntarily
redeeming the requisite number of Shares in any such account in
the amount of such fee),
and/or
require the involuntary redemption of Shares held in, those
accounts the net asset value of which for any reason falls below
such established minimum investment amounts, or may authorize
the Trust to convert any such Shares in such account to Shares
of another Class or Series, or take any other such action with
respect to minimum investment amounts as may be deemed necessary
or appropriate by the Trustees, in each case upon such terms as
shall be established by the Trustees.
Section 4.5. Voting
by Shareholders. (a) Shareholders shall not
have the power to vote on any matter except: (i) for the
election or removal of Trustees to the extent and as provided in
Article V hereof; and (ii) with respect to such
additional matters relating to the Trust as may be required by
law or as the Trustees may consider and determine necessary or
desirable.
(b) Each whole Share (or fractional Share) outstanding on
the record date established in accordance with the Bylaws shall
entitle the holder thereof to a number of votes as to any matter
on which the Shareholder is entitled to vote equal to the net
asset value of the Share (or fractional Share) in United States
dollars determined at the close of business on the record date.
There shall be no cumulative voting in the election of Trustees
or on any other matter submitted to a vote of the Shareholders.
Shares may be voted in person or by proxy. Until Shares of the
Trust or any Series or Class are issued, the Trustees may
exercise all rights of Shareholders of the Trust or such Series
or Class and may take any action required or permitted by law,
this Declaration or the Bylaws of the Trust to be taken by
Shareholders of the Trust, such Series or Class.
(c) On any matter submitted to a vote of the Shareholders
of the Trust, all Shares of all Series and Classes then entitled
to vote shall be voted together, except that (i) when
required by the 1940 Act to be voted
D-4
by individual Series or Class, Shares shall be voted by
individual Series or Class, and (ii) when the Trustees have
determined that the matter affects only the interests of
Shareholders of one or more Series or Classes, only Shareholders
of such one or more Series or Classes shall be entitled to vote
thereon.
Section 4.6. Meetings. Meetings
of the Shareholders of the Trust or any one or more Series or
Classes thereof may be called and held from time to time for the
purpose of taking action upon any matter requiring the vote or
authority of the Shareholders as herein provided or upon any
other matter deemed by the Trustees to be necessary or
desirable. The Trustees may set in the Bylaws provisions
relating to the calling and holding of meetings (including the
holding of meetings by electronic or other similar means),
notice of meetings, record dates, place of meetings, conduct of
meetings, voting by proxy, postponement, adjournment or
cancellation of meetings and related matters.
Section 4.7. Quorum
and Action. (a) The Trustees shall set forth
in the Bylaws the quorum required for the transaction of
business by the Shareholders at a meeting, which quorum shall in
no event be less than Shares representing thirty percent (30%)
of the voting power of the Shares entitled to vote at such
meeting. If a quorum is present when a duly called and held
meeting is convened, the Shareholders present may continue to
transact business until adjournment, even though the withdrawal
of a number of Shareholders originally present leaves less than
the proportion or number otherwise required for a quorum.
(b) The Shareholders shall take action by the affirmative
vote of the holders of Shares representing a majority, except in
the case of the election of Trustees which shall only require a
plurality, of votes cast at a meeting of Shareholders at which a
quorum is present, except as may be otherwise required by
applicable law or any provision of this Declaration or the
Bylaws.
Section 4.8. Action
by Written Consent in Lieu of Meeting of
Shareholders. Any action required or permitted to
be taken at a meeting of the Shareholders may be taken, if so
directed by the Trustees, without a meeting by written action
executed by Shareholders, as of a record date specified in
accordance with the Bylaws, holding not less than the minimum
voting power that would have been necessary to take the action
at a meeting, assuming that all of the Shareholders entitled to
vote on that action were present and voting at that meeting. The
written action shall be effective when it has been executed by
the requisite number of Shareholders and delivered to the
Secretary of the Trust, unless a different effective time is
provided in the written action. Such a consent may be executed
and delivered by electronic means in accordance with any
procedures that may be adopted by the Trustees from time to time.
Section 4.9. Series
and Classes of Shares.
(a) Series. The current Series of the
Trust are set forth on Schedule A hereto. The Trustees may
from time to time authorize the division of Shares into
additional Series. The relative rights, preferences, privileges,
limitations, restrictions and other relative terms of any Series
shall be established and designated by the Trustees, and may be
modified by the Trustees from time to time, upon and subject to
the following provisions:
(i) Subject to variations between Classes of Shares of a
Series, all Shares shall be identical except that there may be
such variations as shall be fixed and determined by the Trustees
from time to time between different Series, including, without
limitation, as to qualifications for ownership, minimum purchase
amounts, minimum account size, purchase price, fees and
expenses, redemptions, conversions and exchanges, and special
and relative rights as to dividends and on liquidation, and each
Series shall have such business purpose or investment objective
as shall be determined by the Trustees. Each Share of a Series
shall represent a beneficial interest in the net assets
allocated or belonging to such Series only, and such interest
shall not extend to the assets of the Trust generally (except to
the extent that General Assets (as defined below) are allocated
to such Series). All references to Shares in this Declaration
shall be deemed to include references to Shares of any or all
Series as the context may require.
(ii) The number of authorized Shares of each Series and the
number of Shares of each Series that may be issued shall be
unlimited. The Trustees may divide or combine any issued or
unissued Shares of any Series into a greater or lesser number;
classify or reclassify any issued or unissued Shares into one or
D-5
more Series; terminate any one or more Series; change the name
of a Series; and take such other action with respect to the
Series as the Trustees may deem desirable.
(iii) All consideration received by the Trust for the issue
or sale of Shares of a particular Series, together with all
assets in which such consideration is invested or reinvested,
all income, earnings, profits and proceeds thereof, including
any proceeds derived from the sale, exchange or liquidation of
such assets, and any funds or payments derived from any
reinvestment of such proceeds in whatever form the same may be
(collectively, the Assets), shall irrevocably belong
to that Series for all purposes, subject only to the rights of
creditors of such Series, and shall be so recorded upon the
books of the Trust. Such Assets, together with any General
Assets (as hereinafter defined) allocated to that Series as
provided in the following sentence, are herein referred to as
Assets belonging to that Series. In the event that
there are any assets, income, earnings, profits or proceeds
thereof, funds or payments which are not readily identifiable as
Assets belonging to any particular Series (collectively, the
General Assets), the Trustees shall allocate such
General Assets to and among any one or more of the Series
created from time to time in such manner and on such basis as
they deem fair and equitable; and any General Assets allocated
to a particular Series shall be Assets belonging to that Series.
Each such allocation by the Trustees shall be conclusive and
binding upon the Shareholders of all Series for all purposes.
Separate and distinct records shall be maintained for each
Series and the Assets belonging to each Series shall be held and
accounted for in such separate and distinct records separately
from the Assets belonging to all other Series and the General
Assets of the Trust not allocated to such Series.
(iv) The Assets belonging to a particular Series shall be
charged with the debts, liabilities and obligations of the Trust
in respect of that Series and with all expenses, costs, charges
and reserves attributable to that Series (collectively, the
Liabilities), which Liabilities shall be recorded
upon the books of the Trust. Such Liabilities together with any
General Liabilities (as hereinafter defined) allocated to that
Series as provided in the following sentence, are herein
referred to as Liabilities belonging to that Series.
In the event there are any debts, liabilities, obligations,
expenses, costs, charges or reserves of the Trust that are not
readily identifiable as belonging to any particular Series
(collectively, the General Liabilities), the
Trustees shall allocate and charge such General Liabilities to
and among any one or more of the Series created from time to
time in such manner and on such basis as they deem fair and
equitable; and any General Liabilities so allocated to a
particular Series shall belong to that Series. Each such
allocation by the Trustees shall be conclusive and binding upon
all concerned for all purposes. Without limiting the foregoing,
but subject to the right of the Trustees to allocate General
Liabilities as herein provided, the Liabilities belonging to a
particular Series shall be enforceable only against the Assets
belonging to such Series and not against the assets of the Trust
generally or against the Assets belonging to any other Series,
and none of the General Liabilities incurred, contracted for or
otherwise existing with respect to the Trust generally or any
Liabilities incurred, contracted for or otherwise existing with
respect to any other Series shall be enforceable against the
Assets belonging to such Series. Notice of this contractual
limitation on liabilities among Series may be set forth in the
Certificate of Trust (whether originally or by amendment) as
filed or to be filed with the Secretary of State of the State of
Delaware pursuant to the Delaware Act, and upon the giving of
such notice in the Certificate of Trust, the statutory
provisions of § 3806(b)(2) of the Delaware Act
relating to limitations on liabilities among Series (and the
statutory effect under § 3804(a) of setting forth such
notice in the Certificate of Trust) shall become applicable to
the Trust and each Series. Any Person extending credit to,
contracting with or having any claim against any Series may look
only to the Assets belonging to that Series to satisfy or
enforce any Liability belonging to that Series. No Shareholder
or former Shareholder of any Series, in such capacity, shall
have a claim on or any right to any Assets belonging to any
other Series.
(b) Classes. The current Classes are set
forth on Schedule B hereto with respect to those Series
identified on such Schedule. The Trustees may from time to time
authorize the division of Shares of the Trust or any Series
thereof into additional Classes. The relative rights,
preferences, privileges, limitations, restrictions and other
relative terms of a Class shall be established and designated by
the Trustees and may be modified by the Trustees from time to
time. All Shares of a Class of a Series shall be identical with
each other and with the Shares of each other Class of the same
Series except for such variations between Classes as may be
D-6
authorized by the Trustees from time to time and not prohibited
by the 1940 Act, including, without limitation, as to
qualifications for ownership, minimum purchase amounts, minimum
account size, purchase price, fees and expenses, right of
redemption, and the price, terms and manner of redemption,
conversion and exchange rights and features and special and
relative rights as to dividends and on liquidation. The number
of authorized Shares of each Class and the number of Shares of
each Class that may be issued shall be unlimited. The Trustees
may divide or combine the issued or unissued Shares of any Class
into a greater or lesser number; classify or reclassify any
issued or unissued Shares of any Class into one or more Classes;
combine two or more Classes of a Series into a single Class of
such Series; terminate any one or more Classes of Shares; change
the name or other designation of a Class; and take such other
action with respect to the Classes as the Trustees may deem
desirable. To the extent necessary or appropriate to give effect
to the preferences and special or relative rights and privileges
of any Classes, the Trustees may allocate assets, liabilities,
income and expenses of a Series to a particular Class of that
Series or apportion the same among two or more Classes of that
Series. All references to Shares in this Declaration shall be
deemed to include references to Shares of any or all Classes as
the context may require.
(c) Establishment and Designation of Series and
Classes. The establishment and designation of any
Series or Class of Shares shall be made either by the vote of a
majority of the Trustees or by the execution by a majority of
the Trustees of an instrument in each case setting forth such
establishment and designation, the effective date of such
establishment and designation and the relative rights,
preferences, privileges, limitations, restrictions and other
relative terms of such Series
and/or
Class, whether directly in such resolution or instrument or by
reference to one or more documents or instruments outside this
Declaration and outside the resolutions, as the same may be in
effect from time to time, including any Prospectus relating to
such Series or Class, and any such resolutions or instruments
shall be deemed to be incorporated by reference herein as part
of the Trusts governing instrument within the
meaning of the Delaware Act. Additions or modifications to a
designation, including, without limitation, any termination of
an existing Series or Class, shall be made in the same manner as
is permitted for the establishment and designation of such
Series or Class.
Section 4.10. Disclosure
of Shareholder Holdings. The holders of Shares or
other securities of the Trust shall upon demand disclose to the
Trust in writing such information with respect to direct and
indirect ownership of Shares or other securities of the Trust as
the Trustees deem necessary to comply with the provisions of the
Code; to comply with the requirements of any other law or
regulation; or as the Trustees may otherwise decide, and
ownership of Shares may be disclosed by the Trust if so required
by applicable law or as the Trustees may otherwise decide.
Section 4.11. Access
to Trust Records. Except to the extent
otherwise required by law, Shareholders shall only have such
right to inspect the records, documents, accounts and books of
the Trust as may be granted from time to time by the Trustees.
Section 4.12. Communications
with Shareholders. Any notices, reports,
statements, or communications with Shareholders of any kind
required under this Declaration, including any such
communications with Shareholders or their counsel or other
representatives required under Section 9.8 hereof, or
otherwise made by the Trust or its agents on behalf of the Trust
shall be governed by the provisions pertaining thereto in the
Bylaws.
ARTICLE V
THE TRUSTEES
Section 5.1. Management
of the Trust. The business and affairs of the
Trust shall be managed under the direction of the Trustees, and
they shall have all powers necessary and desirable to carry out
that responsibility, including, without limitation, those powers
described more fully in Article VI hereof.
Section 5.2. Qualification
and Number. Each Trustee shall be a natural
person. A Trustee need not be a citizen of the United States or
a resident of the State of Delaware. By a majority vote or
consent of the Trustees as may then be in office, the Trustees
may from time to time establish the number of Trustees. No
decrease in the number of Trustees shall have the effect of
removing any Trustee from office prior to the
D-7
expiration of his term, but the number of Trustees may be
decreased in conjunction with the removal of a Trustee pursuant
to Section 5.4 hereof.
Section 5.3. Term
and Election. Except as provided in
Section 5.4 below, each Trustee shall hold office
until the next meeting of Shareholders called for the purpose of
considering the election or re-election of such Trustee or of a
successor to such Trustee, and until his successor, if any, is
elected, qualified and serving as a Trustee hereunder. Any
Trustee vacancy may be filled by the affirmative vote or consent
of a majority of the Trustees then in office, except as
prohibited by the 1940 Act, or, if for any reason there are no
Trustees then in office, vacancies may be filled by the officers
of the Trust elected pursuant to Section 6.2(b)(iii)
hereof, or may be filled in any other manner permitted by the
1940 Act.
Section 5.4. Resignation,
Retirement and Removal. Any Trustee may resign or
retire as a Trustee by an instrument in writing signed by him
and delivered or mailed to the Chair, if any, the President or
the Secretary, and such resignation or retirement shall be
effective upon such delivery, or at a later date according to
the terms of the instrument. Any Trustee who has attained a
mandatory retirement age or term limit established pursuant to,
or who is otherwise required to retire in accordance with, any
written policy adopted from time to time by at least two-thirds
(2/3) of the Trustees shall, automatically and without action of
such Trustee or the remaining Trustees, be deemed to have
retired in accordance with the terms of such policy, effective
as of the date determined in accordance with such policy; and
any Trustee who has become incapacitated by illness or injury as
determined by a majority of the other Trustees or declared
incompetent by a court of appropriate jurisdiction, may be
retired by written instrument signed by a majority of the other
Trustees. Except as aforesaid, any Trustee may be removed from
office only (i) by action of at least two-thirds (2/3) of
the voting power of the Outstanding Shares, or (ii) by the
action of at least two-thirds (2/3) of the remaining Trustees,
specifying the date when such removal shall become effective.
Except to the extent expressly provided in a written agreement
to which the Trust is a party or in a written policy adopted by
the Trustees, no resigning, retiring or removed Trustee shall
have any right to any compensation for any period following his
resignation, retirement or removal, or any right to damages on
account of such resignation, retirement or removal.
Section 5.5. Vacancies. The
death, resignation, retirement, removal, or incapacity of one or
more of the Trustees, or all of them, shall not operate to annul
the Trust or to revoke any existing agency created pursuant to
the terms of this Declaration. Whenever a vacancy in the number
of Trustees shall occur, until such vacancy is filled as
provided herein, or the number of Trustees as fixed is reduced,
the Trustees in office, regardless of their number, shall have
all the powers granted to the Trustees, and during the period
during which any such vacancy shall occur, only the Trustees
then in office shall be counted for the purposes of the
existence of a quorum or any action to be taken by such Trustees.
ARTICLE VI
POWERS OF
TRUSTEES
Section 6.1. General
Powers. The Trustees shall have exclusive and
absolute control over the Trust Property and over the
business of the Trust but with full powers of delegation, except
as may otherwise be expressly prohibited by this Declaration.
The Trustees shall have the power to direct the business and
affairs of the Trust and carry on the Trusts operations
and maintain offices both within and outside the State of
Delaware, and to do or authorize all such other things and
execute or authorize the execution of all such instruments as
they deem necessary, proper or desirable in order to promote the
interests of the Trust. With respect to any power or authority
of the Trustees hereunder, whether stated or implied, the
Trustees shall have all further powers and authority as may be
necessary, incidental, relative, conductive, appropriate or
desirable for the accomplishment, carrying out or attainment of
any action authorized by the Trustees. In construing the
provisions of this Declaration, the presumption shall be in
favor of a grant of power to the Trustees. Without limiting the
foregoing, the Trustees shall have power and authority to
operate and carry on the business of an investment company and
the Trustees shall exercise all the powers as are necessary,
convenient, appropriate, incidental or customary in connection
therewith and may exercise all powers which are ordinarily
exercised by the trustees of a statutory trust. The enumeration
of any specific power herein shall not be construed as
D-8
limiting the aforesaid general powers. Such powers of the
Trustees may be exercised without order of or resort to any
court. Whenever in this Declaration the Trustees are given
authority to act on behalf of the Trust or to direct, authorize
or cause the Trust to take any action, such power and authority
shall apply, mutatis mutandis, to any action of the Trust
on behalf of any Series or Class.
Section 6.2. Certain
Specific Powers. (a) Investments. The
Trustees shall not in any way be bound or limited by present or
future laws, rules, regulations, or customs in regard to
investments by fiduciaries, but shall have full authority and
power to authorize the Trust to make, invest and reinvest in, to
buy or otherwise acquire, to hold, for investment or otherwise,
to borrow, to sell, terminate, exercise or otherwise dispose of,
to lend or to pledge, to write, enter into, engage, trade or
deal in any and all investments or investment strategies as they
may deem proper at any time and from time to time to accomplish
the purpose of the Trust or any Series thereof. In furtherance
of, and in no way limiting, the foregoing, the Trustees shall
have power and authority to authorize the Trust:
(i) to exercise powers and rights of subscription or
otherwise which in any manner arise out of ownership of
securities or other assets;
(ii) to hold any security or property in a form not
indicating any trust, whether in bearer, unregistered or other
negotiable form or either in the Trusts name or in the
name of a custodian or a nominee or nominees;
(iii) to exercise all rights, powers and privileges of
ownership or interest in all securities and other assets
included in the Trust Property, including the right to vote
thereon and otherwise act with respect thereto and to do all
acts for the preservation, protection, improvement and
enhancement in value of all such assets;
(iv) to acquire (by purchase, lease or otherwise) and to
hold, use, maintain, develop and dispose of (by sale or
otherwise) any property, real or personal, tangible or
intangible, including cash, securities, currencies, any
commodities, and any interest therein;
(v) to borrow money for any purpose and in this connection
issue notes or other evidence of indebtedness;
(vi) to secure borrowings by mortgaging, pledging or
otherwise subjecting as security all or any portion of the
Trust Property;
(vii) to endorse, guarantee, or undertake the performance
of any obligation or engagement of any other Person;
(viii) to lend money or any other Trust Property;
(ix) to aid by further investment any corporation, company,
trust, association or firm, any obligation of or interest in
which is included in the Trust Property or in the affairs
of which the Trustees have any direct or indirect interest and
to do all acts and things designed to protect, preserve, improve
or enhance the value of such obligation or interest;
(x) to guarantee or become surety on any or all of the
contracts, stocks, bonds, notes, debentures and other
obligations of any such corporation, company, trust, association
or firm;
(xi) to consent to or participate in any plan for the
reorganization, consolidation or merger of any corporation or
issuer, any security or property of which is held in the Trust;
(xii) to consent to any contract, lease, mortgage,
purchase, or sale of property by such corporation or issuer;
(xiii) to pay calls or subscriptions with respect to any
security held in the Trust; and
(xiv) to join with other security holders in acting through
a committee, depositary, voting trustee or otherwise, and in
that connection to deposit any security with, or transfer any
security to, any such committee, depositary or trustee, and to
delegate to them such power and authority with relation to any
D-9
security (whether or not so deposited or transferred) as the
Trustees shall deem proper, and to agree to pay, and to pay,
such portion of the expenses and compensation of such committee,
depositary or trustee as the Trustees shall deem proper.
(b) Additional Powers. The Trustees shall
have the power and authority on behalf of the Trust:
(i) to employ, engage or contract with, or make payments
to, such Persons as the Trustees may deem desirable for the
transaction of the business of the Trust or any Series thereof,
including, without limitation, any Trustee or officer of the
Trust or any firm of which any such Trustee or officer is a
member, whether as agents or independent
contractors of the Trust or any Series thereof, or as delegates
of the Trustees, officers, or any other Person who may be
involved with the management of the business affairs of the
Trust or any Series thereof, to have such titles, and such
rights, powers and duties as the Trustees may determine from
time to time, to terminate any such employment, engagement or
contract or other relationship, and to delegate to any such
Person the supervision of any other Person that has been so
employed, engaged or contracted with;
(ii) to authorize the Trust to enter into joint ventures,
partnerships and any other combinations or associations;
(iii) to elect and remove such officers as they consider
appropriate;
(iv) to authorize the Trust to indemnify any Person with
whom the Trust has dealings, including, without limitation, any
service provider employed pursuant to Article VII hereof,
to such extent as the Trustees shall determine;
(v) to authorize the Trust to purchase, and pay for out of
Trust Property, (A) insurance policies insuring the
Shareholders, Trustees, officers, employees and any other
Persons, including, without limitation, any service provider
employed pursuant to Article VII hereof, against any or all
claims arising by reason of holding any such position or by
reason of any action taken or omitted by any such Person in such
capacity whether or not the Trust would have the power to
indemnify such Person against such liability, (B) insurance
for the protection of Trust Property, (C) insurance as may
be required by applicable law, or (D) such other insurance
as the Trustees shall deem advisable, in each case as the
Trustees shall determine;
(vi) to authorize the Trust to establish pension,
profit-sharing, share purchase, and other retirement, incentive
and benefit plans, including the purchasing of life insurance
and annuity contracts as a means of providing such retirement
and other benefits, for any Trustees, officers, employees and
agents of the Trust;
(vii) to authorize the Trust to guarantee indebtedness or
contractual obligations of others;
(viii) to determine and change the fiscal year of the Trust
or any Series and the method by which its accounts shall be kept;
(ix) to adopt a seal for the Trust, but the absence of such
seal shall not impair the validity of any instrument executed on
behalf of the Trust; and
(x) to engage in any other lawful act or activity in
connection with or incidental to any of the powers enumerated in
this Declaration, to do everything necessary, suitable or proper
for the accomplishment of any purpose or the attainment of any
object or the furtherance of any power herein set forth, either
alone or in association with others, and to do every other act
or thing incidental or appurtenant to or growing out of or
connected with the aforesaid business or purposes, objects or
powers.
(c) The foregoing enumeration of the powers and authority
of the Trustees shall be read as broadly and liberally as
possible, it being the intent of the foregoing in no way to
limit the Trustees powers and authority.
Section 6.3. Issuance
and Repurchase of Shares. The Trustees shall have
the power to authorize the Trust to issue, sell, repurchase,
redeem, retire, cancel, acquire, hold, resell, reissue, dispose
of, transfer, and
D-10
otherwise deal in Shares and in any options, warrants or other
rights to purchase Shares or any other interests in the Trust
other than Shares.
Section 6.4. Delegation;
Committees. The Trustees shall have power to
delegate from time to time to one or more of their number or to
officers, employees or agents of the Trust the doing of such
things and the execution of such instruments either in the name
of the Trust or the names of the Trustees or otherwise as the
Trustees may deem expedient, except to the extent such
delegation is prohibited by applicable law. Without limiting the
foregoing, and notwithstanding any provisions herein to the
contrary, the Trustees may by resolution appoint committees
consisting of one or more, but less than the whole number of,
Trustees then in office and such other members as the Trustees
shall approve, which committees may be empowered to act for and
bind the Trustees and the Trust, as if the acts of such
committees were the acts of all the Trustees then in office.
Section 6.5. Collection
and Payment. The Trustees shall have the power to
authorize the Trust or its agents to: collect all money or other
property due to the Trust; to pay all claims, including taxes,
against the Trust Property; to prosecute, defend,
arbitrate, compromise or abandon any claims relating to the
Trust Property; to foreclose any security interest securing
any obligations, by virtue of which any money or other property
is owed to the Trust; and to enter into releases, agreements and
other instruments; but the Trustees shall have no liability for
failing to authorize any of the foregoing.
Section 6.6. Expenses. The
Trustees shall have the power to authorize the Trust to incur
and pay any expenses which, in the opinion of the Trustees, are
necessary or incidental to carry out any of the purposes of this
Declaration, to pay compensation from the funds of the Trust to
themselves as Trustees and to reimburse themselves from the
funds of the Trust for their expenses and disbursements. The
Trustees shall fix the compensation of all officers, employees
and Trustees.
Section 6.7. Manner
of Acting. Except as otherwise provided herein,
under applicable law or in the Bylaws, any action to be taken or
determination made by the Trustees may be taken or made by a
majority of the Trustees present at a meeting of Trustees (a
quorum being present), including any meeting held by means of a
conference telephone circuit or similar communications equipment
by means of which all persons participating in the meeting can
hear each other, or by written consents of a majority of
Trustees then in office. Any such action or determination may be
made by reference to one or more documents or instruments or
policies or procedures outside this Declaration and outside the
resolutions of the Trustees. Except as set forth specifically in
this Declaration, any action that may be taken by the Trustees
may be taken by them in their sole discretion and without the
vote or consent of Shareholders.
Section 6.8. Bylaws. The
Trustees may adopt Bylaws not inconsistent with this Declaration
to provide for the conduct of the business of the Trust and
shall have the exclusive power to amend or repeal such Bylaws.
Section 6.9. Principal
Transactions. Except in transactions not
permitted by the 1940 Act, the Trustees may authorize the Trust
to buy any securities or other assets from or sell or lend any
securities or other assets of the Trust to, any affiliate of the
Trust or any account managed by an affiliate of the Trust, any
Trustee or officer of the Trust or any firm of which any such
Trustee or officer is a member acting as principal, or have any
such dealings with any service provider employed pursuant to
Article VII hereof.
Section 6.10. Effect
of Trustees Determination. Any action taken
or determination made by or pursuant to the direction of the
Trustees in good faith and consistent with the provisions of
this Declaration shall be final and conclusive and shall be
binding upon the Trust, every holder at any time of Shares and
any other Person.
D-11
ARTICLE VII
SERVICE
PROVIDERS
Section 7.1. Investment
Adviser and Administrator. The Trust may enter
into contracts with one or more Persons, to act as investment
adviser, investment sub-adviser, manager, administrator,
sub-administrator or other agent to the Trust or Series, and as
such to perform such functions as the Trustees may deem
reasonable and proper, including, without limitation, investment
advisory, management, research, valuation of assets, clerical
and administrative functions, under such terms and conditions,
and for such compensation, as the Trustees may deem advisable.
The Trustees may also authorize any adviser or sub-adviser to
employ one or more sub-advisers from time to time and any
administrator to employ one or more sub-administrators from time
to time, upon such terms and conditions as shall be approved by
the Trustees.
Section 7.2. Underwriter;
Transfer Agent; Shareholder Servicing Agent; Custodian.
The Trust may enter into a contract or contracts
with one or more Persons to act as underwriters, distributors or
placement agents whereby the Trust may either agree to sell
Shares of the Trust or any Series or Class to the other party or
parties to the contract or appoint such other party or parties
its sales agent or agents for such Shares and with such other
provisions as the Trustees may deem reasonable and proper, and
the Trust may from time to time enter into transfer agency,
sub-transfer agency
and/or
shareholder servicing contract(s), in each case with such terms
and conditions, and providing for such compensation, as the
Trustees may deem advisable.
All securities and cash of the Trust shall be held pursuant to a
written contract or contracts with one or more custodians and
subcustodians or shall otherwise be held in accordance with the
1940 Act.
Section 7.3. Parties
to Contract. Any contract of the character
described in this Article VII may be entered into with any
Person, including, without limitation, the investment adviser,
any investment sub-adviser or an affiliate of the investment
adviser or sub-adviser, although one or more of the Trustees,
officers, or Shareholders of the Trust may be an officer,
director, trustee, shareholder, or member of such other party to
the contract, or otherwise interested in such contract, and no
such contract shall be invalidated or rendered voidable by
reason of the existence of any such relationship, nor shall any
Person holding such relationship be liable merely by reason of
such relationship for any loss or expense to the Trust under or
by reason of said contract or accountable for any profit
realized directly or indirectly therefrom, provided that the
contract when entered into was not inconsistent with the
provisions of this Article VII or the Bylaws. The same
Person may be a party to more than one contract entered into
pursuant to this Article VII and any individual may be
financially interested or otherwise affiliated with Persons who
are parties to any or all of the contracts mentioned in this
Article VII.
Section 7.4. Further
Authority of Trustees. The authority of the
Trustees hereunder to authorize the Trust to enter into
contracts or other agreements or arrangements shall include the
authority of the Trustees to modify, amend, waive any provision
of, supplement, assign all or a portion of, novate, or terminate
such contracts, agreements or arrangements. The enumeration of
any specific contracts in this Article VII shall in no way
be deemed to limit the power and authority of the Trustees as
set forth in Section 6.2 hereof to authorize the Trust to
employ, contract with or make payments to such Persons as the
Trustees may deem desirable for the transaction of the business
of the Trust.
ARTICLE VIII
DISTRIBUTIONS;
REDEMPTIONS; DETERMINATION OF NET ASSET VALUE
Section 8.1. Distributions. The
Trustees may from time to time declare and authorize the payment
of, or may prescribe and set forth in a duly adopted vote or
votes of the Trustees, the bases and time or frequency, which
may be monthly or otherwise, for the declaration and payment of,
such dividends and distributions on Shares of a particular
Series or Class thereof as they may deem necessary or desirable,
after providing for actual and accrued expenses and liabilities
(including such reserves as the Trustees may establish)
determined in accordance with good accounting practices. All
dividends and distributions on Shares of a particular Series
shall be distributed only from the Assets belonging to that
Series, as such term is defined in Section 4.9
D-12
hereof, and shall be distributed pro rata to the Shareholders of
that Series in proportion to the number of Shares of that Series
held by such Shareholders at the date and time of record for the
payment of such dividends or distributions, subject to any
variations with respect to Classes of Shares of such Series, if
any, and in a manner consistent with the 1940 Act and the Code.
Such distributions may be paid in cash
and/or in
securities or other property, and the composition of any such
distribution shall be determined by the Trustees and may be
different among Shareholders (including differences among
Shareholders in the same Series or Class).
Section 8.2. Redemption
of Shares. All shares of the Trust shall be
redeemable, at the redemption price determined in the manner set
out in this Declaration. The Trust shall redeem the Shares of
the Trust or any Series or Class thereof at the price determined
as hereinafter set forth, at such offices or agencies and in
accordance with such conditions, not inconsistent with the 1940
Act, regarding the redemption of Shares as may be described in
the applicable Prospectus.
Section 8.3. Redemption Price. Shares
of each Series and Class thereof shall be redeemed at their net
asset value determined as set forth in Section 8.7 hereof
as of such time or times as the Trustees shall have theretofore
prescribed, less such fees
and/or
charges, if any, as may be established by the Trustees from time
to time.
Section 8.4. Payment. Payment
of the redemption price of Shares of any Series or Class thereof
shall be made in cash or in property or any combination thereof,
out of the Assets belonging to such Series, as such term is
defined in Section 4.9 hereof, and the composition of any
such payment may be different among Shareholders (including
differences among Shareholders in the same Series or Class), at
such time and in the manner as may be specified from time to
time in the applicable Prospectus. In no event shall the Trust
be liable for any delay of any other Person in transferring
securities or other property selected for delivery as all or
part of any such payment.
Section 8.5. Redemption
of Shareholders Interest By Action of
Trust. Subject to the provisions of the 1940 Act,
the Trust may redeem some or all of the Shares of the Trust or
one or more Series or Classes held by any Shareholder for any
reason and under terms set by the Trustees, including by way of
illustration, for the following reasons:
(a) the value of such Shares held by such Shareholder being
less than the minimum amount established from time to time by
the Trustees;
(b) the determination that direct or indirect ownership of
Shares by any Person has become concentrated in such Shareholder
to any extent that would disqualify that Series as a regulated
investment company under the Code;
(c) the failure of a Shareholder to supply a tax
identification or other identification or if the Trust is unable
to verify a Shareholders identity;
(d) the failure of a Shareholder to pay when due for the
purchase of Shares issued to such Shareholder;
(e) the failure of a Shareholder to meet or maintain the
qualifications for ownership of a particular Class or Series of
Shares;
(f) the payment of account fees or other charges, expenses
and/or fees
as set by the Trustees, including without limitation any small
account fees permitted by Section 4.4 hereof;
(g) the determination that ownership of Shares by a
particular Shareholder is not in the best interests of the
remaining Shareholders of the Trust or applicable Series or
Class;
(h) the failure of a holder of Shares or other securities
of the Trust to comply with a demand pursuant to
Section 4.10 hereof;
(i) in connection with the termination of any Series or
Class of Shares; or
(j) when the Trust is requested or compelled to do so by
governmental authority or applicable law.
D-13
Section 8.6. Suspension
of Right of Redemption. Notwithstanding the
foregoing, the Trust may postpone payment of the redemption
price and may suspend the right of the holders of Shares to
require the Trust to redeem Shares to the extent permissible
under the 1940 Act.
Section 8.7. Determination
of Net Asset Value; Valuation of Portfolio
Assets. The Trustees may from time to time
prescribe such bases and times for determining the per Share net
asset value of the Shares of the Trust or any Series or Class
thereof and may prescribe or approve the procedures and methods
for determining the value of portfolio assets as they may deem
necessary or desirable.
The Trust may suspend the determination of net asset value
during any period when it may suspend the right of the holders
of Shares to require the Trust to redeem Shares.
Section 8.8. Constant
Net Asset Value. With respect to any Series that
holds itself out as a money market or stable value fund, the
Trustees shall have the power to reduce the number of
Outstanding Shares of the Series by reducing the number of
Shares in the account of each Shareholder on a pro rata basis,
or to take such other measures as are not prohibited by the 1940
Act, so as to maintain the net asset value per share of such
Series at a constant dollar amount.
Section 8.9. Reserves. The
Trustees may set apart, from time to time, out of any funds of
the Trust or Series or out of funds allocable to a Class thereof
a reserve or reserves for any proper purpose, and may abolish
any such reserve.
Section 8.10. Determination
by Trustees. The Trustees may make any
determinations they deem necessary with respect to the
provisions of this Article VIII, including, but not limited
to, the following matters: the amount of the assets,
obligations, liabilities and expenses of the Trust; the amount
of the net income of the Trust from dividends, capital gains,
interest or other sources for any period and the amount of
assets at any time legally available for the payment of
dividends or distributions; which items are to be treated as
income and which as capital; the amount, purpose, time of
creation, increase or decrease, alteration or cancellation of
any reserves or charges and the propriety thereof (whether or
not any obligation or liability for which such reserves or
charges were created shall have been paid or discharged); the
market value, or any other price to be applied in determining
the market value, or the fair value, of any security or other
asset owned or held by the Trust; the number of Shares of the
Trust issued or issuable; the net asset value per Share; and any
of the foregoing matters as it may pertain to any Series or
Class.
ARTICLE IX
LIMITATION
OF LIABILITY AND INDEMNIFICATION
Section 9.1. No
Personal Liability of and Indemnification of
Shareholders. No personal liability for any debt,
liability or obligation or expense incurred by, contracted for,
or otherwise existing with respect to, the Trust or any Series
or Class shall attach to any Shareholder or former Shareholder
of the Trust. In case any Shareholder or former Shareholder of
the Trust shall be held to be personally liable solely by reason
of his being or having been a Shareholder and not because of his
acts or omissions or for some other reason, the Shareholder or
former Shareholder (or his heirs, executors, administrators or
other legal representatives or in the case of a corporation or
other entity, its corporate or other general successor) shall be
entitled out of the assets of the Trust or, if the Trust has
more than one Series, the applicable Series, to be held harmless
from and indemnified against all loss and expense arising from
such liability; provided, however, there shall be no
liability or obligation of the Trust arising hereunder to
reimburse any Shareholder for taxes paid by reason of such
Shareholders ownership of any Shares or for losses
suffered by reason of any changes in value of any Trust assets.
The Trust shall, upon request by the Shareholder or former
Shareholder, assume the defense of any claim made against the
Shareholder for any act or obligation of the Trust and satisfy
any judgment thereon.
Section 9.2. Limitation
of Liability of Trustees and
Others. (a) No Liability to Third
Parties. No person who is or has been a Trustee, officer, or
employee of the Trust shall be subject to any personal liability
whatsoever to any Person, other than the Trust or its
Shareholders, in connection with the affairs of the Trust;
D-14
and all Persons shall look solely to the Trust Property or
Property of a Series for satisfaction of claims of any nature
arising in connection with the affairs of the Trust or such
Series.
Every note, bond, contract, instrument, certificate, Share or
undertaking and every other act or thing whatsoever executed or
done by or on behalf of the Trust or the Trustees or any of them
in connection with the Trust shall be conclusively deemed to
have been executed or done only in or with respect to their or
his capacity as Trustees or Trustee and neither such Trustees or
Trustee nor the Shareholders shall be personally liable thereon.
All Persons extending credit to, contracting with or having any
claim against the Trust or a Series shall look only to the
assets of the Trust Property or the Trust Property of
such Series for payment under such credit, contract or claim;
and neither the Trustees, nor any of the Trusts officers,
employees or agents, whether past, present or future, shall be
personally liable therefor.
(b) Limitation of Liability to Trust and
Shareholders. No person who is or has been a
Trustee, officer or employee of the Trust shall be liable to the
Trust or to any Shareholder for any action or failure to act
except for his or her own bad faith, willful misfeasance, gross
negligence or reckless disregard of his or her duties involved
in the conduct of the individuals office, and for nothing
else, and shall not be liable for errors of judgment or mistakes
of fact or law.
(c) No Liability for Acts of
Others. Without limiting the foregoing
limitations of liability contained in this Section 9.2, a
Trustee shall not be responsible for or liable in any event for
any neglect or wrongdoing of any officer, employee, investment
adviser, sub-adviser, principal underwriter, custodian or other
agent of the Trust, nor shall any Trustee be responsible or
liable for the act or omission of any other Trustee (or for the
failure to compel in any way any former or acting Trustee to
redress any breach of trust), except in the case of such
Trustees own willful misfeasance, bad faith, gross
negligence or reckless disregard of the duties involved in the
conduct of his or her office.
Section 9.3. Experts;
No Bond or Surety. The Trustees may rely upon
advice of counsel or other experts with respect to the meaning
and operation of this Declaration and their duties as Trustees
hereunder, and shall be under no liability for any act or
omission in accordance with such advice or for merely failing to
follow such advice. In discharging their duties, the Trustees,
when acting in good faith, shall be entitled to rely upon the
books of account of the Trust and upon written reports made to
the Trustees by any officer appointed by them, any independent
registered public accounting firm and (with respect to the
subject matter of the contract involved) any officer, partner or
responsible employee of any other party to any contract entered
into hereunder. The appointment, designation or identification
of a Trustee as chair of the Trustees, a member or chair of a
committee of the Trustees, an expert on any topic or in any area
(including an audit committee financial expert), or the lead
independent Trustee, or any other special appointment,
designation or identification of a Trustee, shall not impose on
that person any standard of care or liability that is greater
than that imposed on that person as a Trustee in the absence of
the appointment, designation or identification, and no Trustee
who has special skills or expertise, or is appointed, designated
or identified as aforesaid, shall be held to a higher standard
of care by virtue thereof. In addition, no appointment,
designation or identification of a Trustee as aforesaid shall
affect in any way that Trustees rights or entitlement to
indemnification or advancement of expenses. The Trustees shall
not be required to give any bond as such, nor any surety if a
bond is required.
Section 9.4. Liability
of Third Persons Dealing with the Trust or
Trustees. No third Person dealing with the Trust
or the Trustees shall be bound to make any inquiry concerning
the validity of any transaction made or to be made by the Trust
or Trustees or to see to the application of any payments made or
property transferred to the Trust or upon its order.
Section 9.5. Indemnification
and Advancement of Expenses. Subject to the
exceptions and limitations contained in this Section 9.5,
every person who is, or has been, a Trustee, officer, or
employee of the Trust, including persons who serve at the
request of the Trust as directors, trustees, officers, employees
or agents of another organization in which the Trust has an
interest as a shareholder, creditor or otherwise (hereinafter
referred to as a Covered Person), shall be
indemnified by the Trust to the fullest extent permitted by law
D-15
against liability and against all expenses reasonably incurred
or paid by him in connection with any claim, action, suit or
proceeding in which he becomes involved as a party or otherwise
by virtue of his being or having been such a Trustee, director,
officer, employee or agent and against amounts paid or incurred
by him in settlement thereof.
No indemnification shall be provided hereunder to a Covered
Person to the extent such indemnification is prohibited by
applicable federal law.
The rights of indemnification herein provided may be insured
against by policies maintained by the Trust, shall be severable,
shall not affect any other rights to which any Covered Person
may now or hereafter be entitled, shall continue as to a person
who has ceased to be such a Covered Person and shall inure to
the benefit of the heirs, executors and administrators of such a
person.
Subject to applicable federal law, expenses of preparation and
presentation of a defense to any claim, action, suit or
proceeding subject to a claim for indemnification under this
Section 9.5 shall be advanced by the Trust prior to final
disposition thereof upon receipt of an undertaking by or on
behalf of the recipient to repay such amount if it is ultimately
determined that he is not entitled to indemnification under this
Section 9.5.
To the extent that any determination is required to be made as
to whether a Covered Person engaged in conduct for which
indemnification is not provided as described herein, or as to
whether there is reason to believe that a Covered Person
ultimately will be found entitled to indemnification, the Person
or Persons making the determination shall afford the Covered
Person a rebuttable presumption that the Covered Person has not
engaged in such conduct and that there is reason to believe that
the Covered Person ultimately will be found entitled to
indemnification.
As used in this Section 9.5, the words claim,
action, suit or proceeding
shall apply to all claims, demands, actions, suits,
investigations, regulatory inquiries, proceedings or any other
occurrence of a similar nature, whether actual or threatened and
whether civil, criminal, administrative or other, including
appeals, and the words liability and
expenses shall include without limitation,
attorneys fees, costs, judgments, amounts paid in
settlement, fines, penalties and other liabilities.
Section 9.6. Further
Indemnification. Nothing contained herein shall
affect any rights to indemnification to which any Covered Person
or other Person may be entitled by contract or otherwise under
law or prevent the Trust from entering into any contract to
provide indemnification to any Covered Person or other Person.
Without limiting the foregoing, the Trust may, in connection
with the acquisition of assets subject to liabilities pursuant
to Section 4.2 hereof or a merger or consolidation pursuant
to Section 10.2 hereof, assume the obligation to indemnify
any Person including a Covered Person or otherwise contract to
provide such indemnification, and such indemnification shall not
be subject to the terms of this Article IX.
Section 9.7. Amendments
and Modifications. Without limiting the
provisions of Section 11.1(b) hereof, in no event will any
amendment, modification or change to the provisions of this
Declaration or the Bylaws adversely affect in any manner the
rights of any Covered Person to (a) indemnification under
Section 9.5 hereof in connection with any proceeding in
which such Covered Person becomes involved as a party or
otherwise by virtue of being or having been a Trustee, officer
or employee of the Trust or (b) any insurance payments
under policies maintained by the Trust, in either case with
respect to any act or omission of such Covered Person that
occurred or is alleged to have occurred prior to the time such
amendment, modification or change to this Declaration or the
Bylaws.
Section 9.8. Derivative
Actions. (a) The purpose of this
Section 9.8 is to adopt additional standards and
restrictions to protect the interests of the Trust and its
Shareholders by establishing a process that will permit
legitimate inquiries and claims to be made and considered while
avoiding the time, expense, distraction and other harm that can
be caused to the Trust and its Shareholders as a result of
spurious shareholder demands and derivative actions.
D-16
(b) Subject to the Delaware Act, no Shareholder may bring a
derivative or similar action or proceeding in the right of the
Trust or any Series to recover a judgment in its favor (a
derivative action) unless each of the following
conditions is met:
(i) Each Complaining Shareholder was a Shareholder of
(A) the Series on behalf of or in the right of which the
action is proposed to be brought and (B) a Class of the
Series affected by the action or failure to act complained of,
to the extent that fewer than all Classes were affected (the
affected Series or Class), at the time of the action
or failure to act complained of, or acquired the Shares
afterwards by operation of law from a Person who was a
Shareholder at that time;
(ii) Each Complaining Shareholder was a Shareholder of the
affected Series or Class at the time the demand required by
subparagraph (iii) below was made;
(iii) Prior to the commencement of such derivative action,
the Complaining Shareholders have made a written demand on the
Trustees requesting that the Trustees cause the Trust to file
the action itself on behalf of the affected Series or Class (a
demand), which demand (A) shall be executed by
or on behalf of no less than three Complaining Shareholders,
each of which shall be unaffiliated and unrelated (by blood or
by marriage) to any other Complaining Shareholder executing such
written demand and (B) shall include at least the following:
(1) a detailed description of the action or failure to act
complained of, the facts upon which each such allegation is made
and the reasonably estimated damages or other relief sought;
(2) a statement to the effect that the Complaining
Shareholders believe in good faith that they will fairly and
adequately represent the interests of similarly situated
Shareholders in enforcing the right of the affected Series or
Class and an explanation of why the Complaining Shareholders
believe that to be the case;
(3) a certification that the requirements of subparagraphs
(i) and (ii) of this paragraph (b) have been met,
as well as information reasonably designed to allow the Trustees
to verify that certification;
(4) a list of all other derivative or class actions in
which any of the Complaining Shareholders is or was a named
plaintiff, the court in which such action was filed, the date of
filing, the name of all counsel to any plaintiffs and the
outcome or current status of such actions;
(5) a certification of the number of Shares of the affected
Series or Class owned beneficially or of record by each
Complaining Shareholder at the time set forth in subparagraphs
(i), (ii) and (iii) of this paragraph (b) and an
undertaking that each Complaining Shareholder will be a
Shareholder of the affected Series or Class as of the
commencement of and throughout the derivative action and will
notify the Trust in writing of any sale, transfer or other
disposition by any of the Complaining Shareholders of any such
Shares within three business days thereof; and
(6) an acknowledgment of the provisions of paragraphs
(f) and (g) of this Section 9.8 below;
(iv) Shareholders owning Shares representing at least five
percent (5%) of the voting power of the affected Series or Class
must join in initiating the derivative action; and
(v) A copy of the proposed derivative complaint must be
served on the Trust, assuming the requirements of subparagraphs
(i) through (iv) above have already been met and the
derivative action has not been barred in accordance with
paragraph (d) below.
(c) Within 90 calendar days of the receipt of a Shareholder
demand submitted in accordance with the requirements above,
those Trustees who are independent for purposes of considering
the demand or a committee comprised of some or all of such
Trustees (the independent Trustees) will consider,
with the assistance of counsel who may be retained by such
Trustees on behalf and at the expense of the Trust, the merits
of the claim and determine whether maintaining a suit would be
in the best interests of the Trust. If, during this
90-day
period, those independent Trustees conclude that a determination
as to the maintenance of a suit cannot reasonably be made within
the 90-day
period, those independent Trustees may extend the
90-day
D-17
period by a period of time that the independent Trustees
consider will be sufficient to permit them to make such a
determination, not to exceed 60 calendar days from the end of
the initial
90-day
period (such
90-day
period, as may be extended as provided hereunder, the
review period). Notice of any such decision to
extend the review period shall be sent in accordance with the
provisions of Section 4.12 hereof to the Complaining
Shareholders, or, the Shareholders counsel if represented
by counsel, in writing within five business days of any decision
to extend the period. Trustees who are not deemed to be
Interested Persons of the Trust are deemed independent for all
purposes, including for the purpose of approving or dismissing a
derivative action. A Trustee otherwise independent for purposes
of considering the demand shall not be considered not to be
independent solely by virtue of (i) the fact that such
Trustee receives remuneration for his service as a Trustee of
the Trust or as a trustee or director of one or more investment
companies with the same or an affiliated investment adviser or
underwriter, (ii) the amount of such remuneration,
(iii) the fact that such Trustee was identified in the
demand as a potential defendant or witness, or (iv) the
fact that the Trustee approved the act being challenged in the
demand if the act resulted in no material personal benefit to
the Trustee or, if the Trustee is also a Shareholder, no
material personal benefit that is not shared pro rata with other
Shareholders.
(d) If the demand has been properly made under paragraph
(b) of this Section 9.8, and a majority of the
independent Trustees have considered the merits of the claim and
have determined that maintaining a suit would not be in the best
interests of the Trust, the demand shall be rejected and the
Complaining Shareholders shall not be permitted to maintain a
derivative action unless they first sustain the burden of proof
to the court that the decision of the Trustees not to pursue the
requested action was not a good faith exercise of their business
judgment on behalf of the Trust. If upon such consideration a
majority of the independent Trustees determine that such a suit
should be maintained, then the appropriate officers of the Trust
shall cause the Trust to commence that suit and such suit shall
proceed directly rather than derivatively or permit the
Complaining Shareholders to proceed derivatively, provided
however that any counsel representing the interests of the Trust
shall be approved by the Trustees. The Trustees, or the
appropriate officers of the Trust, shall inform the Complaining
Shareholders of any decision reached under this paragraph
(d) by sending in accordance with the provisions of
Section 4.12 hereof written notice to each Complaining
Shareholder, or the Shareholders counsel, if represented
by counsel, within five business days of such decision having
been reached.
(e) If notice of a decision has not been sent to the
Complaining Shareholders or the Shareholders counsel
within the time permitted by paragraph (d) above, and
subparagraphs (i) through (v) of paragraph
(b) above have been complied with, the Complaining
Shareholders shall not be barred by this Declaration from
commencing a derivative action.
(f) A Complaining Shareholder whose demand is rejected
pursuant to paragraph (d) above shall be responsible for
the costs and expenses (including attorneys fees) incurred
by the Trust in connection with the Trusts consideration
of the demand if a court determines that the demand was made
without reasonable cause or for an improper purpose. A
Shareholder who commences or maintains a derivative action in
violation of this Section 9.8 shall reimburse the Trust for
the costs and expenses (including attorneys fees) incurred
by the Trust in connection with the action if the action is
dismissed on the basis of the failure to comply with this
Section 9.8. If a court determines that any derivative
action has been brought without reasonable cause or for an
improper purpose, the costs and expenses (including
attorneys fees) incurred by the Trust in connection with
the action shall be borne by the Shareholders who commenced the
action.
(g) The Trust shall be responsible for payment of
attorneys fees and legal expenses incurred by a
Complaining Shareholder in any circumstances only if required by
law. The Trust shall not be obligated to pay any attorneys
fees so incurred by a Complaining Shareholder other than fees
that are reasonable and that do not exceed an amount calculated
using reasonable hourly rates.
(h) No Shareholder may make demand or commence a derivative
action on behalf of any Series of the Trust of which he or she
is not a shareholder.
D-18
ARTICLE X
TERMINATION;
MERGERS AND SALE OF ASSETS
Section 10.1. Termination
of Trust or Series. (a) Unless terminated as
provided herein, the Trust shall continue without limitation of
time. The Trust or any Series of the Trust may be terminated at
any time by the Trustees by written notice to the Shareholders
of the Trust or such Series as the case may be.
(b) Upon the requisite action of the Trustees to terminate
the Trust or such Series, after paying or otherwise providing
for all charges, taxes, expenses and liabilities, whether due or
accrued or anticipated, as may be determined by the Trustees and
as required by the Delaware Act, which may include the
establishment of a liquidating trust or similar vehicle, the
Trust shall, in accordance with such procedures as the Trustees
consider appropriate, reduce the remaining assets of the Trust
or assets of the particular Series thereof to distributable form
in cash or other securities, or any combination thereof, and
distribute the proceeds to the Shareholders of the Shares of the
Trust or such Series in the manner determined by the Trustees,
provided that Shareholders of a particular Series shall be
entitled to receive a pro rata share of the net assets of such
Series only, subject to any variations with respect to Classes
of Shares of such Series, if any. Thereupon, the Trust or any
affected Series shall terminate, and the Trustees and the Trust
shall be discharged of any and all further liabilities and
duties relating thereto or arising therefrom, and the right,
title, and interest of all parties with respect to the Trust or
such Series shall be canceled and discharged.
(c) Any Class of the Trust may be terminated by the
Trustees as provided in Article IV hereof.
(d) Upon termination of the Trust, following completion of
winding up of its business, the Trustees (or, if there is no
remaining Trustee at that time, any remaining officer of the
Trust) shall direct that a Certificate of Cancellation of the
Trust be executed and filed with the Secretary of State of the
State of Delaware.
Section 10.2. Merger
and Consolidation. Subject to applicable law, the
Trust may merge or consolidate with or into one or more
statutory trusts or other business entities or series or classes
thereof formed or organized or existing under the laws of
Delaware or any other state or the United States or any foreign
country or other foreign jurisdiction by the affirmative vote of
two-thirds (2/3) of the Trustees. Pursuant to and in accordance
with § 3815(f) of the Delaware Act, and
notwithstanding anything to the contrary contained in this
Declaration, an agreement of merger or consolidation so approved
by the Trustees in accordance with this Section 10.2 may
(a) effect any amendment to the governing instrument of the
Trust; or (b) effect the adoption of a new governing
instrument of the Trust if it is the surviving or resulting
trust in the merger or consolidation.
Section 10.3. Sale
of Assets; Reorganization. The Trustees may
authorize the Trust or any Series or Class thereof, to sell,
lease, transfer, pledge, exchange, convey or dispose of all or
substantially all of the Trust Property (or all or
substantially all of the Trust Property allocated or
belonging to a particular Series or Class), including its good
will, to any one or more business or statutory trusts or other
business entities or series or classes thereof (including
another Series or Class of the Trust) upon such terms and
conditions and for such consideration (which may include the
assumption of some or all of the outstanding obligations and
liabilities, accrued or contingent, whether known or unknown, of
the Trust or such Series or Class) as may be authorized by the
Trustees. Without limiting the generality of the foregoing, this
provision may be utilized to permit the Trust or any Series or
Class thereof to pursue its investment program through one or
more subsidiary vehicles or to operate in a master-feeder or
fund of funds structure.
Section 10.4. Conversion. The
Trustees may authorize the creation of one or more statutory
trusts to which all or any part of the assets, liabilities,
profits, or losses of the Trust or any Series or Class thereof
may be transferred and may provide for the conversion of Shares
of the Trust or any Series or Class thereof into beneficial
interests in any such newly created trust or trusts or any
series or classes thereof.
Section 10.5. Combination
of Classes. The authority of the Trustees under
this Article X with respect to the merger, consolidation,
sale of assets or reorganization of any Series of the Trust or
any Class thereof is in addition to the authority of the
Trustees under Section 4.9 hereof to combine two or more
Classes of a Series into a single Class.
D-19
ARTICLE XI
AMENDMENTS;
FILINGS; MISCELLANEOUS
Section 11.1. Amendments
to Declaration and Certificate of
Trust. (a) The Trustees may by vote of a
majority of the Trustees then in office amend or otherwise
supplement the Declaration by making an amendment, a Declaration
supplemental hereto or an amended and restated Declaration,
provided, however, that an amendment to any provision of
Article V hereof shall require the vote of two-thirds (2/3)
of the Trustees then in office.
(b) Nothing contained in this Declaration shall permit the
amendment of this Declaration to impair the exemption from
personal liability of any Person who is or has been a
Shareholder, Trustee, officer, or employee of the Trust, or
limit the rights to indemnification or insurance provided in
Article IX with respect to actions or omissions of persons
entitled to indemnification under such Article prior to such
amendment.
(c) The Trusts Certificate of Trust may be amended at
any time for any purpose as the Trustees may determine and such
amendment shall be signed by one or more of the Trustees or by
an officer of the Trust as duly authorized by vote of a majority
of the Trustees then in office.
Section 11.2. Filing
of Certificate; Copies of Declaration; Counterparts;
Headings. Any amendment to the Certificate of
Trust shall be filed with the Secretary of State of the State of
Delaware. The original or a copy of this instrument and of each
amendment
and/or
restatement hereto shall be kept in the office of the Trust
where it may be inspected by any Shareholder. Anyone dealing
with the Trust may rely on a certificate by an officer or
Trustee of the Trust as to whether or not any such amendments or
restatements have been made and as to any matters in connection
with the Trust hereunder, and with the same effect as if it were
the original, may rely on a copy certified by an officer or
Trustee of the Trust to be a copy of this instrument or of any
such amendments or restatements. This instrument may be executed
in any number of counterparts, each of which shall be deemed an
original. Headings are placed herein for convenience of
reference only, and in case of any conflict, the text of this
instrument, rather than the headings, shall control.
Section 11.3. Trustees
May Resolve Ambiguities. The Trustees may
construe any of the provisions of this Declaration insofar as
the same may appear to be ambiguous or inconsistent with any
other provisions hereof, and any such construction hereof by the
Trustees in good faith shall be conclusive as to the meaning to
be given to such provisions.
Section 11.4. Applicable
Law; Forum Selection; Jury Waiver. (a) The
Trust set forth in this instrument is created under and is to be
governed by and construed and administered according to the laws
of the State of Delaware, without reference to its conflicts of
law rules, as a Delaware statutory trust under the Delaware Act,
and without limiting the provisions hereof, the Trust
specifically reserves the right to exercise any of the powers
and privileges afforded to statutory trusts or actions that may
be engaged in by statutory trusts under the Delaware Act, and
the absence of a specific reference herein to any such power,
privilege, or action shall not imply that the Trust may not
exercise such power or privilege or take such actions.
(b) Notwithstanding the first sentence of
Section 11.4(a) hereof, there shall not be applicable to
the Trust, the Trustees, or this Declaration any provisions of
the laws (statutory or common) of the State of Delaware (other
than the Delaware Act) or any other state pertaining to trusts,
including by way of illustration and without limitation, laws
that relate to or regulate: (i) the filing with any court
or governmental body or agency of trustee accounts or schedules
of trustee fees and charges; (ii) affirmative requirements
to post bonds for trustees, officers, agents, or employees of a
trust; (iii) the necessity for obtaining a court or other
governmental approval concerning the acquisition, holding, or
disposition of real or personal property; (iv) fees or
other sums applicable to trustees, officers, agents or employees
of a trust; (v) the allocation of receipts and expenditures
to income or principal; (vi) restrictions or limitations on
the permissible nature, amount, or concentration of trust
investments or requirements relating to the titling, storage, or
other manner of holding of trust assets; or (vii) the
establishment of fiduciary or other standards or
responsibilities or limitations on the acts or powers or
liabilities or authorities and powers of trustees if such laws
are inconsistent with the authorities and powers or the
limitation on liability of the Trustees set forth or referenced
in this Declaration.
D-20
(c) No provision of this Declaration shall be effective to
require a waiver of compliance with any provision of the
Securities Act of 1933, as amended, the Securities Exchange Act
of 1934, as amended or the 1940 Act, or of any valid rule,
regulation or order of the Commission thereunder.
(d) Subject to the Delaware Act, any action commenced by a
Shareholder, directly or derivatively, against or on behalf of
the Trust or a Series or Class thereof, its Trustees, officers,
or employees, shall be brought only in the U.S. District
Court for the Southern District of New York, or if such action
may not be brought in that court, then such action shall be
brought in the New York Supreme Court with assignment to the
Commercial Division to the extent such assignment is permitted
under the Uniform Civil Rules for the Supreme Court, including
§ 202.70 thereof (each, a Chosen Court).
The Trust, its Trustees, officers, employees and Shareholders
(a) waive any objection to venue in either Chosen Court and
(b) waive any objection that either Chosen Court is an
inconvenient forum.
(e) In any action commenced by a Shareholder against the
Trust or any Series or Class thereof, its Trustees or officers,
or as a derivative action on behalf of the Trust, or any Series
or Class thereof there shall be no right to a jury trial. THE
RIGHT TO A TRIAL BY JURY IS EXPRESSLY WAIVED TO THE FULLEST
EXTENT PERMITTED BY LAW.
Section 11.5. Statutory
Trust Only. The Trust is not intended to be,
shall not be deemed to be, and shall not be treated as, a
general or a limited partnership, joint venture, corporation or
joint stock company, nor shall the Trustees or Shareholders or
any of them for any purpose be deemed to be, or be treated in
any way whatsoever as though they were, liable or responsible
hereunder as partners or joint venturers.
Section 11.6. Provisions
in Conflict with Law or Regulations. (a) The
provisions of this Declaration are severable, and if the
Trustees shall determine, with the advice of counsel, that any
such provision, in whole or in part, conflicts with the 1940
Act, the regulated investment company provisions of the Code,
and the regulations thereunder, the Delaware Act or with other
applicable laws and regulations, the conflicting provision, or
the conflicting part or parts thereof, shall be deemed not to
constitute a part of this Declaration; provided, however, that
such determination shall not affect any of the remaining
provisions of this Declaration or render invalid or improper any
action taken or omitted prior to such determination.
(b) If any provision of this Declaration shall be held
invalid or unenforceable, in whole or in part, in any
jurisdiction, such invalidity or unenforceability shall attach
only to such provision, or such part or parts thereof, in such
jurisdiction and shall not in any manner affect such provision
in any other jurisdiction or any other provision of this
Declaration in any jurisdiction.
Section 11.7. Writings. To
the fullest extent permitted by applicable law, except as the
Trustees may otherwise determine:
(a) any requirements in this Declaration or in the Bylaws
that any action be taken by means of any writing, including,
without limitation, any written instrument, any written consent
or any written agreement, shall be deemed to be satisfied by
means of any electronic record in such form that is acceptable
to the Trustees provided such form is capable of conversion into
a written form within a reasonable time; and
(b) any requirements in this Declaration or in the Bylaws
that any writing be signed shall be deemed to be satisfied by
any electronic signature in such form that is acceptable to the
Trustees.
D-21
IN WITNESS WHEREOF, the undersigned, being the Trustees
of the Trust, have executed this instrument as of the date first
written above.
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
[Name], as Trustee
[Address]
D-22
SCHEDULE A
Series of
Shares of Beneficial Interests
(Effective
as of
[ ])
WHEREAS, the Trustees of the Trust, acting pursuant to the
Trusts agreement and declaration of trust as then in
effect, have previously established and designated one or more
series of shares of beneficial interest in the Trust (each, a
Series) pursuant to one or more designations of
series (the Prior Designations);
WHEREAS, in connection with the adoption of an Amended and
Restated Agreement and Declaration of Trust dated as of
[ ] (the
Declaration), pursuant to Section 4.9(a) of the
Declaration, the previously established and designated Series
are hereby included on this Schedule A, which
Schedule A shall be deemed an amendment and restatement of
the Prior Designations.
NOW THEREFORE, the following Series of the Trust are established
with such relative rights, preferences, privileges, limitations,
restrictions and other relative terms as are set forth below:
[ ]
1. Each Share of each Series is entitled to all the rights
and preferences accorded to Shares under the Declaration.
2. The number of authorized Shares of each Series is
unlimited.
3. Each Series shall be authorized to hold cash, invest in
securities, instruments and other property, use investment
techniques, and have such goals or objectives as from time to
time described in the prospectus and statement of additional
information contained in the Trusts then currently
effective registration statement under the Securities Act of
1933 to the extent pertaining to the offering of Shares of the
Series, as the same may be amended and supplemented from time to
time (Prospectus). Each Share of a Series shall
represent a beneficial interest in the net assets allocated or
belonging to such Series only, and such interest shall not
extend to the assets of the Trust generally (except to the
extent that General Assets (as defined in the Declaration) are
allocated to such Series), and shall be entitled to receive its
pro rata share of the net assets of the Series upon liquidation
of the Series, all as set forth in Section 4.9 of the
Declaration.
4. With respect to each Series, (a) the purchase price
of the Shares, (b) fees and expenses,
(c) qualifications for ownership, if any, (d) the
method of determination of the net asset value of the Shares,
(e) minimum purchase amounts, if any, (f) minimum
account size, if any, (g) the price, terms and manner of
redemption of the Shares, (h) any conversion or exchange
feature or privilege, (i) the relative dividend rights, and
(j) any other relative rights, preferences, privileges,
limitations, restrictions and other relative terms have been
established by the Trustees in accordance with the Declaration
and are set forth in the Prospectus with respect to such Series.
5. The Trustees may from time to time modify any of the
relative rights, preferences, privileges, limitations,
restrictions and other relative terms of a Series that have been
established by the Trustees or redesignate any of the Series
without any action or consent of the Shareholders.
6. The designation of any Series hereby shall not impair
the power of the Trustees from time to time to designate
additional Series of Shares of the Trust.
7. Capitalized terms not defined herein have the meanings
given to such terms in the Declaration.
D-23
SCHEDULE B
Designation
of Classes of Shares
(Effective
as of
[ ])
WHEREAS, the Trustees of the Trust, acting pursuant to the
Trusts agreement and declaration of trust as then in
effect, have previously established and designated one or more
series of shares of beneficial interest in the Trust (each, a
Series) and have previously established and
designated one or more classes of Shares (each, a
Class) for some or all of the Series pursuant to one
or more designations of Classes (the Prior
Designations);
WHEREAS, in connection with the adoption of an Amended and
Restated Agreement and Declaration of Trust dated as of
[ ] (the
Declaration), pursuant to Section 4.9(b) of the
Declaration, the previously established and designated Classes
are hereby included on this Schedule B, which
Schedule B shall be deemed an amendment and restatement of
the Prior Designations.
NOW THEREFORE, the following Classes as listed below with
respect to the identified Series of the Trust are established
with such relative rights, preferences, privileges, limitations,
restrictions and other relative terms as are set forth below:
1. Each Share of each Class is entitled to all the rights
and preferences accorded to Shares under the Declaration.
2. The number of authorized Shares of each Class is
unlimited.
3. All Shares of a Class of a Series shall be identical
with each other and with the Shares of each other Class of the
same Series except for such variations between Classes as may be
authorized by the Trustees from time to time and set forth in
the Trusts then currently effective registration statement
under the Securities Act of 1933 to the extent pertaining to the
offering of Shares of the Class of such Series, as the same may
be amended and supplemented from time to time
(Prospectus). The Trustees may change the name or
other designation of a Class; and take such other action with
respect to the Classes as the Trustees may deem desirable.
4. With respect to the Shares of a Class of a Series,
(a) the time and method of determining the purchase price,
(b) the fees and expenses, (c) the qualifications for
ownership, if any, (d) minimum purchase amounts, if any,
(e) minimum account size, if any, (f) the price, terms
and manner of redemption of, (g) any conversion or exchange
feature or privilege, (h) the relative dividend rights, and
(i) any other relative rights, preferences, privileges,
limitations, restrictions and other relative terms have been
established by the Trustees in accordance with the Declaration
and are set forth in the Prospectus with respect to such Class
of such Series.
5. The Trustees may from time to time modify any of the
relative rights, preferences, privileges, limitations,
restrictions and other relative terms of a Class of a Series
that have been established by the Trustees, divide or combine
the issued or unissued Shares of any Class of a Series into a
greater or lesser number; classify or reclassify any issued or
unissued Shares of any Class of a Series into one or more
Classes of such Series; combine two or more Classes of a Series
into a single Class of such Series; in each case without any
action or consent of the Shareholders.
6. The designation of any Class hereby shall not impair the
power of the Trustees from time to time to designate additional
Classes of Shares of a Series or terminate any one or more
Classes of a Series hereby designated.
7. Capitalized terms not defined herein have the meanings
given to such terms in the Declaration.
D-24
Appendix E
Audit
Fees, Audit-Related Fees, Tax Fees and All Other Fees
Audit
Fees and Audit-Related Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit-Related Fees
|
|
|
|
Audit Fees
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Prior to Most
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal
Year ($)
|
|
|
Recent Fiscal
Year End ($)
|
|
|
Fiscal
Year ($)
|
|
|
Year
End ($)
|
|
|
Transamerica IDEX Mutual
Funds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX AllianceBernstein
International Value
|
|
|
9,519
|
|
|
|
0
|
|
|
|
592
|
|
|
|
0
|
|
TA IDEX American Century Large
Company Value
|
|
|
11,716
|
|
|
|
16,329
|
|
|
|
729
|
|
|
|
2,674
|
|
TA IDEX Asset
Allocation Conservative Portfolio
|
|
|
19,083
|
|
|
|
16,888
|
|
|
|
1,187
|
|
|
|
2,766
|
|
TA IDEX Asset
Allocation Growth Portfolio
|
|
|
48,628
|
|
|
|
35,142
|
|
|
|
3,026
|
|
|
|
5,755
|
|
TA IDEX Asset
Allocation Moderate Growth Portfolio
|
|
|
90,723
|
|
|
|
68,451
|
|
|
|
5,646
|
|
|
|
11,211
|
|
TA IDEX Asset
Allocation Moderate Portfolio
|
|
|
56,541
|
|
|
|
47,362
|
|
|
|
3,518
|
|
|
|
7,757
|
|
TA IDEX Bjurman, Barry Micro
Emerging Growth
|
|
|
1,573
|
|
|
|
0
|
|
|
|
98
|
|
|
|
0
|
|
TA IDEX BlackRock Global Allocation
|
|
|
14,121
|
|
|
|
0
|
|
|
|
879
|
|
|
|
0
|
|
TA IDEX BlackRock Large Cap Value
|
|
|
17,860
|
|
|
|
11,777
|
|
|
|
1,111
|
|
|
|
1,929
|
|
TA IDEX BlackRock Natural
Resources*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Clarion Global Real Estate
Securities
|
|
|
6,481
|
|
|
|
5,413
|
|
|
|
403
|
|
|
|
887
|
|
TA IDEX Evergreen Health Care
|
|
|
15,863
|
|
|
|
12,726
|
|
|
|
987
|
|
|
|
2,084
|
|
TA IDEX Evergreen International
Small Cap
|
|
|
12,472
|
|
|
|
8,931
|
|
|
|
776
|
|
|
|
1,463
|
|
TA IDEX Federated Market
Opportunity
|
|
|
3,520
|
|
|
|
0
|
|
|
|
219
|
|
|
|
0
|
|
TA IDEX Jennison Growth
|
|
|
5,477
|
|
|
|
4,345
|
|
|
|
341
|
|
|
|
712
|
|
TA IDEX JPMorgan International Bond
|
|
|
18,415
|
|
|
|
0
|
|
|
|
1,146
|
|
|
|
0
|
|
TA IDEX JPMorgan Mid Cap Value
|
|
|
9,516
|
|
|
|
6,041
|
|
|
|
592
|
|
|
|
989
|
|
TA IDEX Legg Mason Partners All Cap
|
|
|
6,415
|
|
|
|
18,715
|
|
|
|
399
|
|
|
|
3,065
|
|
TA IDEX Legg Mason Partners
Investors Value
|
|
|
4,362
|
|
|
|
11,998
|
|
|
|
271
|
|
|
|
1,965
|
|
TA IDEX Loomis Sayles
Bond*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Marsico Growth
|
|
|
5,776
|
|
|
|
4,631
|
|
|
|
359
|
|
|
|
758
|
|
E-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit-Related Fees
|
|
|
|
Audit Fees
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Prior to Most
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal
Year ($)
|
|
|
Recent Fiscal
Year End ($)
|
|
|
Fiscal
Year ($)
|
|
|
Year
End ($)
|
|
|
TA IDEX Marsico International
Growth
|
|
|
13,596
|
|
|
|
11,686
|
|
|
|
846
|
|
|
|
1,914
|
|
TA IDEX Mellon Market Neutral
Strategy*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX MFS International Equity
|
|
|
2,655
|
|
|
|
5,909
|
|
|
|
165
|
|
|
|
968
|
|
TA IDEX Multi-Manager Alternative
Strategies
Fund*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Multi-Manager
International Fund
|
|
|
3,472
|
|
|
|
0
|
|
|
|
216
|
|
|
|
0
|
|
TA IDEX Neuberger Berman
International
|
|
|
17,205
|
|
|
|
0
|
|
|
|
1,071
|
|
|
|
0
|
|
TA IDEX Oppenheimer Developing
Markets
|
|
|
13,077
|
|
|
|
0
|
|
|
|
814
|
|
|
|
0
|
|
TA IDEX Oppenheimer Small- &
Mid-Cap Value
|
|
|
3,246
|
|
|
|
0
|
|
|
|
202
|
|
|
|
0
|
|
TA IDEX PIMCO Real Return TIPS
|
|
|
25,576
|
|
|
|
22,872
|
|
|
|
1,592
|
|
|
|
3,746
|
|
TA IDEX PIMCO Total Return
|
|
|
9,897
|
|
|
|
6,290
|
|
|
|
616
|
|
|
|
1,030
|
|
TA IDEX Protected Principal Stock
|
|
|
1,750
|
|
|
|
2,104
|
|
|
|
109
|
|
|
|
345
|
|
TA IDEX Templeton Transamerica
Global
|
|
|
5,266
|
|
|
|
20,102
|
|
|
|
328
|
|
|
|
3,292
|
|
TA IDEX Third Avenue
Value*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Balanced
|
|
|
4,946
|
|
|
|
11,128
|
|
|
|
308
|
|
|
|
1,822
|
|
TA IDEX Transamerica Convertible
Securities
|
|
|
8,505
|
|
|
|
8,902
|
|
|
|
529
|
|
|
|
1,458
|
|
TA IDEX Transamerica Equity
|
|
|
30,906
|
|
|
|
12,358
|
|
|
|
1,923
|
|
|
|
2,024
|
|
TA IDEX Transamerica Flexible
Income
|
|
|
13,390
|
|
|
|
10,666
|
|
|
|
833
|
|
|
|
1,747
|
|
TA IDEX Transamerica Growth
Opportunities
|
|
|
20,428
|
|
|
|
13,614
|
|
|
|
1,271
|
|
|
|
2,230
|
|
TA IDEX Transamerica High-Yield
Bond
|
|
|
19,532
|
|
|
|
17,248
|
|
|
|
1,215
|
|
|
|
2,825
|
|
TA IDEX Transamerica Money Market
|
|
|
63,057
|
|
|
|
7,937
|
|
|
|
3,924
|
|
|
|
1,300
|
|
TA IDEX Transamerica
Science & Technology
|
|
|
8,327
|
|
|
|
3,587
|
|
|
|
518
|
|
|
|
587
|
|
TA IDEX Transamerica Short-Term
Bond
|
|
|
13,813
|
|
|
|
7,979
|
|
|
|
860
|
|
|
|
1,307
|
|
TA IDEX Transamerica Small/Mid Cap
Value
|
|
|
14,237
|
|
|
|
17,287
|
|
|
|
886
|
|
|
|
2,831
|
|
TA IDEX Transamerica Value Balanced
|
|
|
2,396
|
|
|
|
3,040
|
|
|
|
149
|
|
|
|
498
|
|
E-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit-Related Fees
|
|
|
|
Audit Fees
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Prior to Most
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal
Year ($)
|
|
|
Recent Fiscal
Year End ($)
|
|
|
Fiscal
Year ($)
|
|
|
Year
End ($)
|
|
|
TA IDEX UBS Dynamic
Alpha*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX UBS Large Cap Value
|
|
|
7,516
|
|
|
|
5,129
|
|
|
|
468
|
|
|
|
840
|
|
TA IDEX Van Kampen Emerging
Markets Debt
|
|
|
15,375
|
|
|
|
5,336
|
|
|
|
957
|
|
|
|
874
|
|
TA IDEX Van Kampen Mid-Cap Growth
|
|
|
2,531
|
|
|
|
0
|
|
|
|
158
|
|
|
|
0
|
|
TA IDEX Van Kampen Small Company
Growth
|
|
|
10,034
|
|
|
|
3,051
|
|
|
|
624
|
|
|
|
500
|
|
AEGON/Transamerica
Series Trust
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
American Century Large Company
Value
|
|
|
3,062
|
|
|
|
4,168
|
|
|
|
226
|
|
|
|
186
|
|
Asset Allocation
Conservative Portfolio
|
|
|
18,586
|
|
|
|
14,358
|
|
|
|
1,372
|
|
|
|
642
|
|
Asset Allocation
Growth Portfolio
|
|
|
32,671
|
|
|
|
21,992
|
|
|
|
2,412
|
|
|
|
983
|
|
Asset Allocation
Moderate Growth Portfolio
|
|
|
81,195
|
|
|
|
49,409
|
|
|
|
5,993
|
|
|
|
2,209
|
|
Asset Allocation
Moderate Portfolio
|
|
|
57,226
|
|
|
|
40,979
|
|
|
|
4,224
|
|
|
|
1,832
|
|
BlackRock Large Cap Value
|
|
|
23,931
|
|
|
|
16,079
|
|
|
|
1,766
|
|
|
|
719
|
|
Capital Guardian Global
|
|
|
5,431
|
|
|
|
8,744
|
|
|
|
401
|
|
|
|
391
|
|
Capital Guardian U.S. Equity
|
|
|
6,334
|
|
|
|
5,849
|
|
|
|
468
|
|
|
|
262
|
|
Capital Guardian Value
|
|
|
18,348
|
|
|
|
17,666
|
|
|
|
1,354
|
|
|
|
790
|
|
Clarion Global Real Estate
Securities
|
|
|
18,303
|
|
|
|
9,703
|
|
|
|
1,351
|
|
|
|
434
|
|
Federated Market Opportunity
|
|
|
13,962
|
|
|
|
12,129
|
|
|
|
1,031
|
|
|
|
542
|
|
International Moderate Growth Fund
|
|
|
527
|
|
|
|
0
|
|
|
|
39
|
|
|
|
0
|
|
Jennison Growth
|
|
|
3,485
|
|
|
|
2,935
|
|
|
|
257
|
|
|
|
131
|
|
JPMorgan Core Bond
|
|
|
4,341
|
|
|
|
4,699
|
|
|
|
320
|
|
|
|
210
|
|
JPMorgan Enhanced Index
|
|
|
4,700
|
|
|
|
4,825
|
|
|
|
347
|
|
|
|
216
|
|
JPMorgan Mid Cap Value
|
|
|
8,261
|
|
|
|
7,843
|
|
|
|
610
|
|
|
|
351
|
|
Legg Mason Partners All Cap
|
|
|
9,084
|
|
|
|
12,292
|
|
|
|
671
|
|
|
|
550
|
|
Marsico Growth
|
|
|
4,928
|
|
|
|
3,801
|
|
|
|
364
|
|
|
|
170
|
|
MFS High Yield
|
|
|
10,307
|
|
|
|
13,658
|
|
|
|
761
|
|
|
|
611
|
|
MFS International Equity
|
|
|
7,758
|
|
|
|
5,443
|
|
|
|
573
|
|
|
|
243
|
|
Munder Net50
|
|
|
2,651
|
|
|
|
2,031
|
|
|
|
196
|
|
|
|
91
|
|
PIMCO Total Return
|
|
|
19,228
|
|
|
|
15,253
|
|
|
|
1,419
|
|
|
|
682
|
|
Templeton Transamerica Global
|
|
|
14,277
|
|
|
|
13,391
|
|
|
|
1,054
|
|
|
|
599
|
|
Third Avenue Value
|
|
|
26,769
|
|
|
|
15,729
|
|
|
|
1,976
|
|
|
|
703
|
|
Transamerica Balanced
|
|
|
1,858
|
|
|
|
1,462
|
|
|
|
137
|
|
|
|
65
|
|
E-3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Audit-Related Fees
|
|
|
|
Audit Fees
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Prior to Most
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal
Year ($)
|
|
|
Recent Fiscal
Year End ($)
|
|
|
Fiscal
Year ($)
|
|
|
Year
End ($)
|
|
|
Transamerica Convertible Securities
|
|
|
10,129
|
|
|
|
8,066
|
|
|
|
748
|
|
|
|
361
|
|
Transamerica Equity
|
|
|
49,036
|
|
|
|
28,287
|
|
|
|
3,619
|
|
|
|
1,265
|
|
Transamerica Equity II
|
|
|
472
|
|
|
|
423
|
|
|
|
35
|
|
|
|
19
|
|
Transamerica Growth Opportunities
|
|
|
12,028
|
|
|
|
8,956
|
|
|
|
888
|
|
|
|
400
|
|
Transamerica Money Market
|
|
|
11,397
|
|
|
|
12,644
|
|
|
|
841
|
|
|
|
565
|
|
Transamerica Science &
Technology
|
|
|
3,466
|
|
|
|
4,113
|
|
|
|
256
|
|
|
|
184
|
|
Transamerica Small/Mid Cap Value
|
|
|
10,310
|
|
|
|
9,457
|
|
|
|
761
|
|
|
|
423
|
|
Transamerica U.S. Government
Securities
|
|
|
4,513
|
|
|
|
4,640
|
|
|
|
333
|
|
|
|
207
|
|
Transamerica Value Balanced
|
|
|
10,961
|
|
|
|
10,913
|
|
|
|
809
|
|
|
|
488
|
|
T. Rowe Price Equity Income
|
|
|
19,795
|
|
|
|
20,837
|
|
|
|
1,461
|
|
|
|
932
|
|
T. Rowe Price Growth Stock
|
|
|
7,285
|
|
|
|
7,139
|
|
|
|
538
|
|
|
|
319
|
|
T. Rowe Price Small Cap
|
|
|
7,319
|
|
|
|
6,873
|
|
|
|
540
|
|
|
|
307
|
|
Van Kampen Active International
Allocation
|
|
|
5,244
|
|
|
|
3,752
|
|
|
|
387
|
|
|
|
168
|
|
Van Kampen Large Cap Core
|
|
|
4,635
|
|
|
|
4,756
|
|
|
|
342
|
|
|
|
213
|
|
Van Kampen Mid-Cap Growth
|
|
|
15,187
|
|
|
|
14,570
|
|
|
|
1,121
|
|
|
|
651
|
|
Transamerica Income Shares,
Inc.
|
|
|
36,000
|
|
|
|
34,000
|
|
|
|
1,000
|
|
|
|
1,000
|
|
|
|
|
|
|
Does not include the following
aggregate fees paid by TA IDEX on behalf of funds that have
ceased operations: $2,207 and $54,029 in audit fees for the most
recent fiscal year and the prior fiscal year, respectively, and
$137 and $8,849 in audit-related fees for the most recent fiscal
year and the prior fiscal year, respectively. Does not include
the following aggregate fees paid by ATST on behalf of funds
that have ceased operations: $42,135 in audit fees and $1,884 in
audit-related fees for the fiscal year prior to the most recent
fiscal year.
|
|
*
|
|
Fund commenced operations since the
end of the most recent fiscal year.
|
E-4
Tax Fees
and All Other Fees
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax Fees
|
|
|
All Other Fees
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Prior to Most
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal Year End
($)
|
|
|
Year
End ($)
|
|
|
Fiscal Year End ($)
|
|
|
Year End ($)
|
|
|
Transamerica IDEX Mutual
Funds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX AllianceBernstein
International Value
|
|
|
2,080
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX American Century Large
Company Value
|
|
|
2,560
|
|
|
|
2,171
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Asset
Allocation Conservative Portfolio
|
|
|
4,170
|
|
|
|
2,245
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Asset
Allocation Growth Portfolio
|
|
|
10,626
|
|
|
|
4,672
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Asset
Allocation Moderate Growth Portfolio
|
|
|
19,825
|
|
|
|
9,100
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Asset
Allocation Moderate Portfolio
|
|
|
12,356
|
|
|
|
6,297
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Bjurman, Barry Micro
Emerging Growth
|
|
|
344
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX BlackRock Global Allocation
|
|
|
3,086
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX BlackRock Large Cap Value
|
|
|
3,903
|
|
|
|
1,566
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX BlackRock Natural
Resources*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Clarion Global Real Estate
Securities
|
|
|
1,416
|
|
|
|
720
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Evergreen Health Care
|
|
|
3,466
|
|
|
|
1,692
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Evergreen International
Small Cap
|
|
|
2,725
|
|
|
|
1,187
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Federated Market
Opportunity
|
|
|
769
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Jennison Growth
|
|
|
1,197
|
|
|
|
578
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX JPMorgan International Bond
|
|
|
4,024
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX JPMorgan Mid Cap Value
|
|
|
2,079
|
|
|
|
803
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Legg Mason Partners All Cap
|
|
|
1,402
|
|
|
|
2,488
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Legg Mason Partners
Investors Value
|
|
|
953
|
|
|
|
1,595
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Loomis Sayles
Bond*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Marsico Growth
|
|
|
1,262
|
|
|
|
616
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Marsico International
Growth
|
|
|
2,971
|
|
|
|
1,554
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Mellon Market Neutral
Strategy*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX MFS International Equity
|
|
|
580
|
|
|
|
786
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Multi-Manager Alternative
Strategies
Fund*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
E-5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax Fees
|
|
|
All Other Fees
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Prior to Most
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal Year End
($)
|
|
|
Year
End ($)
|
|
|
Fiscal Year End ($)
|
|
|
Year End ($)
|
|
|
TA IDEX Multi-Manager
International Fund
|
|
|
759
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Neuberger Berman
International
|
|
|
3,760
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Oppenheimer Developing
Markets
|
|
|
2,858
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Oppenheimer Small- &
Mid-Cap Value
|
|
|
709
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX PIMCO Real Return TIPS
|
|
|
5,589
|
|
|
|
3,041
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX PIMCO Total Return
|
|
|
2,163
|
|
|
|
836
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Protected Principal Stock
|
|
|
382
|
|
|
|
280
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Templeton Transamerica
Global
|
|
|
1,151
|
|
|
|
2,673
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Third Avenue
Value*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Balanced
|
|
|
1,081
|
|
|
|
1,479
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Convertible
Securities
|
|
|
1,859
|
|
|
|
1,184
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Equity
|
|
|
6,754
|
|
|
|
1,643
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Flexible
Income
|
|
|
2,926
|
|
|
|
1,418
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Growth
Opportunities
|
|
|
4,464
|
|
|
|
1,810
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica High-Yield
Bond
|
|
|
4,268
|
|
|
|
2,293
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Money Market
|
|
|
13,779
|
|
|
|
1,055
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica
Science & Technology
|
|
|
1,820
|
|
|
|
477
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Short-Term
Bond
|
|
|
3,018
|
|
|
|
1,061
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Small/Mid Cap
Value
|
|
|
3,111
|
|
|
|
2,298
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Transamerica Value Balanced
|
|
|
524
|
|
|
|
404
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX UBS Dynamic
Alpha*
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX UBS Large Cap Value
|
|
|
1,642
|
|
|
|
682
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Van Kampen Emerging
Markets Debt
|
|
|
3,360
|
|
|
|
709
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Van Kampen Mid-Cap Growth
|
|
|
553
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
TA IDEX Van Kampen Small Company
Growth
|
|
|
2,193
|
|
|
|
406
|
|
|
|
0
|
|
|
|
0
|
|
AEGON/Transamerica
Series Trust
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
American Century Large Company
Value
|
|
|
339
|
|
|
|
330
|
|
|
|
0
|
|
|
|
0
|
|
E-6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax Fees
|
|
|
All Other Fees
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Prior to Most
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal Year End
($)
|
|
|
Year
End ($)
|
|
|
Fiscal Year End ($)
|
|
|
Year End ($)
|
|
|
Asset Allocation
Conservative Portfolio
|
|
|
2,058
|
|
|
|
1,138
|
|
|
|
0
|
|
|
|
0
|
|
Asset Allocation
Growth Portfolio
|
|
|
3,617
|
|
|
|
1,743
|
|
|
|
0
|
|
|
|
0
|
|
Asset Allocation
Moderate Growth Portfolio
|
|
|
8,990
|
|
|
|
3,917
|
|
|
|
0
|
|
|
|
0
|
|
Asset Allocation
Moderate Portfolio
|
|
|
6,336
|
|
|
|
3,248
|
|
|
|
0
|
|
|
|
0
|
|
BlackRock Large Cap Value
|
|
|
2,650
|
|
|
|
1,275
|
|
|
|
0
|
|
|
|
0
|
|
Capital Guardian Global
|
|
|
601
|
|
|
|
693
|
|
|
|
0
|
|
|
|
0
|
|
Capital Guardian U.S. Equity
|
|
|
701
|
|
|
|
464
|
|
|
|
0
|
|
|
|
0
|
|
Capital Guardian Value
|
|
|
2,031
|
|
|
|
1,400
|
|
|
|
0
|
|
|
|
0
|
|
Clarion Global Real Estate
Securities
|
|
|
2,026
|
|
|
|
769
|
|
|
|
0
|
|
|
|
0
|
|
Federated Market Opportunity
|
|
|
1,546
|
|
|
|
961
|
|
|
|
0
|
|
|
|
0
|
|
International Moderate Growth Fund
|
|
|
58
|
|
|
|
0
|
|
|
|
0
|
|
|
|
0
|
|
Jennison Growth
|
|
|
386
|
|
|
|
233
|
|
|
|
0
|
|
|
|
0
|
|
JPMorgan Core Bond
|
|
|
481
|
|
|
|
373
|
|
|
|
0
|
|
|
|
0
|
|
JPMorgan Enhanced Index
|
|
|
520
|
|
|
|
382
|
|
|
|
0
|
|
|
|
0
|
|
JPMorgan Mid Cap Value
|
|
|
915
|
|
|
|
622
|
|
|
|
0
|
|
|
|
0
|
|
Legg Mason Partners All Cap
|
|
|
1,006
|
|
|
|
974
|
|
|
|
0
|
|
|
|
0
|
|
Marsico Growth
|
|
|
546
|
|
|
|
301
|
|
|
|
0
|
|
|
|
0
|
|
MFS High Yield
|
|
|
1,141
|
|
|
|
1,083
|
|
|
|
0
|
|
|
|
0
|
|
MFS International Equity
|
|
|
859
|
|
|
|
431
|
|
|
|
0
|
|
|
|
0
|
|
Munder Net50
|
|
|
294
|
|
|
|
161
|
|
|
|
0
|
|
|
|
0
|
|
PIMCO Total Return
|
|
|
2,129
|
|
|
|
1,209
|
|
|
|
0
|
|
|
|
0
|
|
Templeton Transamerica Global
|
|
|
1,581
|
|
|
|
1,061
|
|
|
|
0
|
|
|
|
0
|
|
Third Avenue Value
|
|
|
2,964
|
|
|
|
1,247
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Balanced
|
|
|
206
|
|
|
|
116
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Convertible Securities
|
|
|
1,121
|
|
|
|
639
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Equity
|
|
|
5,429
|
|
|
|
2,242
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Equity II
|
|
|
52
|
|
|
|
34
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Growth Opportunities
|
|
|
1,332
|
|
|
|
710
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Money Market
|
|
|
1,262
|
|
|
|
1,002
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Science &
Technology
|
|
|
384
|
|
|
|
326
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Small/Mid Cap Value
|
|
|
1,141
|
|
|
|
750
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica U.S. Government
Securities
|
|
|
500
|
|
|
|
368
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Value Balanced
|
|
|
1,214
|
|
|
|
865
|
|
|
|
0
|
|
|
|
0
|
|
T. Rowe Price Equity Income
|
|
|
2,192
|
|
|
|
1,652
|
|
|
|
0
|
|
|
|
0
|
|
E-7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tax Fees
|
|
|
All Other Fees
|
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
Fiscal Year
|
|
|
|
|
|
|
Prior to Most
|
|
|
|
|
|
Prior to Most
|
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
|
Most Recent
|
|
|
Recent Fiscal
|
|
Fund
|
|
Fiscal Year End
($)
|
|
|
Year
End ($)
|
|
|
Fiscal Year End ($)
|
|
|
Year End ($)
|
|
|
T. Rowe Price Growth Stock
|
|
|
807
|
|
|
|
566
|
|
|
|
0
|
|
|
|
0
|
|
T. Rowe Price Small Cap
|
|
|
810
|
|
|
|
545
|
|
|
|
0
|
|
|
|
0
|
|
Van Kampen Active International
Allocation
|
|
|
581
|
|
|
|
297
|
|
|
|
0
|
|
|
|
0
|
|
Van Kampen Large Cap Core
|
|
|
513
|
|
|
|
377
|
|
|
|
0
|
|
|
|
0
|
|
Van Kampen Mid-Cap Growth
|
|
|
1,682
|
|
|
|
1,155
|
|
|
|
0
|
|
|
|
0
|
|
Transamerica Income Shares,
Inc.
|
|
|
1,000
|
|
|
|
1,000
|
|
|
|
0
|
|
|
|
0
|
|
|
|
|
|
|
Does not include the following
aggregate fees paid by TA IDEX on behalf of funds that ceased
operations prior to the most recent fiscal year end: $482 and
$7,183 in tax fees for the most recent fiscal year and the prior
fiscal year, respectively. Does not include the following
aggregate fees paid by ATST on behalf of funds that ceased
operations prior to the most recent fiscal year end: $3,340 in
tax fees for the fiscal year prior to the most recent fiscal
year.
|
|
*
|
|
Fund commenced operations since the
end of the most recent fiscal year.
|
E-8
Appendix F
Beneficial
Owners of 5% or More of the Outstanding Shares of the
Funds
As of August 15, 2007, the following persons owned of record the
amounts indicated of each applicable Fund:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Fund
|
|
Ownership (%)
|
|
|
Name
|
|
|
Address
|
|
|
Transamerica IDEX Mutual
Funds
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX AllianceBernstein
International Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX American Century Large
Company Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Asset
Allocation Conservative Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Asset
Allocation Growth Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Asset
Allocation Moderate Growth Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Asset
Allocation Moderate Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Bjurman, Barry Micro
Emerging Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX BlackRock Global Allocation
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX BlackRock Large Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX BlackRock Natural Resources
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Clarion Global Real Estate
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Evergreen Health Care
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Evergreen International
Small Cap
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Federated Market
Opportunity
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Jennison Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX JPMorgan International Bond
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX JPMorgan Mid Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Legg Mason Partners All Cap
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Legg Mason Partners
Investors Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Loomis Sayles Bond
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Marsico Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Marsico International
Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Mellon Market Neutral
Strategy
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX MFS International Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Multi-Manager Alternative
Strategies Fund
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Multi-Manager
International Fund
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Neuberger Berman
International
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Oppenheimer Developing
Markets
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Oppenheimer Small- &
Mid-Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX PIMCO Real Return TIPS
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX PIMCO Total Return
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Protected Principal Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Templeton Transamerica
Global
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Third Avenue Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Balanced
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Convertible
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
F-1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Fund
|
|
Ownership (%)
|
|
|
Name
|
|
|
Address
|
|
|
TA IDEX Transamerica Flexible
Income
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Growth
Opportunities
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica High-Yield
Bond
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Money Market
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica
Science & Technology
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Short-Term
Bond
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Small/Mid Cap
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Transamerica Value Balanced
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX UBS Dynamic Alpha
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX UBS Large Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Van Kampen Emerging
Markets Debt
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Van Kampen Mid-Cap Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
TA IDEX Van Kampen Small Company
Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
AEGON/Transamerica
Series Trust
|
|
|
|
|
|
|
|
|
|
|
|
|
American Century Large Company
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Allocation
Conservative Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Allocation
Growth Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Allocation
Moderate Growth Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
Asset Allocation
Moderate Portfolio
|
|
|
|
|
|
|
|
|
|
|
|
|
BlackRock Large Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Guardian Global
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Guardian U.S. Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Guardian Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Clarion Global Real Estate
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Federated Market Opportunity
|
|
|
|
|
|
|
|
|
|
|
|
|
International Moderate Growth Fund
|
|
|
|
|
|
|
|
|
|
|
|
|
Jennison Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
JPMorgan Core Bond
|
|
|
|
|
|
|
|
|
|
|
|
|
JPMorgan Enhanced Index
|
|
|
|
|
|
|
|
|
|
|
|
|
JPMorgan Mid Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Legg Mason Partners All Cap
|
|
|
|
|
|
|
|
|
|
|
|
|
Marsico Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
MFS High Yield
|
|
|
|
|
|
|
|
|
|
|
|
|
MFS International Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Munder Net50
|
|
|
|
|
|
|
|
|
|
|
|
|
PIMCO Total Return
|
|
|
|
|
|
|
|
|
|
|
|
|
Templeton Transamerica Global
|
|
|
|
|
|
|
|
|
|
|
|
|
Third Avenue Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Balanced
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Convertible Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Equity II
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Growth Opportunities
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Money Market
|
|
|
|
|
|
|
|
|
|
|
|
|
F-2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage
|
|
|
|
|
|
|
|
Fund
|
|
Ownership (%)
|
|
|
Name
|
|
|
Address
|
|
|
Transamerica Science &
Technology
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Small/Mid Cap Value
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica U.S. Government
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Value Balanced
|
|
|
|
|
|
|
|
|
|
|
|
|
T. Rowe Price Equity Income
|
|
|
|
|
|
|
|
|
|
|
|
|
T. Rowe Price Growth Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
T. Rowe Price Small Cap
|
|
|
|
|
|
|
|
|
|
|
|
|
Van Kampen Active International
Allocation
|
|
|
|
|
|
|
|
|
|
|
|
|
Van Kampen Large Cap Core
|
|
|
|
|
|
|
|
|
|
|
|
|
Van Kampen Mid-Cap Growth
|
|
|
|
|
|
|
|
|
|
|
|
|
Transamerica Income Shares,
Inc.
|
|
|
|
|
|
|
|
|
|
|
|
|
F-3
FORM OF
PROXY CARD*
Transamerica IDEX Mutual Funds
AEGON/Transamerica Series Trust
Transamerica Income Shares, Inc.
(Each an
Investment Company and collectively, the
Investment Companies)
570
Carillon Parkway
St. Petersburg, Florida 33716
PROXY FOR
A SPECIAL MEETING OF SHAREHOLDERS ON OCTOBER 30, 2007
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARDS OF THE FUND(S)
LISTED BELOW
The undersigned hereby appoints each of John Carter, Dennis P.
Gallagher, Elizabeth L. Belanger or any of them, as Proxies of
the undersigned with full power of substitution, to vote and act
with respect to all shares in each series of the Investment
Companies with respect to which the undersigned is entitled to
vote at the Special Meeting of shareholders of each such series
to be held at the offices of Transamerica Fund Advisors,
Inc., 570 Carillon Parkway, St. Petersburg, Florida 33716,
on October 30, 2007, at 11:00 a.m. (Eastern time),
and at any adjournment or postponement thereof.
This proxy will be voted as instructed. If no specification is
made for a proposal, the proxy will be voted FOR the
proposal. The proxies are authorized in their discretion to vote
upon such other matters as may come before the meeting or any
adjournment or postponement thereof.
Please vote, date and sign this proxy and return it promptly in
the enclosed envelope.
Please indicate your vote by an x in the appropriate
box below.
Proxy
Voting Instructions
The Investment Companies encourage all shareholders to provide
voting instructions. We now provide the following convenient
methods of voting:
1. PROXY CARD: Complete, sign, date and return the proxy
card attached below in the enclosed postage-paid envelope by
following the enclosed instructions; or
2. TELEPHONE; or
3. INTERNET.
[Proxy solicitor to provide telephone number and URL]
If you choose to provide voting instructions by telephone or via
the Internet, do not return your proxy card unless you
later decide to change your instructions.
THE BOARD OF
EACH INVESTMENT COMPANY RECOMMENDS A VOTE FOR THE
FOLLOWING PROPOSALS.
FUNDS
[Name of applicable Fund]
[Name of applicable Fund]
[Name of applicable Fund]
|
|
* |
This form of proxy card lists all proposals that have been
approved by the Boards. Shareholders are only being asked to
vote on those proposals relevant to them. The proxy card that
each shareholder receives will be tailored to indicate the
Fund(s) in which that shareholder has shares and will list only
those proposals with respect to which the shareholder is
entitled to vote.
|
[Voting
options to be provided for each Fund applicable to a
shareholder]
I. To elect a new Board.
Nominees:
(01) Leo J. Hill
(02) Russell A. Kimball, Jr.
(03) Norm R. Nielsen
(04) John W. Waechter
(05) Neal M. Jewell
(06) Eugene M. Mannella
(07) Joyce Galpern Narden
(08) Patricia L. Sawyer
(09) John K. Carter
[Name of Applicable
Fund] o FOR
ALL o AGAINST
ALL o FOR
ALL
EXCEPT
[Name of Applicable
Fund] o FOR
ALL o AGAINST
ALL o FOR
ALL
EXCEPT
[Name of Applicable
Fund] o FOR
ALL o AGAINST
ALL o FOR
ALL
EXCEPT
If you do not wish your shares voted FOR a
particular Nominee, mark the FOR ALL EXCEPT box and
write the Nominees number on the line provided below. Your
shares will be voted for the remaining Nominee(s).
II. To approve amendment to the Agreement and
Declaration of Trust.
[Name of Applicable
Fund] o FOR o AGAINST o ABSTAIN
[Name of Applicable
Fund] o FOR o AGAINST o ABSTAIN
[Name of Applicable
Fund] o FOR o AGAINST o ABSTAIN
The undersigned hereby revokes any prior proxy and acknowledges
receipt of the Notice of Special Meeting of Shareholders and the
Joint Proxy Statement.
|
|
|
|
|
Date
|
Signature
(if held jointly)
|
|
Date
|
This proxy must be signed exactly as your name(s) appears
hereon. If as an attorney, executor, guardian or in some
representative capacity or as an officer of a corporation,
please add titles as such. Joint owners must each sign.